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Abstract
The ubiquitin-proteasome system (UPS) and autophagy are essential pathways for
maintaining protein quality control (PQC) in cells. Misfolded proteins and large
aggregates are cleared by UPS and autophagy signaled by ubiquitin (Ub) or
polyubiquitin (polyUb) chains. Shuttle proteins facilitate cargo transporting by interacting
with both ubiquitin and degradation machineries. Previously, our lab discovered that the
shuttle protein Ubiquilin-2 (UBQLN2) is recruited to stress granules in cells and
undergoes liquid-liquid phase separation (LLPS) in vitro. LLPS is a biophysical process
by which proteins separate themselves from the surrounding aqueous solution by
forming protein-rich droplets. The overarching goals of this work are to understand how
the UBQLN family of proteins form droplets via phase separation, as well as how
UBQLN2 LLPS is regulated by interactions with protein quality control (PQC) proteins,
specifically Ub and polyUb chains.
Chapter two focused on studying the molecular driving forces of UBQLN2 LLPS.
Previously, our lab identified residues of UBQLN2 that promote self-interactions and
phase separation, which are called “stickers” and the sequences separating stickers are
called “spacers”. Here, I systematically introduced all 19 single amino acid substitutions
at three “stickers” and two “spacers”, leading to a UBQLN2 library of 95 point mutants.
By screening for the phase transitions of these proteins and mapping out phase
diagrams, we discovered that the LLPS of UBQLN2 is largely driven by hydrophobic

amino acids in the sticker positions but not spacers. Amino acid substitutions in the
sticker positions significantly changed the shape of the phase diagram as well as the
characteristics of the dense phase, which is the protein-rich phase inside the
condensates.
PolyUb chains of different linkages have different functions in cells. Preliminary data
from our lab suggest that K48-linked and K63-linked polyubiquitin chains differentially
modulate UBQLN2 LLPS. Chapter three revealed how interactions between UBQLN2
and polyUb chains affect UBQLN2 functionality and its ability to phase separate. The
data suggest that polyUb chains of different linkages differentially modulate UBQLN2
LLPS. I found that the compact Ub4 chains (K11 and K48) largely drive disassembly of
UBQLN2 condensates, while extended and more flexible Ub4 chains (K63 and M1)
promote multi-component LLPS via heterotypic interactions with UBQLN2.
The UBQLN family consists of 5 protein members (UBQLN1-4 and UBQLNL), with
highly conserved sequences and structures. Besides UBQLN2, UBQLN4 also plays a
role in PQC. However, the phase behavior of UBQLN4 is largely unknown, as well as
the sequence and structural basis for the phase behavior of the protein. In chapter four,
I characterize the LLPS properties of UBQLN4 for the first time and compare its
behavior with UBQLN2. I successfully designed, cloned, expressed, and purified various
UBQLN4 C-terminal deletion constructs. Turbidity assay data suggest that the LLPS
behavior of UBQLN4 constructs is concentration- and temperature-dependent, like

UBQLN2, but in a different manner than UBQLN2 equivalent constructs. More stringent
studies are needed to unravel the differences in LLPS behavior of different UBQLNs.
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Chapter I: Introduction

Portions of this chapter have been previously published and reprinted with permission
from the publisher. Reference: (Yang et al., 2019; Zheng et al., 2020).

Zheng, T.*, Yang, Y.*, and Castañeda, C.A. (2020). Structure, dynamics and functions of
UBQLNs: at the crossroads of protein quality control machinery. Biochem J 477, 3471–
3497. *These authors contributed equally.

Yang, Y., Jones, H.B., Dao, T.P., and Castañeda, C.A. (2019). Single Amino Acid
Substitutions in Stickers, but Not Spacers, Substantially Alter UBQLN2 Phase
Transitions and Dense Phase Material Properties. J. Phys. Chem. B 123, 3618–3629.
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1.1 Protein quality control is essential to maintaining cell health
Eukaryotic cells must contend with wide diversity of misfolded forms of proteins to
maintain the integrity of the proteome for cell viability. Elaborate protein quality control
(PQC) strategies have evolved to monitor and maintain protein homeostasis, which
involved protein degradation factors as well as molecular chaperones (Bukau et al.,
2006; Frydman, 2001; Hartl and Hayer-Hartl, 2009). Folding of secondary proteins
generally take place in the endoplasmic reticulum (ER) (Anken and Braakman, 2005).
Due to stress conditions, stochastic fluctuations, mutations and metabolic challenges,
which typically take place during cancer or aging (Chen et al., 2011; Hartl and HayerHartl, 2009), folding of secondary protein in ER is quite challenging. Failing to correctly
fold causes accumulation of misfolded proteins, which can be deleterious to the cell,
partially because they interact with some cellular components and may accumulate into
protein inclusions and aggregates that may cause potential cellular toxicity (Chen et al.,
2011; Lansbury and Lashuel, 2006). The exact underlying mechanism of how misfolded
proteins lead to toxicity are not completely understood, but it has been shown that the
misfolded proteins have a higher tendency to aggregate (Dobson, 2003). Protein
aggregates or inclusions have been considered as a pathological hallmark of many
neurodegenerative disorders, including Alzheimer's disease (AD), Huntington’s disease
(HD), Parkinson’s disease (PD), and Amyotrophic Lateral Sclerosis (ALS) (Deng et al.,
2

2011; Lansbury and Lashuel, 2006). These neurodegenerative diseases are considered
protein aggregation diseases, since the misfolded proteins gather and accumulate,
leading to a β-sheet structure that may enhance the formation of fibril and aggregates
(Ross and Poirier, 2004; Takalo et al., 2013).
Eukaryotic cells have at least three distinct but interconnected strategies to maintain
protein homeostasis, including refolding, degrading and sequestration of misfolded
proteins (Chen et al., 2011; Hartl and Hayer-Hartl, 2009; Powers et al., 2009; Takalo et
al., 2013). All these strategies centrally involve molecular chaperones, which recognize
the misfolded protein and maintain the balance of the system (Chen et al., 2011; Hartl
and Hayer-Hartl, 2002) (Figure 1.1). Each strategy has its advantages and risks, but
how PQC network components crosstalk and decide whether a misfolded protein should
be degraded, sequestered or sent to be refolded remains a big question in the field.
Failure of any of these cellular strategies may compromise protein homeostatic balance
and reduce cell viability (Chen et al., 2011).

3

Figure 1.1. The main cellular strategies to maintain protein homeostasis.
Misfolded proteins can be refolded, degraded, or sequestered to distinct PQC
compartments. Proteins targeted for degradation are sent to degradation machineries to
undergo ubiquitin-proteasome system (UPS) pathway, autophagy or ERAD. Misfolded
proteins can be sequestered through two kinds of compartments: insoluble protein
deposit (IPOD) and juxtanuclear quality control (JUNQ). All the three strategies require
the involvement of molecular chaperones.
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1.1.1 Molecular chaperones play a central role in the cellular strategies of PQC
To maintain protein homeostasis, all cellular strategies rely on the function of
molecular chaperones (Bukau et al., 2006; Chen et al., 2011; Frydman, 2001).
Chaperones recognize misfolded proteins, assist in the refolding, and prevent them
from forming toxic aggregates (Hartl et al., 2011; Morimoto, 2008; Warrick et al., 1999).
For instance, the small heat shock proteins (smHSPs) interact with unfolded proteins to
form stable and defined substrate-chaperone complexes. As a result, these substratechaperone complexes prevent the formation of aggregates (Haslbeck et al., 2005).
Moreover, chaperones assist the folding of nascent proteins and provide assistance in
the translocation of these polypeptides across membranes (Dobson, 2003; Hartl et al.,
2011). The molecular chaperones also play a role in protein degradation, by interacting
with the ubiquitination machinery and targeting the misfolded proteins to the ubiquitinproteasome system (UPS) (Ciechanover et al., 2000; Dikic et al., 2009) or the
autophagosome (Glick et al., 2010; Parzych and Klionsky, 2014) for degradation.
Beyond all the well-established role of chaperones in protein folding, refolding and
degradation, interestingly, some chaperones showed the ability to extract proteins from
aggregates. Examples include the ring-shaped hexameric AAA-ATPases, which extract
proteins from aggregates with ATP needed (Wendler et al., 2007). Another example will
be chaperone heat shock protein Hsp104 in yeast, as well as bacterial heat shock
5

protein ClpB, which also exhibit the ability to extract misfolded proteins from aggregates
(Lum et al., 2004; Wendler et al., 2009). The extracted misfolded proteins can be
translocated for refolding or degradation with the assistance of Hsp70 and Hsp40
chaperones (Buchberger et al., 2010; Chen et al., 2011; Lotz et al., 2010).
In eukaryotic cells, there are two groups of chaperone networks that regulate PQC:
one group is the chaperones linked to protein synthesis (CLIPS), which are associated
with the function of translation machinery and play a role in the folding of newly
synthesized polypeptides (Albanèse et al., 2006); the other group is the heat shock
proteins (HSPs), which are activated by heat shock factors and assist to keep the
proteostasis from stress (Haslbeck et al., 2005).

1.1.2 Causes of protein misfolding and aggregation
Under normal and physiological growth conditions, cells form and accumulate
misfolded proteins due to both genetic and cellular environmental factors, including
mutations, polymorphisms of promotors, as well as ineffective protein biogenesis,
surplus of oligomeric protein subunits that are unassembled, and mitochondrial or
secretory protein precursors that are not efficiently translocated (Balch et al., 2008;
Chen et al., 2011; Takalo et al., 2013; Voisine et al., 2010). Besides the causes stated
above, there are pathological factors that may also cause proteins to misfold and
6

aggregate, including metabolic and environmental stresses, aging and cancer (Chen et
al., 2011; Haigis and Yankner, 2010). Possible metabolic stresses may include nutrient
depletion, mitochondrial dysregulation and reactive oxygen species (ROS) production
(Chen et al., 2011). Potential environmental stresses include severe temperature
change, chemical exposure, injury and infections from virus or bacteria. Aging and
cancer all affect protein homeostasis in cell, but in different manners. Cancer causes
elevated rate of cell division and rate of mutations, leading to the accumulation of
misfolded proteins. Therefore, chaperones are normally overexpressed in cancer cells,
and environmental stress response (ESR) is activated (Chen et al., 2011; Takalo et al.,
2013; Whitesell and Lindquist, 2005). However, aging reduces the cells’ ability to
manage misfolded proteins or aggregates, and declines the capacity of PQC system
(Morley and Morimoto, 2004). As a result, misfolded proteins and deleterious mutations
accumulate and further damage protein homeostasis, and may lead to cell death
(Douglas and Dillin, 2010).

1.1.3 Misfolded proteins can be degraded by the ubiquitin-proteasome system
(UPS), autophagy and endoplasmic reticulum-associated protein degradation
(ERAD) pathways
In eukaryotic cells, the ubiquitin-proteasome system (UPS) is an essential protein
7

degradation pathway, which mostly assists the clearance of soluble misfolded proteins.
The proper functions of UPS rely on many factors, including the ubiquitination of
substrates, shuttle protein activity and the proteolytic activity of the proteasome (Zheng
et al., 2020). Ubiquitination is a post-translational modification, that enzymatically
involves ubiquitin activating enzyme E1, ubiquitin conjugating enzyme E2 and ubiquitin
ligase E3, to covalently attach mono-Ub or polyubiquitin (polyUb) chains onto protein
substrates through one of the seven lysines (K6, K11, K27, K29, K33, K48, K63)
(Pickart and Fushman, 2004). PolyUb chains formed via these different lysine linkages
exhibit unique structural and dynamical properties (Castañeda et al., 2013, 2016;
Pickart and Fushman, 2004). The most common and abundant polyUb chains are K48linked and K63-linked chains (Zientara-Rytter and Subramani, 2019). These Ub or
polyUb chains can act as signaling tags to direct proteins to various cellular pathways,
including UPS and autophagy. K48-linked polyUb signals misfolded proteins to the
proteasome for degradation, while K63-linked polyUb play a role in DNA repair,
trafficking, and autophagy (Pickart, 2000). In addition, different ubiquitin states (monovs. polyUb chains) can modulate the trafficking of proteins and their activity level (Chen
et al., 2011; Finley et al., 2004).
Shuttle proteins direct ubiquitin-tagged substrates to degradation by the 26S
proteasome, which is composed of a 20S proteolytic core and a 19S regulatory cap
8

(Pickart and Cohen, 2004). Shuttle proteins are typically defined by a UBL-UBA domain
architecture, whereby the UBL (Ubiquitin-Like) domain interacts with proteasomal
receptors Rpn10, Rpn3 and Rpn13; and the UBA (Ubiquitin-Associated) domain
interacts with ubiquitin or polyUb chains tagged on the substrate for degradation (Chen
et al., 2019; Ko et al., 2004).
Autophagy is another vital cellular degradative pathway, which requires the delivery
of misfolded proteins to the lysosome (Parzych and Klionsky, 2014). Different from
degrading small proteins and single proteins by UPS, autophagy is generally essential
in degrading bulky protein aggregates, RNA and organelles (Glick et al., 2010; He and
Klionsky, 2009). There are three types of autophagy pathways in eukaryotic cells,
specifically, macro-autophagy, micro-autophagy and chaperone-mediated autophagy
(CMA). Macro-autophagy is the most studied autophagy in mammalian cells, which
forms the double membrane bound autophagosomes to function (Glick et al., 2010).
Micro-autophagy can directly engulf proteins and organelles into lysosomes. However,
CMA relies on chaperones, such as Hsp70 to transport the substrates to lysosome for
degradation. Both the acidic environment and the cocktail of hydrolases provided by the
lysosomes are needed in the three types of autophagy pathways (Parzych and Klionsky,
2014; Zheng et al., 2020). Same as UPS, autophagy is important in maintaining protein
homeostasis. For example, autophagy enhances the clearance of soluble small size
9

aggregates, providing a protective mechanism in PQC (Mizushima et al., 2008;
Rubinsztein et al., 2007). Meanwhile, it is crucial in stress response by promoting cell
survival, especially during starvation times (Parzych and Klionsky, 2014; Zheng et al.,
2020).
As discussed in Chapter 1.1, in general, folding of nascent proteins takes place in
the endoplasmic reticulum (ER) (Anken and Braakman, 2005). Despite the assistance
of a variety of cellular chaperones, a large number of newly synthesized proteins end up
misfolded (Levine et al., 2005). The endoplasmic reticulum-associated degradation
(ERAD) is another major protein degradation pathway. It prevents the accumulation of
misfolded proteins with potential toxicity, by translocating them from the ER to the
cytosolic proteasomes for degradation (Parzych and Klionsky, 2014).
How do cells decide which protein degradation pathway to use when they need to
get rid of a misfolded protein or aggregate? Hypotheses are, first, depending on the size
of aggregates, cells adopt different degradation pathways. Generally, small and soluble
misfolded proteins are sent to proteasome while protein aggregates in large sizes and
organelles are degraded by autophagy. Second, different ubiquitin tags direct the
misfolded proteins to different places for degradation. Importantly, there are no distinct
boundaries among these degradation pathways. Research has shown that UPS,
autophagy and ERAD pathways are interconnected, and they work together to keep
10

functional PQC. For instance, defect in the UPS activates compensatory autophagy
pathway (Chen et al., 2011; Pandey et al., 2007), however knockdown of autophagy
components in mice model induces proteasomal degradation, as is evidenced by the
accumulation of proteasomal substrates (Hara et al., 2006; Komatsu et al., 2005).
ERAD, which involves the translocation of misfolded proteins from ER to the cytosol,
partitions between proteasomal degradation and autophagy. Under normal conditions,
retranslocated misfolded proteins are degraded by the proteasome. However, if ERAD
is weakened or damaged, resulting in the less effective clearance of the accumulated
misfolded proteins, autophagy degradation pathway will be activated (Ishida et al.,
2009). Together, the evidence suggested that UPS, autophagy and ERAD pathways
crosstalk to degrade misfolded proteins and prevent the cells from potential hazards.

1.1.4 Cells involve protein refolding and sequestration as strategies to maintain
protein homeostasis
Protein refolding is a fast cellular response, which requires the assistance of
chaperones, such as Hsp40, 70 and 104 (Buchberger et al., 2010; Chen et al., 2011;
Lotz et al., 2010). Moreover, there are alternative strategies for clearing the misfolded
protein and keeping PQC mechanisms, such as sequestration, which is related to the
formation of inclusions (Johnston and Samant, 2021). Eukaryotic cells have various
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types of cellular inclusions, including ones that accumulate with insoluble protein
aggregates, as well as ones with soluble proteins. The cellular inclusions have different
functions under the PQC network, including but not limited to sequestering misfolded
aggregates (Chen et al., 2011).
Recently, people classified the mechanisms for sequestering misfolded proteins into
two compartments: juxtanuclear quality control (JUNQ) and insoluble protein deposit
(IPOD). (Kaganovich et al., 2008). The JUNQ and the IPOD are distinct compartments
that present different separation of cytosolic inclusions, both spatially and temporally
(Chen et al., 2011; Sontag et al., 2014). The JUNQ can concentrate soluble misfolded
proteins which can be either refolded with the assistance of chaperones or degraded by
the 26S proteasome (Sontag et al., 2017a). In eukaryotic cells, soluble misfolded
proteins are stored in Q-bodies on their way to the JUNQ (Sontag et al., 2017b). On the
other hand, the IPOD contains insoluble protein aggregates. It is suggested that IPOD is
associated with autophagy because it colocalizes with macroautophagy marker Atg8 but
not proteasomes (Kaganovich et al., 2008; Sontag et al., 2014, 2017b). Notably, the
molecular chaperone Hsp104 is also sequestered in the IPOD (Chen et al., 2011).
The mechanisms of how JUNQ and the IPOD modulate PQC differ. The JUNQ
promotes clearance and removes soluble misfolded proteins from cellular environment.
However, IPOD prevents the insoluble aggregates from obstructing the proteasome and
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sequestering soluble chaperones (Chen et al., 2011). Importantly, the functions of JUNQ
and IPOD compartments are believed to be conserved among species, since they are
observed in both mammalian cells and yeast cells (Kaganovich et al., 2008).

1.1.5 How cells keep the balance among protein degradation, refolding and
sequestration remains unclear
As discussed in the previous sections in this Chapter, misfolding of protein is
common even under normal growth condition. As a result, cells have developed distinct
but interconnected strategies to maintain protein homeostasis. Misfolded proteins are
degraded, refolded or sequestered from the cell to protect the cell from potential
deleterious species. Each pathway has its own benefits and drawbacks. Protein
degradation can recycle materials including amino acids, but it requires degradation
machineries to work, which may cause the overload of proteasomes or
autophagosomes. Protein refolding is a fast response, and the good news is proteins
are recovered. However, it may cause the overload of chaperones and result in protein
misfolding again. Sequestration, which can protect the cells from harmful species and
reduce the burden of the proteostasis network, may cause risks including sequestering
non-specific proteins (Chen et al., 2011). However, how chaperones decide whether to
refold the misfolded protein, or to send it to proteasome or autophagosome for
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degradation, or to sequester it as an inclusion remains a question.
It is believed that soluble misfolded proteins are generally refolded with the
assistance of chaperones or are degraded by protein degradation machineries, while
the insoluble aggregates are sequestered from the cell to prevent toxicity (Chen et al.,
2011). Further studies are needed to fully understand the mechanisms of how the PQC
network balances among the various strategies.

1.2 Ubiquilins (UBQLNs) are shuttle proteins involved in protein
quality control mechanisms
Cells must monitor and maintain an elaborate protein homeostasis to maintain
proper function and survival. Due to the highly complex and crowded nature of the
cellular environment, substrate targeting in the PQC pathways can be challenging. To
facilitate this process, cells employ shuttle proteins that have dual capability to interact
with both substrates and the protein degradation machineries (Jantrapirom et al., 2019).
Ubiquilins (UBQLNs) are one group of shuttle proteins that shuttle and facilitate the
degradation of substrates through the ubiquitin-proteasome system (UPS), autophagy,
and endoplasmic-reticulum-associated protein degradation (ERAD) pathways (Ko et al.,
2004; Lim et al., 2009; Stieren et al., 2011; Yun Lee et al., 2013). In addition, UBQLNs
also exhibit molecular chaperone functions to prevent protein substrates from
14

misfolding, or to help the cells to sequester misfolded protein into separate locations
(Deng et al., 2011; Yang et al., 2018). Moreover, UBQLNs are involved in cellular stress
responses, as our lab and others recently demonstrated that UBQLN2 is recruited to
stress granules in cells (Dao et al., 2018), and associates with stress granule
components and might be involved in the assembly/disassembly of SGs (Alexander et
al., 2018). UBQLNs also participate in DNA/RNA metabolism, DNA damage response
and cell differentiation/development (Figure 1.3).

1.2.1 Subcellular locations and structures of UBQLNs
The UBQLN family consists of 5 protein members (UBQLN1-4 and UBQLNL), which
belong to the UBL-UBA shuttle proteins by containing an ubiquitin-like (UBL) domain at
the N-terminus and an ubiquitin-associated domain (UBA) at the C-terminus (Figure
1.2). Among these five UBQLN proteins, UBQLN3 and UBQLNL are exclusively
expressed in the testes (Conklin et al., 2000; Yuan et al., 2015), whereas UBQLN1, 2
and 4 are widely expressed in all tissues (Marín, 2014). Notably, UBQLN proteins have
different subcellular localizations: UBQLN1 is generally evenly expressed in nucleus
and cytoplasm (Kleijnen et al., 2000; Mah et al., 2000); UBQLN4 is in the nucleus,
cytoplasm and endoplasmic reticulum (ER) with even expression levels (Jachimowicz et
al., 2019), while UBQLN2 is cytoplasmic in general, but is also found in nucleus
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depending on the cell states (Kleijnen et al., 2000; Mah et al., 2000). Remarkably,
UBQLN2 expression is elevated in the nervous system (Marín, 2014; Wu et al., 1999).
Based on the studies, it is concluded that different spatial arrangements and different
expression levels are related to cellular signals and UBQLN’s functions (Dao and
Castañeda, 2020).
UBQLN1, 2 and 4 share similar domain architecture. Besides the well-structured
UBL and UBA domains, UBQLNs have a largely intrinsically disordered region in the
middle, consisting of two STI1 region, which confer flexibility and dynamics that
contribute to functionality. UBQLN2 contains a unique proline-rich region (PXX), where
locates neurodegenerative disease-related mutations (Zheng et al., 2020).
The UBL domain has a similar structure as ubiquitin, as the name implies. The
hydrophobic patch formed by Ub residues L8, I44, V70, which is essential in binding, is
mostly conserved in the UBL domain (UBQLN2 residues T39, I75, V101) (Zheng et al.,
2020). As a result, the binding partners of UBL domain and Ub are largely similar,
including the Ub-binding shuttle protein hHR23b and proteasome subunits Rpn3,
Rpn10, and Rpn13, but with different binding affinities (Kang et al., 2007). Notably, the
Rpn13 and Rpn10 proteasome subunits preferentially interact with UBQLN UBL domain
over ubiquitin. However, the Rpn10 binding preference favors polyUb over UBL domain
in the presence of long K48-linked polyUb chains (Zhang et al., 2009).
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The other well-structured domain is Ubiquitin-associated domain (UBA), which has
a helical structure. UBA domain is also highly conserved, especially among proteins that
are involved in ubiquitination and degradation processes. Sequences of the UBA
domains in all UBQLNs are over 93% identical (Zheng et al., 2020). As the name
suggests, UBA domain can interact with ubiquitin. The α1 helix residues (UBQLN1
M557 and F559) and α3 helix residues (UBQLN1 I576, I580 and L584) form the binding
interface with the hydrophobic patch on Ub (L8, I44 and V70) (Ohno et al., 2005; Zhang
et al., 2008), and these UBA residues are conserved across all UBQLNs. Substrates
could be transferred by the shuttle protein UBQLNs to the proteasome for degradation.
Besides targeting ubiquitinated substrates to the proteasome for degradation, UBA
domain plays a protective role for certain proteins by binding to Ub thus blocking polyUb
chain elongation on substrate proteins (Zheng et al., 2020). Examples include antiapoptotic BCL2-like protein BCLb, Insulin-like growth factor-1 receptor (IGF1R), and
ER-associated membrane protein extended synaptotagmin 2 (ESYT2) (Heinen et al.,
2011; Kurlawala et al., 2017).
The intrinsically disordered region, STI1-I and STI1-II were named from stressinduced phosphoprotein 1 or HSP70/HSP90 organizing protein (STI1/Hop), which is a
co-chaperone protein that mediates heat shock response of the HSP70 genes (Song
and Masison, 2005). The STI1 regions are conserved among the UBQLN1, 2 and 4
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proteins (Zheng et al., 2020). Due to the unique amino acid composition and the
intrinsically disordered structure, it is speculated that STI1 regions of UBQLNs might
interact with many proteins (Zheng et al., 2020). It has been shown that STI1 regions
interact with PQC components, such as HSP70 chaperone (Hjerpe et al., 2016),
mammalian target of rapamycin (mTOR) (Wu et al., 2002), and autophagosomeassociated LC3 (Rothenberg et al., 2010).
Of all UBQLN proteins, UBQLN2 is special in having the proline-rich (PXX) region,
which is located between the STI1-II region and UBA domain. Notably, the PXX region
harbors most of the disease-linked mutations, specifically linked to Amyotrophic lateral
sclerosis (ALS) and FTD (Deng et al., 2011; Fahed et al., 2014; Gellera et al., 2013;
Gkazi et al., 2019; Synofzik et al., 2012; Teyssou et al., 2017; Vengoechea et al., 2013).
The amino acid sequence in the PXX region mimics that of collagen with a high
representation of Pro and Gly residues, with mostly hydrophobic residues in between. In
addition, our lab has showed that the PXX domain is intrinsically disordered, by NMR
spectroscopy (Dao et al., 2018). Interestingly, the PXX domain participates in the selfassociation of UBQLN2, thus contributing to UBQLN oligomerization and LLPS (Chapter
1.2.2) (Dao et al., 2018; Zheng et al., 2020).
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Figure 1.2. Domain structures and sequence alignments of UBQLNs (1, 2 and 4)
(A) Domain architecture map of UBQLN1, UBQLN2 and UBQLN4 with UBL, STI1-I,
STI1-II, PXX, and UBA domains colored as red, dark blue, blue, magenta, and green,
respectively. PXX is a proline-rich region unique to UBQLN2. (UBQLN4 and UBQLN2
share similar domain architecture, with the exception of the PXX domain, which only
exists in UBQLN2. (B) Sequence alignment of UBQLN1, UBQLN2, and UBQLN4
performed using T-Coffee (Notredame et al., 2000). UBL STI1-I, STI1-II, PXX, and UBA
domains are colored as red, dark blue, blue, magenta, and green, respectively.
Visualized with Jalview (Waterhouse et al., 2009), and residues colored according to
this scheme: beige for hydrophobic, blue for positive, red for negative, green for polar,
magenta for prolines and glycines, and yellow for aromatic amino acids. UBQLN4 and
UBQLN2 show 56% sequence identity. (C) Predictions for UBQLN disorder, prion-like
propensity, and phase separation propensity. PONDR-FIT (Xue et al., 2010) and
DISOPRED3 (Jones and Cozzetto, 2015) predict intrinsically disordered regions.
PONDR-FIT is a meta-predictor that produces prediction scores by combining results
from a series of algorithms; DISORPRED3 is a separate program trained on conserved
sequence features of intrinsically disordered regions, identified by missing residues in
high-resolution X-ray structures (Jones and Cozzetto, 2015; Xue et al., 2010). For both
programs, higher values represent protein regions likely to be disordered. PLAAC
identifies prion-like domains (PrD.like) consisting of certain hydrophobic residue
patterns that can speed amyloid formation [98]. Phase-separation propensity scores
(PScore) identifies intrinsically disordered protein sequences that may drive liquid–liquid
phase separation (LLPS), mainly by pi–pi contact contributions (Vernon et al., 2018).
The overall PScores for UBQLN1, 2 and 4 are 2.91, 3.24 and 3.7, respectively. This
figure has been reproduced with permission from (Zheng et al., 2020) (Appendix I).
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1.2.2 Oligomerization of UBQLNs and liquid-liquid phase separation (LLPS)
It has been shown that oligomerization is important for the functionality of many
shuttle proteins including UBQLNs (Bertolaet et al., 2001; Dao et al., 2018; Wurzer et
al., 2015). UBQLNs form homo- and hetero-dimers, including UBQLN1, UBQLN2 and
UBQLN4 homodimers (Dao et al., 2019; Ford and Monteiro, 2006; Yun Lee et al.,
2013), as well as UBQLN1- UBQLN4 heterodimers and UBQLN2-UBQLN4
heterodimers (Yun Lee et al., 2013). In addition to dimeric forms, UBQLN1 and
UBQLN2 can exist in oligomeric assemblies of various sizes (Dao et al., 2019; Ford and
Monteiro, 2006). The oligomerization property of UBQLNs mainly depends on the STI1II region (Dao et al., 2018; Ford and Monteiro, 2006; Kurlawala et al., 2017). Recently,
our lab showed that UBQLN2 oligomerization propensity is linked to its liquid-liquid
phase separation (LLPS) behavior (Dao et al., 2018). We showed that UBQLN2 is
recruited to biomolecular condensates in cells and undergoes liquid-liquid phase
separation (LLPS) in vitro (Dao et al., 2018). It is observed that UBQLN2 undergoes a
phase transition into forming round, dynamic and protein-dense condensates, as
temperature is increased to near physiological conditions (Dao et al., 2018). This phase
behavior is called lower critical solution temperature (LCST) behavior, as the protein
solution does not phase separate when the temperature is below LCST.
Our lab found out that the phase behavior of UBQLN2 relies on some residues in
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the STI1-II region as well as the UBA domain (Dao et al., 2018). Removal of STI1-II
eliminates LLPS under all conditions tested, and deletion of the UBA domain
significantly increased the protein concentration required for UBQLN2 LLPS.
Additionally, the UBL domain also affect UBQLN2 LLPS. Removal of UBL domain
dramatically enhances UBQLN2 LLPS (Zheng et al., 2021). Together, these data
showed us that interactions among domains drive the oligomerization of UBQLN2,
which in turn promotes or disrupts LLPS behavior of UBQLN2 (Figure 1.3E).

1.2.3 Physiological Functions of UBQLNs
UBQLNs are versatile and multifaceted shuttle proteins that participate in diverse
cellular protein degradation pathways, including the ubiquitin-proteasome system
(UPS), autophagy, and endoplasmic-reticulum-associated protein degradation (ERAD).
Additionally, UBQLNs also participate in DNA/RNA metabolism, cell
differentiation/development and DNA damage response (Figure 1.3A).
The ubiquitin-proteasome system (UPS), the most well-studied function of the
UBQLNs, plays a vital role in the protein degradation mechanism in eukaryotes. As
discussed in Chapter 1.1.3, the proper function of UPS relies on many components,
including enzymes (E1, E2, E3) responsible for the ubiquitination of the substrates,
shuttle proteins and ultimately the proteolytic activity of the proteasome (Zheng et al.,
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2020). Ubiquitin, a PQC component, acts as signaling protein by tagging protein
designated for degradation. K48-linked polyUb signals for proteasomal degradation,
whereas K63-linked polyUb is the common tag for DNA repair, trafficking, and
autophagy (Pickart, 2000). UBQLN1, 2 and 4 transport ubiquitinated substrates to the
proteasome by binding proteasomal subunits and ubiquitinated proteins via their UBL
and UBA domains, respectively (Figures 1.3B). Consistent with their shuttle protein
functionality, UBQLNs associate with the proteasome, generally via proteasome
subunits Rpn10 and Rpn13 receptors (Chen et al., 2016; Wang and Monteiro, 2007).
When the UBL domain predominantly interacts with the proteasome, other parts of
UBQLN appear to modulate UBL-proteasome interactions (Zheng et al., 2020).
Additionally, our lab discovered that Ub binding to the UBA domain of UBQLN2 drives
the disassembly of UBQLN2 droplets in vitro (Figure 1.3E). Notably, interaction between
UBQLN2 and K48-Ub4, the canonical signal for proteasomal degradation, disassemble
UBQLN2 condensates (Dao et al., 2018). We speculate that Ub-mediated phase
transitions of UBQLN2 also occur in cells, enabling a mechanism where UBQLN2 could
shuttle ubiquitinated proteins out of condensates or membraneless organelles (Zheng et
al., 2020).
Autophagy is another major degradation pathways for maintaining PQC in cells
(Chapter 1.1.3). Compared with UPS, the molecular mechanisms of UBQLNs in
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autophagy are less understood. Three types of autophagy, specifically macroautophagy, micro-autophagy and chaperone-mediated autophagy (CMA) all rely on the
lysosome to function, which provides an acidic environment to degrade the substrates
(Glick et al., 2010; Parzych and Klionsky, 2014). Autophagy must remain tightly
regulated to maintain homeostasis, because it is involved in stress response that
promotes cell survival, especially during times of starvation (Parzych and Klionsky,
2014). UBQLN1, UBQLN2, and UBQLN4 bind to macroautophagy/autolysosome
component 1A/1B-light chain 3 (LC3) and facilitate the maturation of LC3-I to LC3-II
(Rothenberg et al., 2010; Wu et al., 2020; Yun Lee et al., 2013), which initiates the
formation and elongation of the autophagosome (Parzych and Klionsky, 2014) (Figure
1.3D). Moreover, UBQLN1 may indirectly regulate autophagic flux by interacting with
and modulating the activity of the mechanistic target of rapamycin (mTOR) (Şentürk et
al., 2019a), whose kinase activity inhibits autophagosome formation and lysosome
biogenesis (Dunlop and Tee, 2014; Puertollano, 2014). Another mechanism by which
UBQLNs may participate in autophagy is through their association with polyUb chains
(Zheng et al., 2020). UBQLN1 exhibits a binding preference for K63-linked polyUb
chains over K48 (Harman and Monteiro, 2019). As K63-linked polyUb chains are often
associated with autophagy, UBQLN1 interactions with these chains could be important
for regulating autophagy (Grumati and Dikic, 2018).
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The endoplasmic reticulum-associated degradation (ERAD) pathway prevents
potential cellular toxicity by forming complexes between ER components and the
ubiquitinated misfolded protein and directing it to the cytosolic proteasomes for
degradation. UBQLNs participate in ERAD mainly by facilitating the translocation of
ERAD substrate from the ER to the proteasome (Lim et al., 2009). Specifically, UBQLN1
forms a complex with the segregase, Valosin-containing protein (VCP/p97), and UBXcontaining protein UBXD2/erasin (Figure 1.3C) (Lim et al., 2009); UBQLN2 interacts
with another ERAD adapter, UBXD8 (Xia et al., 2014; Xu et al., 2013); UBQLN4
recognizes the exposed hydrophobic transmembrane domains of the target proteins
(Suzuki and Kawahara, 2016). In addition to ERAD substrate extraction, UBQLN2 is
also involved in ER-Golgi trafficking (Halloran et al., 2020).
Besides all of the PQC mechanisms in which UBQLNs participate, they also act as
molecular chaperones to assist proper protein folding and prevent protein aggregation.
(Lackie et al., 2017; Rosenzweig et al., 2019; Zuiderweg et al., 2017). In addition,
UBQLNs associate with the cytoskeleton to impact cell differentiation and development
(Wu et al., 1999). UBQLNs also participate in the DNA/RNA regulation metabolism, as
proteomics studies reveal interactions between UBQLNs and DNA/RNA-binding
proteins such as hnRNPA1, FUS, and TDP-43 (Alexander et al., 2018; Gilpin et al.,
2015; Kim et al., 2009) (Figure 1.3A).
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Figure 1.3. Physiological functions of UBQLNs.
(A) Schematic representation of UBQLN physiological functions. (B) UBQLNs target
proteins for degradation via UPS. UBQLNs shuttle K48-linked polyUb-tagged substrates
to the proteasome via UBA-polyUb interactions and UBL-proteasome interactions (Chen
et al., 2016, 2019; Ko et al., 2004). (C) UBQLNs form complexes with ERAD adaptors
such as VCP/p97 and UBXD8 to facilitate the extraction of ERAD substrates from the
ER, then transport the substrate to the proteasome for degradation (Lim et al., 2009; Xu
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et al., 2013). (D) UBQLNs regulate autophagy at several steps. UBQLN interacts with
macroautophagy/autolysosome component LC3 and mediates autophagosome
maturation (Rothenberg et al., 2010; Wu et al., 2020; Yun Lee et al., 2013). UBQLN
stabilizes V-ATPase, which is essential for lysosome acidification and autophagic
degradation (Şentürk et al., 2019b). UBQLN also regulates autophagic flux by
interacting with mTOR (Şentürk et al., 2019a). (E) Tuning of UBQLN oligomerization
likely plays a role in PQC pathways. UBQLN2 oligomerizes under physiological
conditions and self-assembles into liquid-like condensates upon stress (Dao et al.,
2018). UBQLN2 condensates are disassembled by ubiquitin or K48-linked polyUb (Dao
et al., 2018). Introduction of a disease-linked UBQLN mutation may cause the formation
of aggregates (Sharkey et al., 2018). This figure has been reproduced with permission
from (Zheng et al., 2020) (Appendix I).
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1.2.4 Mutations in UBQLNs affect proper protein degradation pathways and are
related to neurodegenerative diseases
Protein aggregates or inclusions have been considered as a pathological hallmark
of many neurodegenerative disorders, such as Alzheimer's disease (AD), Huntington’s
disease (HD), and Amyotrophic Lateral Sclerosis (ALS) (Deng et al., 2011; Lansbury
and Lashuel, 2006). The involvement of UBQLNs in aggregates could either be
physiological or pathological (Zheng et al., 2020). On the one hand, UBQLNs may
associate with aggregates to exercise their physiological functions in promoting
degradation via PQC pathways. On the other hand, UBQLNs may be trapped in
aggregates due to STI1-driven association with the aggregated client protein and/or
UBA interactions with the polyUb tag on the aggregated protein (Zheng et al., 2020).
Mutations in UBQLNs may affect their involvement in PQC mechanisms, resulting in
toxicity caused by protein aggregation.
ALS-linked mutations in the PXX region of UBQLN2 (P497H, P497S, P506T,
P509S, and P525S) are defective in transporting ubiquitinated substrates to the
proteasome due to decreased affinity with Rpn10 of the regulatory cap (Chang and
Monteiro, 2015). Disease-linked mutations, UBQLN1 E54D and UBQLN4 D90A also
impair proteasomal degradation (Edens et al., 2017; González-Pérez et al., 2012). The
positions of UBQLN1 E54D and UBQLN4 D90A are in or near the UBL domain, but not
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on the binding interface between UBL and proteasomal receptors Rpn10 and Rpn13,
which could lead to decreased binding to the proteasome (Zheng et al., 2020).
As discussed in Chapter 1.2.3, UBQLNs binding to LC3 facilitates the maturation of
LC3-I to LC3-II, which ensures proper autophagy degradation. However, an ALS-linked
mutant of UBQLN2 (P497H) causes a decreased LC3-II to LC3-I ratio (Chen et al.,
2018). P497H also reduces expression levels of several autophagy proteins, including
LC3, p62, ATG7 and a lysosome/CMA protein LAMP2a over time (Chen et al., 2018). In
addition, proper function of proton pump V-ATPase is essential in lysosome acidification
and autophagic degradation (Şentürk et al., 2019b; Wu et al., 2020). Interaction
between V-ATPase and UBQLN2 protects V-ATPase from degradation and promotes
stable V-ATPase formation (Şentürk et al., 2019b). It has been shown that loss of
UBQLN2 or ALS-linked mutation (P497S) causes autophagosome acidification
reduction (Wu et al., 2020). In addition, three other UBQLN2 mutants (P494L, P497S,
and P506A) disturb autophagic degradation in lymphoblast (Teyssou et al., 2017).
ERAD is disturbed when the interaction between UBQLN2 and UBXD8 is impaired
by ALS-linked mutation UBQLN2 P497H (Xia et al., 2014). UBQLN2 P497H and P506T
inhibit protein transport from ER to the Golgi in neuronal cells, resulting in disorganized
and fragmented Golgi (Halloran et al., 2020).
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Figure 1.4. Known disease-linked mutations of UBQLN proteins.
Mutations are indicated by arrows; all are linked to neurodegenerative diseases. The
UBQLN2 PXX region harbors most of the mutations, followed by the STI1-II region.
UBQLN1 and UBQLN4 each carry one known missense mutation. Asterisks represent
mutations that were detected in patients with neurodegenerative diseases, but the
underlying mechanism of action is unknown. This figure has been reproduced with
permission from (Zheng et al., 2020) (Appendix I).
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1.3 Membraneless organelles (MLOs) and liquid-liquid phase
separation (LLPS)
Eukaryotic cells organize their intracellular space into membrane-bound organelles,
but recently, studies have shown the existence of membraneless organelles (MLOs),
which include nucleoli, Cajal bodies, nuclear speckles in the nucleus (Handwerger and
Gall, 2006; Mao et al., 2011; Mitrea and Kriwacki, 2016); stress granules, P-bodies, and
germ granules in the cytoplasm (Decker and Parker, 2012; Mitrea and Kriwacki, 2016).
Stress granules are a type of MLO, which rapidly assembles in response to external
stressors, including oxidative stress, heat shock and proteasomal inhibition (Li et al.,
2013; Protter and Parker, 2016). Due to the absence of lipid bilayer membrane, MLOs
are dynamic and can exchange materials with the surroundings rapidly (Brangwynne et
al., 2009; Gomes and Shorter, 2019).
Liquid-liquid phase separation (LLPS), which has been discussed in Chapter 1.2.2,
is generally believed to be the molecular basis of the formation of MLOs (Boeynaems et
al., 2018; Gomes and Shorter, 2019). The main components of the MLOs are
macromolecules such as RNAs and proteins (Langdon et al., 2018). Multivalent
interactions among these molecules are a requirement for LLPS, which include proteinprotein interaction, protein-RNA interaction and RNA-RNA interaction (Lee et al., 2016).
Multivalency is the key principle of phase separation (Gomes and Shorter, 2019).
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Notably, increasing interaction valency promotes association and assembly. An increase
in the number of multivalent interactions promotes LLPS (Figure 1.5).

Figure 1.5. Increasing interaction valency promotes self-assembly and LLPS.
A protein exhibiting a single interaction site (valency of 1) results in the formation of
dimers with 0 dimension. A protein with two interaction sites (valency of 2) results in the
formation of chains with 1 dimension. A protein exhibiting three interaction sites (valency
of 3) results in the formation of nets with 2 dimensions. This figure is inspired by Clifford
P. Brangwynne's talk from the 2021 Friday Evening Lectures at Woods Hole Marine
Biological Laboratory.
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1.4 Aims of this work
In this work, we use a combination of biochemical and biophysical methods and
techniques to answer the following questions regarding UBQLN family proteins and
protein quality control (PQC) mechanisms. First, how does the UBQLN family of
proteins form droplets via phase separation (Chapter 2 and 4)? Second, how is
UBQLN2 LLPS regulated by interactions with PQC proteins, specifically ubiquitin and
polyUb chains (Chapter 3)? We took advantage of the phase separation property of the
UBQLN family to devise a “salting out” method that enabled purification of over a
hundred UBQLN variants, and adopted chromatography methods to optimize protein
purifications. We used UV-Vis spectrophotometry and microscopy as our main tools to
characterize the phase separation behavior and droplet formation of UBQLNs. Solution
Nuclear Magnetic Resonance (NMR) spectroscopy was chosen to probe the
interactions between UBQLN2 and polyUb chains on an atomic basis. This work helps
to design thermo-responsive biopolymers and benchmark molecular simulations of
phase separation, as well as provides insights in elucidating the role of UBQLN phase
separation in PQC and neurodegenerative disorders.
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Chapter II:
Single Amino Acid Substitutions in Stickers, but not Spacers,
Substantially Alter UBQLN2 Phase Transitions and Dense Phase
Material Properties
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Abstract
UBQLN2 450-624 oligomerizes and undergoes temperature-responsive liquid-liquid
phase transitions following a closed-loop temperature-concentration phase diagram. We
recently showed that disease-linked mutations to UBQLN2 450-624 impart highly
varying effects to its phase behavior, ranging from little change to significant decrease
of saturation concentration and formation of gels and aggregates. However, how single
mutations lead to these properties is unknown. Here, we use UBQLN2 450-624 as a
model system to study the sequence determinants of phase separation. We
hypothesized that UBQLN2 450-624 regions previously identified to promote its
oligomerization are the “stickers” that drive inter-chain interactions and phase
separation. We systematically investigated how phase behavior is affected by all 19
possible single amino acid substitutions at three sticker and two spacer (sequences
separating stickers) positions. Overall, substitutions to stickers, but not spacers,
substantially altered the shape of the phase diagram. Within the sticker regions,
increasing hydrophobicity decreased saturation concentrations at low temperatures and
enhanced oligomerization propensity and viscoelasticity of the dense phase.
Conversely, substitutions to acidic residues at all positions greatly increased saturation
concentrations. Our data demonstrate that single amino acid substitutions follow a
molecular code to tune phase transition behavior of biopolymers.
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2.1 Introduction
Liquid-liquid phase separation (LLPS) is a process by which a solution of
macromolecules demixes into a species-rich liquid dense phase in equilibrium with a
species-poor dilute phase. LLPS is hypothesized to underlie the assembly of
biomolecular condensates essential for various cellular processes (Brangwynne et al.,
2009; Hyman et al., 2014). In phase-separating proteins, a major characteristic is
multivalency, the existence of multiple associative motifs of intrinsically-disordered
segments or structured domains that form intra- and inter-chain interactions (Banani et
al., 2016; Li et al., 2012; Lin et al., 2015). Accumulating evidence shows that phase
transition behavior is encoded in the amino acid sequence (Lin et al., 2017; Pak et al.,
2016; Wang et al., 2018). Mutations can tune the conditions necessary for LLPS, as well
as the material properties of these condensates in vitro and in vivo (Molliex et al., 2015;
Patel et al., 2015). Indeed, dysregulation of condensate dynamics, assembly and/or
disassembly is linked to diseases, including amyotrophic lateral sclerosis (ALS) among
others. Therefore, deciphering the molecular code that drives phase transitions of
biopolymers is key to understanding diseases, as well as designing stimuli-responsive
polymers with emergent properties.
The sticker and spacer framework is emerging as useful language to describe the
origins of LLPS behavior in proteins. Stickers are the associative motifs that drive LLPS,
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whereas the spacers connect the sticker regions and tune LLPS behavior as well as
impart flexibility (Harmon et al., 2017; Rubinstein and Dobrynin, 1997; Semenov and
Rubinstein, 1998). The chemical basis of sticker interactions that governs phase
transition behavior varies across phase-separating systems. For instance, Arg and Tyr
residues in the FUS family of proteins use cation-𝜋 and 𝜋-𝜋 stacking interactions to
drive LLPS (Wang et al., 2018). The hydrophobic effect modulates LLPS of elastin and
elastin-like proteins, and other proteins such as Pab1 (Riback et al., 2017; Yeo et al.,
2011; Zai-Rose et al., 2018). Aromatic residues are essential for mediating TDP-43
LLPS (Li et al., 2018). Electrostatic interactions formed via clusters of either positively or
negatively charged residues stabilize Ddx4 protein droplets (Nott et al., 2015). These
experimental data must be combined to deduce the molecular grammar underpinning
LLPS at physiological conditions for biological systems. Indeed, 𝜋-𝜋 contact propensity
can be used to predict LLPS based solely on amino acid sequence (Vernon et al.,
2018).
Evaluating the effects of amino acid substitutions on phase transition behavior
requires elucidation of full phase diagrams which map the conditions where the solution
phase separates into protein-dilute and protein-dense phases. For some systems, the
protein-dense phase also intersects a liquid-gel phase boundary where the dense
phase undergoes gelation, a switch from liquid droplets to a non-covalent physically
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cross-linked network of molecules (Harmon et al., 2017). The equilibrium protein
concentrations in the protein-dilute and protein-dense phases are described by the
binodal or coexistence curve comprising both low and high concentration arms. The low
concentration arm defines the protein saturation concentration (c s), below which the
system will be mixed and homogeneous, and above which, the system will form a
distinct second phase such as protein-dense liquid droplets (Posey et al., 2018;
Rubinstein and Colby, 2003; Ruff et al., 2018). Coexistence curves are determined by
the free energy of the system thereby including entropy of mixing, as well as the
enthalpies of protein-protein, protein-solvent and solvent-solvent interactions. The
complex interplay of these terms provides the thermodynamic basis for LLPS in
biological systems. Obtaining experimental phase diagrams and predicting these via
computational modeling and/or simulation are ideal metrics to determine the molecular
driving forces of phase separation and phase separation-driven gelation (Harmon et al.,
2017). Therefore, experimental systems are needed to address this goal, as
emphasized in recent literature (Dzuricky et al., 2018; Ruff et al., 2018).
UBQLN2, a proteasomal shuttle factor involved in cellular protein quality control
mechanisms, phase separates under physiological conditions. We previously
characterized the LLPS properties of full-length UBQLN2 and several deletion
constructs, including the C-terminal construct of UBQLN2 (450-624) (Dao et al., 2018).
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It has been demonstrated that UBQLN2 oligomerization is a prerequisite for UBQLN2 to
phase separate in vivo and in vitro, as expected and observed for many other LLPS
systems. We established a model biopolymer system using UBQLN2 (450-624), since it
generally mimics the LLPS behavior of full-length UBQLN2 (Dao et al., 2018) and can
be easily expressed and purified from bacteria, enabling the establishment of a large
mutagenesis library to study the sequence effects on phase transitions. Because of its
small size (~175 amino acids), we could use nuclear magnetic resonance (NMR)
spectroscopy to monitor its backbone amide chemical shifts as a function of protein
concentration on a residue-by-residue basis.
We previously observed concentration-dependent chemical shifts for residues 450509, 555-570, 592-596, and 615-620 in NMR experiments, indicating that these
residues are involved in UBQLN2 oligomerization (Figures 2.1A, 2.2A, and 2.2B). These
residues are called “stickers” while the sequences separating stickers are “spacers”.
Our lab showed that ALS-linked mutations P497H, P497L, P497S, P506A, P506S and
P506T, but not P525S, significantly altered UBQLN2 450-624 LLPS properties, which
was consistent with our NMR data that residues P497 and P506 are in sticker regions
and P525 is in a spacer region (Dao et al., 2019). We hypothesized that mutations in
the sticker regions would greatly affect both the dense and dilute phases (e.g. saturation
concentrations, droplet morphology, droplet fusion kinetics), whereas mutations in the
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spacer regions would not. To test this hypothesis, we systematically substituted each of
the 19 natural amino acids into three stickers P497, P506 and V564 and two spacers
P525 and V538, in the UBQLN2 450-624 background, and obtained low-concentration
arms of temperature-concentration phase diagrams. Our data illustrate that single
amino acid substitutions at designated positions in the amino acid sequence of a protein
substantially modify phase transition behavior of biopolymers. These data can be used
to benchmark analytical and computational models of phase transitions.
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2.2 Results
2.2.1 Turbidity Assays Screened for Effects of Amino Acid Substitutions on LLPS
To systematically screen for the effects of UBQLN2 mutations on LLPS, we
monitored the change of A600 values between 16 °C and 60 °C of samples containing a
fixed protein concentration and buffer composition (see Materials & Methods). Previous
work from our lab showed that high and low A600 values correlate with UBQLN2 droplet
formation and droplet clearance, respectively (Dao et al., 2018). To ensure
reproducibility, we repeated these assays a minimum of eight times using at least two
purified protein stocks (Figure 2.3C).
Wild-type UBQLN2 undergoes two temperature-responsive phase transitions
(Figure 2.1C). Critical solution temperature is the temperature at which miscibility of two
liquids is disturbed when the temperature is raised (LCST- lower critical solution
temperature) or lowered (UCST- upper critical solution temperature). When the
temperature of the solution is below the LCST, or above the UCST, the solute is miscible
with a solvent; and when the temperature is above LCST, or below UCST, LLPS can
happen (Seuring and Agarwal, 2012). First, UBQLN2 phase separates as temperature
is increased between 16 and 45 °C. This phase transition has a LCST (lower critical
solution temperature), below which the protein solution is always mixed, regardless of
protein concentration. Second, a solution of phase-separated UBQLN2 becomes less
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turbid as temperature is increased between 45 and 60 °C. This second phase transition
has a UCST (upper critical solution temperature), above which the protein solution is
always mixed. Together, these data are indicative of phase behavior following a
UCST+LCST closed loop phase diagram (Figure 2.4A) (Ruff et al., 2018). Turbidity was
generally reversible when temperature was decreased from 60 to 16 oC (Figure 2.3D).
These results are consistent with our prior work (Dao et al., 2019).
Focusing first on the overall turbidity assay trends across all positions, we
immediately noticed that mutations in sticker positions 497, 506, and 564 substantially
impacted the temperature ranges where phase separation was observed, as compared
to mutations in spacer positions 525 and 538. There is considerable variation in the
extent of phase separation among the different amino acid substitutions in the sticker
positions. It is important to note that for positions 497, 506 and 525, the wild-type amino
acid is proline whereas for positions 538 and 564, it is valine. Regardless of the wildtype amino acid, the trends for spacer positions 525 and 538 were nearly identical. In
contrast, the overall extent of phase separation for the sticker substitution at position
564 was greatly reduced compared to positions 497 and 506. The turbidity data across
the five positions were consistent with our initial hypothesis that residues 497, 506, and
564 are stickers whereas residues 525 and 538 are spacers (Figure 2.1C).
Second, we organized our turbidity assay results by amino acid type: hydrophobic
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(A, G, I, L, M, P, V), aromatic (F, W, Y), basic (H, K, R), acidic (D, E), and polar (C, N, Q,
S, T). We note the difficulties in assigning amino acids to these classes, particularly G
and P due to their roles in modulating protein flexibility and solubility (Holehouse and
Pappu, 2018). We presented our amino acid substitutions in terms of decreasing
hydrophobicity, largely following the experimental hydrophobicity scale determined by
(Urry et al., 1992). Among the sticker positions 497, 506, and 564, increased
hydrophobicity promoted UBQLN2 LLPS and lowered the temperature threshold for
phase separation. Aromatic substitutions at the sticker positions decreased the
temperatures when phase separation was first observed, in many cases below 16 °C,
the starting temperature of the experiment. Notably, the effects on the mutations on the
turbidity profiles varied by position even among stickers. For example, UBQLN2
mutants with Ile or Phe substitutions at position 506 remained turbid for the entire
temperature range (16-60 °C), whereas phase-separating solutions of P497F and P497I
began clarifying at 40 °C. These observations illustrated that Ile and Phe substitutions to
both P497 and P506 impact LCST and UCST phase transitions, but via different
mechanisms. Of the 95 mutants, only six visibly aggregated during the turbidity assay
experiments: P497H, P497S, P497N, P497Q, P506N, and P506Q (Figure 2.3E). Of
these, two are disease-linked mutations (P497H and P497S). Although the effects of the
spacer mutations on LLPS were much less drastic compared to those in the sticker
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positions, we still observed large increases in the absolute intensity of the absorbance
signal, especially among substitutions to aromatic and more hydrophobic residues. It is
possible that these substitutions made the spacer positions more sticker-like, hence
increasing the degree of phase separation of the solution. Moreover, the turbidity assay
does not directly measure the number of droplets, but the scattering of the samples.
Scattering is highly dependent on differences in the size of the droplets, which might
change as the result of the substitutions. One notable similarity between stickers and
spacers was the effect of Asp and Glu substitutions, both of which significantly disrupted
phase separation at all positions tested. Together, these data emphasize that
perturbations to LLPS properties of proteins are very sensitive to both the type of amino
acid substitution and the position in the amino acid sequence.
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Figure 2.1. Turbidity assay screens for mutants in sticker and spacer regions of
UBQLN2 450-624.
(A) Domain architecture of UBQLN2 450-624 with STI1-II, PXX, and UBA domains
colored as cyan, magenta, and green, respectively. Highlighted in yellow are regions
identified by NMR to promote UBQLN2 oligomerization and hypothesized to be
“stickers” (Dao et al., 2018). Red and blue labels represent sticker and spacer positions
studied here, respectively. Immediately below marks the location of ionizable residues
and their expected charge state at pH 7. All of the arginines and most of the negatively
charged residues reside in the folded UBA domain. (B) Fraction of the different types of
amino acids in UBQLN2 450-624, which is high in hydrophobic, polar, glycine and
proline and depleted of aromatic and charged residues. Pie chart follows the general
organization in (Ruff et al. 2018). (C) Results from spectrophotometric turbidity assay as
a function of temperature comparing LLPS of different UBQLN2 mutants using 50 μM
protein in 20 mM NaPhosphate and 200 mM NaCl (pH 6.8). The blue asterisks
represent WT UBQLN2 turbidity profile for each position. The red asterisks represent
mutants that form unevenly distributed aggregates at one point during the assay.
P497H, S, N and Q formed aggregates early in the experiment, whereas P506N and Q
aggregated at temperatures above 44 °C). Turbidity profiles of amino acid substitutions
at each position are separated by amino acid type: aromatic, hydrophobic, basic, polar,
and acidic. Hypothesized stickers and spacers are color-coded red and blue,
respectively, at the top. This figure has been reproduced with permission from (Yang et
al., 2019) (Appendix II)
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Figure 2.2. (A) Amino acid sequence of UBQLN2 450-624 construct, with yellow
highlighting putative sticker regions as suggested from panel B. (B) Chemical shift
perturbation (CSP) plot adapted from (Dao et al., 2019) showing which residues exhibit
concentration-dependent backbone amide chemical shifts between 50 µM and 350 µM
protein concentrations. Gray bars denote NMR signals that broadened beyond detection
at high protein concentration. (C) Rank order plot of amino acids and their occurrence
percentage in UBQLN2 450-624. This figure has been reproduced with permission from
(Yang et al., 2019) (Appendix II)
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Figure 2.3. (A) SDS-PAGE gels showing the purity of representative P506 and V538
UBQLN2 mutants. Molecular weight markers are labeled on left side in kDa. V538R
(marked by a red asterisk) migrated faster than other mutants, but molecular weight was
verified by mass spectrometry in (B). (B) Electrospray mass spectra of V538R and
P506G as representative UBQLN2 mutants. Mass spectrometry showed the molecular
weight of V538R is 17798 Da (calculated: 17799 Da) and P506G is 17700 Da
(calculated: 17702 Da). All samples were confirmed by mass spectrometry before
assays were done. (C) Representative UBQLN2 mutants (P506G, P497W and V538T)
showed reproducibility among turbidity assays. Turbidity curves were averaged over at
least 8 trials, and error bars represent standard deviations. (D) Spectrophotometric
turbidity assays in both sticker region (P506) and spacer region (V538) showed
reversibility as temperature was decreased from 60 to 16 °C. All the assays were
conducted under the same condition as the assays in Figure 1C. The blue asterisks
represent WT UBQLN2 turbidity profile for each position. The red asterisks in P506N
and Q represent unevenly distributed aggregates at temperatures after 44 °C. (E)
Cuvettes with P497N and Q samples after the turbidity assays. Visible aggregates were
observed at the bottom of the cuvettes. This figure has been reproduced with
permission from (Yang et al., 2019) (Appendix II)
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2.2.2 Effects of Amino Acid Substitutions on Phase Diagrams
To quantitatively compare the effects of single amino acid substitutions on phase
transitions of UBQLN2 and determine the driving forces for UBQLN2 phase separation,
we experimentally obtained temperature-concentration phase diagrams for the 19
substitutions at two representative positions: a sticker residue (P506) and a spacer
residue (V538) (Figure 2.4). At a protein concentration for which no LLPS was observed
at the start of the experiment, we carried out temperature-ramping turbidity assays and
determined Tcp(infl), the cloud point temperature at the inflection point of the transition
(Osváth and Iván, 2017) (Figure 2.5). There are other methods to characterize the
conditions when phase transitions occur, including using microscopy to monitor onset,
or applying a threshold to changes in absorbance-temperature curves. For practical
reasons, we chose the inflection point, T cp(infl), for comparison across different protein
samples. The experimental Tcp at different protein concentrations were used to map out
the coexistence curves (Figure 2). Since UBQLN2 exhibits both LCST and UCST phase
transition behavior, Tcp associated with the LCST transition were determined by
increasing temperature from 16 to 60 oC, whereas Tcp values associated with the UCST
transition were determined by starting turbidity assay experiments at 60 oC and ramping
down to 16 oC (see Materials and Methods). We tried these experiments at low (μM) as
well as high (up to 3 mM) protein concentrations. However, the protein solutions were
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always cloudy or contained aggregates at the higher concentration ranges at the start of
the experiments (both 16 and 60 oC). Therefore, we focused on obtaining the lowconcentration arm (cs) of the coexistence curves (Figure 2.4A). As expected from the
turbidity assays (Figure 2.1C), the experimental phase diagram for WT UBQLN2
resembles that of a UCST-LCST closed loop phase diagram, indicating two
temperature-responsive phase transitions between 16 and 60 oC (Figure 2.4B).
Strikingly, amino acid substitutions at sticker position 506 not only shifted the
position of the coexistence curves but also changed the overall shape of the phase
diagram (Figure 2.4B). Meanwhile, amino acid substitutions at spacer position 538 only
mildly shifted coexistence curves, but generally displayed a phase diagram with similar
shape to that of WT. In other words, mutations at position 538 minimally perturbed the c s
needed for LLPS. These observations are entirely consistent with the expected
behaviors of stickers and spacers (Posey et al., 2018; Wang et al., 2018). The major
exception to these observations were acidic amino acid substitutions, for which the cs
values of the dilute phase were greatly increased for all positions (see below).
Among the classes of amino acid substitutions, aromatic and hydrophobic amino
acid mutations at sticker position 506 substantially affected the phase diagram of
UBQLN2. Furthermore, increasing hydrophobicity of the amino acid substitution
correlated with decreasing cs values of the LCST phase transition. The coexistence
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curves all shifted to the left as hydrophobicity of the amino acid substitution increased.
These data are completely consistent with our prior work that showed lowered c s of
UBQLN2 for hydrophobic disease-linked mutations T487I and P497L (Dao et al., 2019).
Together, the data suggest the importance of the hydrophobic amino acids in driving
UBQLN2 phase separation. Indeed, many of the amino acids in sticker regions are
hydrophobic, as we previously characterized (Figure 2.2A) (Dao et al., 2018).
At position 506, aromatic substitutions substantially changed the shape of
UBQLN2’s phase diagram, but differently depending on the amino acid. Tyr and Trp
mutations shifted the UCST arm of the phase diagram downwards compared to WT,
with UCST cloud point temperatures below 50 °C at least up to 200 μM protein
concentrations. The Phe substitution was always phase separated over the entire
temperature range tested, except at low protein concentrations (< 20 μM). On the other
hand, the Phe substitution at position 538 minimally impacted the overall shape of the
phase diagram, while all aromatic substitutions at this position imposed a leftward shift
of the coexistence curves to lower protein concentrations. Notably, we could not obtain
V538 Tyr and Trp UCST phase transition cloud points since we could not establish clear
baselines at 60 oC for any protein concentrations that exhibited turbidity during the
temperature ramping assays. Therefore, these cloud point values are likely to be > 60
°C. We speculate that the aromatic substitutions impart sticker-like properties to position
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538, thus decreasing the cs values for LLPS. It is apparent that 𝜋-stacking interactions
involving aromatic amino acids promote LLPS in other systems, such as FUS and TDP43 (Li et al., 2018; Wang et al., 2018).
Polar substitutions at the sticker but not spacer position affected the phase diagram
of UBQLN2. This makes sense given the polar amino acid composition (Figure 2.1B). At
position 506, both LCST and UCST transitions were perturbed. Interestingly, the LCST
transitions of Ser, Thr, and Gln substitutions nearly superimposed, while the UCST arm
of the coexistence curves decreased in the order C > S > T. We also noted that five of
the six substitutions that produced aggregates were polar substitutions: P497S, P497Q,
P497N, P506Q, P506N.
Basic amino acid substitutions shifted coexistence curves to the left, with little
difference among the three basic amino acids (His, Lys, Arg). The effects were more
substantial for the sticker position than for the spacer. Interestingly, acidic amino acid
substitutions had the opposite effects and greatly increased the saturation
concentrations needed for UBQLN2 LLPS, as well as narrowing the temperature region
where the protein phase-separated. We speculate that these effects can be partially
explained by the bulkiness of the side chain substitution (for Arg and Lys whose side
chains have some hydrophobic character) as well as the charge state of the UBQLN2
construct. At 25 °C, the predicted pI or isoelectric point of the UBQLN2 450-624
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construct is approximately 4.4, with < 7% of the protein containing ionizable residues
(Figure 2.1B). This means that the protein is negatively charged at pH 6.8, the pH
chosen for our experiments. Introduction of positive charges provides attractive
Coulombic interactions between the substitution and the overall charge of the protein,
thereby promoting intermolecular interactions between UBQLN2 molecules to drive
phase separation. In contrast, acidic substitutions may do the opposite, potentially
providing repulsive interactions between UBQLN2 molecules and decreasing phase
separation.
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Figure 2.4. Temperatureconcentration phase diagrams for
representative sticker and spacer
residues in UBQLN2.
(A) Schematic of a closed-loop phase
diagram showing both UCST and LCST
behaviors. The black dots represent the
experimental data points for the low
concentration arm obtained in this study
to partially map out the phase diagram.
(B) Effects of amino acid substitutions in
the sticker (pink, P506) region, and in the
spacer (cyan, V538) region compared to
WT UBQLN2 (black). Circled in black are
D and E mutants for each position. (C)
Effects of amino acid substitutions
separated by amino acid type: aromatic
(F, W, Y), hydrophobic (A, G, I, L, M, P,
V), basic (H, K, R), polar (C, N, Q, S, T),
and acidic (D, E). The dashed lines are
guides that connect the UCST phase
transition cloud point temperatures to the
LCST ones. Both arms of P506N and the
UCST arm of P506Q are missing due to
formation of aggregates during the
assays. The UCST arms for V538W,
V538Y, V538R, V538K, P506D and
P506E are missing since we observed
either no turbidity or non-zero turbidity
values at 60 oC at all concentrations
tested. This figure has been reproduced
with permission from (Yang et al., 2019)
(Appendix II)
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Figure 2.5. Four Parameter Logistic Regression analyses of spectroscopic data to map
out the lower concentration arms for UBQLN2 450-624 mutants (see Methods).
Representative curves and fits for V538L and P506L LCST and UCST arms are shown.
Protein concentrations (in μM) are shown on either top left (LCST) or top right (UCST)
corners of each plot. The black arrows denote the cloud point temperatures obtained
from fitting the four parameter logistic regression equation (Equation 1) to the data. This
figure has been reproduced with permission from (Yang et al., 2019) (Appendix II)
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2.2.3 Hydrophobic Sticker but Not Spacer Substitutions Altered Droplet
Morphology and Increased Viscoelastic Properties
Mapping out the lower concentration arms of the phase diagram allowed us to
evaluate the effects of the substitutions on the dilute phase. However, what are the
consequences of the substitutions on the dense phase? To answer this, we first used
microscopy to investigate the morphology of UBQLN2 droplets of representative amino
acid substitutions from the different classes of residues, including W (aromatic), L and G
(hydrophobic), R (basic), Q (polar) and E (acidic) across the five positions studied here
(Figure 2.6A). In general, the droplet morphologies at these different positions
correlated well with the turbidity assay results. Mutants exhibiting similar turbidity
profiles as WT UBQLN2 (e.g. P525 and V538 mutants) produced spherical droplets of
similar size as WT. Mutants that exhibited significantly enhanced turbidity (P497W,
P497L, P506W, P506L) also formed amorphous droplets (Figures 2.1C and 2.6A).
Microscopy also confirmed the existence of aggregates as observed in the turbidity
assays for P497Q (P506Q aggregates were observed at temperatures higher than 37
oC

during the turbidity assays and therefore were not seen under the microscope).

Surprisingly, acidic substitution E, which showed little or no turbidity at the condition
tested, appeared to form small aggregate-like species at our experimental conditions.
Over time, these aggregate-like species sometimes morphed into droplets as observed
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for V538E (Figure 2.6A). Consistent with our hypothesis, mutations at spacer positions
525 and 538 (except V525R, P525E and V538E) had minimal effects on the
morphology of the droplets while mutations at sticker positions 497, 506 and 564 led to
different morphologies ranging from round like WT-like to amorphous and/or
aggregates.
To describe the effects of amino acid substitutions on the properties of the dense
phase quantitatively, we analyzed droplet fusion kinetics. We noticed that for many
substitutions, two fusing droplets relaxed into spherical shapes within seconds while for
other substitutions, spherical shapes were not achieved within a three-minute
experimental window (Figure 2.6B). Since the sphericity of droplets stems from surface
tension, the rates of droplet fusion report on droplet viscosity and surface tension (Feric
et al., 2016). To assess the liquidity of mutant UBQLN2 droplets, we measured the time
it took for two fusing droplets to return to a spherical shape (or round in two
dimensions). We extracted relaxation times from droplet fusion measurements for seven
amino acid substitutions at the sticker and spacer positions, 506 and 538, respectively,
of protein samples that had been incubated in phase separating conditions for 10
minutes (Figure 2.6B, Figure 2.6C). Remarkably, droplets for V538 mutants fused
quickly and with similar relaxation times as that for WT UBQLN2, despite the markedly
different types of amino acid substitutions tested. These observations are fully
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consistent with the spacer characteristics expected for position 538, in that spacer
amino acid substitutions minimally perturbed phase separation properties. In contrast,
the type of amino acid substitution at sticker position 506 had a substantial impact on
the rate of droplet relaxation. Bulky aromatic and hydrophobic substitutions resulted in
significantly slowed droplet relaxation events, but not for polar and ionizable
substitutions. These data suggest that hydrophobic and aromatic amino acids promote
UBQLN2 intermolecular interactions that increase viscoelasticity of UBQLN2 droplets as
well as drive UBQLN2 phase separation (see below).
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Figure 2.6. Amino acid
substitutions in the sticker, but
not spacer, regions affect droplet
properties.
(A) Schematic of a closed-loop
phase diagram showing both UCST
and LCST behaviors. Th
(A) Light microscopy of different
UBQLN2 mutants over 10 and 30
minutes at 37oC using 100 μM
protein at sticker (P497, P506,
V564) and spacer (P525, V538)
positions. Scale bar = 5 μm. (B)
Snapshots of droplet fusion over a
nine second window (for WT and
V538L and V538W) and a 36 second
window (for P506L and P506W),
indicating differences in droplet
fusion kinetics between substitutions
at a sticker position (P506) and a
spacer position (V538). Droplets
were imaged 10 minutes after
incubating 100 μM protein (except
for P506W, which was at 25 μM, and
P506E and V538E, which were at
300 μM) at 37 oC in buffer containing
20 mM NaPhosphate and 200 mM
NaCl (pH 6.8). Scale bar = 2 μm. (C)
Average characteristic relaxation
times for WT and mutant droplet
fusion. Error bars represent the
standard deviation (SD) over eight
droplets. This figure has been reproduced with permission from (Yang et al., 2019)
(Appendix II)
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2.2.4 Hydrophobic and Aromatic Sticker Substitutions Increase UBQLN2
Oligomerization
As UBQLN2 oligomerization is a prerequisite for phase separation (Dao et al.,
2018), we probed UBQLN2 self-association propensity using size exclusion
chromatography (SEC) under non-phase separating conditions (i.e. 20 mM
NaPhosphate without added NaCl). We previously demonstrated that WT UBQLN2 is
monomeric at low protein concentrations (up to ~100 µM), but forms higher-order
oligomers at higher concentrations (~ 500 µM). Indeed, SEC peak elution volumes for
WT decreased as protein concentration increased between 10 and 500 µM, as
expected for UBQLN2 oligomerization. Therefore, we subjected representative mutants
at each position to size exclusion chromatography using three protein concentrations
(10, 100, 500 µM).
All of the mutants studied exhibited concentration-dependent oligomerization;
increasing protein concentrations led to a decrease in elution volume (Figure 2.7).
Strikingly, almost all of the spacer mutants (P525 and V538) exhibited a concentrationdependence that followed the pattern of WT UBQLN2. The only exception was P525E
where a small population of large particles eluted near the void volume (around 9 mL).
Of all the E mutants, P525E showed the most aggregates by microscopy (Figure 2.6A).
Among the sticker mutants, four oligomerized substantially more than WT: P497W,
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P497L, P506W, and P506L. Sedimentation velocity analytical ultracentrifugation
experiments showed that hydrophobic mutations T487I and P497L also produced highorder oligomers (Dao et al., 2019). V564W and V564L oligomerized slightly more than
WT but not to a significant extent since the wild-type amino acid is valine, which is
already hydrophobic. These data suggest that aromatic and hydrophobic substitutions
promote UBQLN2 self-association and thus drive LLPS at lower protein concentrations
than WT (Figure 2.4) and enhance the viscoelasticity of droplets (Figure 2.6).
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Figure 2.7. Oligomerization propensities of different UBQLN2 mutants.
Representative size exclusion chromatography profiles of UBQLN2 mutants at 10 µM
(thinnest line), 100 µM (medium-thick), and 500 µM (thickest) protein concentrations.
For each mutant, WT SEC curves were plotted in gray for visual comparison. The
standard molecular weights were labeled on top. This figure has been reproduced with
permission from (Yang et al., 2019) (Appendix II)
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Figure 2.8. Representative UBQLN2 mutants show reproducibility between SEC
trials.
(Top) Overlay of P497W trial one (black) with trial two (orange), (Middle) Overlay of
P525R trial one (black) with trial two (blue) and (Bottom) Overlay of P497Q trial one
(black) with trial two (purple) at 10 μM (thinnest line), 100 μM (medium-thick), and 500
μM (thickest) protein concentrations. This figure has been reproduced with permission
from (Yang et al., 2019) (Appendix II)
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2.3 Discussion and Conclusions
How amino acid substitutions alter thermoresponsive phase transition behavior of
proteins is critical to elucidating the driving forces of phase separation. Here, we
demonstrated that both LCST and UCST phase transition behaviors of UBQLN2 can be
differentially tuned by single amino acid substitutions. The observations herein provide
evidence that the sticker and spacer framework is useful to predicting the positions in a
given amino acid sequence that drive phase separation behavior (Posey et al., 2018;
Rubinstein and Dobrynin, 1997; Wang et al., 2018). Regardless of amino acid type,
substitutions at sticker but not spacer positions elicited major changes to the overall
shape and characteristics of the phase diagram (Figures 2.2 and 2.9).
Our original hypothesis considered the stickers of UBQLN2 to be residues that
exhibited large concentration-dependent changes in amide chemical shifts obtained by
NMR spectroscopy (Dao et al., 2018). In the sticker and spacer framework, the number
of stickers and their “stickiness” control the saturation concentrations (cs) and the
coexistence curve for LLPS, whereas spacer residues weakly modulate these
parameters. These expectations are completely in line with our observations on amino
acid substitutions at the three stickers (P497, P506, and V564) and two spacers (P525,
V538) (Figure 2.1C, Figure 2.4B). Strikingly, not only single amino acid substitutions
alone substantially shifted cs values, but the effects of these substitutions followed
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particular trends to create a rich molecular code that governs UBQLN2 LLPS.
Self-association and LLPS of UBQLN2 are mediated by hydrophobicity involving
either aliphatic or aromatic residues (Figure 2.4, Figure 2.7), in line with the hydrophobic
composition of the amino acid sequence (Figure 2.1B). At position 506, decreased cs
values for the LCST phase transition correlated with increased hydrophobicity of amino
acid substitution (Figure 2.10). Indeed, while we did not obtain phase diagrams for P497
mutants, the LCST transition temperatures for aromatic and hydrophobic substitutions
at P497 followed the same trend as P506 (Figure 2.1C). LCST phase transitions require
hydrophobicity (Dao et al., 2018; Martin and Mittag, 2018; Ruff et al., 2018). UBQLN2
also has high proline and glycine content (Figure 2.1B), which is a frequent component
of proteins that undergo LCST phase transitions, such as Pab1, tropoelastins, and the
spindle-associated BuGZ protein (Jiang et al., 2015; Riback et al., 2017; Yeo et al.,
2011).
UBQLN2 exhibits a closed loop phase diagram with both LCST and UCST phase
transitions, such that the protein solution is well-mixed either above the UCST or below
the LCST (Figure 2.4A). The thermodynamics of the underlying phase transitions can be
explained by the entropic and enthalpic forces experienced by nonpolar particles in
water as a function of temperature (Moelbert and De Los Rios, 2003). At low
temperature, solubility of hydrophobic particles is high, partially due to water structuring
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around the hydrophobic groups. As temperature increases, the entropic cost to organize
water also increases to a point at which solvent molecules are released from
surrounding hydrophobic side chains, promoting demixing (phase separation) to
minimize the free energy of the system. In polymer solutions, dehydration of
hydrophobic groups is accompanied by attractive polymer-polymer interactions that also
contribute to demixing (Matsarskaia et al., 2016). As temperature increases further,
entropy also increases promoting a UCST transition where homogeneous mixing of the
polymer solution occurs. A decrease in polymer-polymer and solvent-solvent
interactions also promotes mixing (Falahati and Haji-Akbari, 2019). This UCST transition
is not always observed as biopolymers generally denature at high temperatures, but
UBQLN2 450-624 remains well-behaved up to 60 oC (Dao et al., 2019).
As illustrated in Figure 2.1B, >25% of UBQLN2 450-624 contains polar residues (Q,
N, S, T). Therefore, the driving forces underlying UBQLN2 phase separation are likely
due to a combination of the hydrophobic effect and polar interactions. Of note, polymers
rich in polar residues (N, Q) undergo a collapse transition reminiscent of the intra-chain
collapse in hydrophobic biopolymers, even though the underlying forces for polar
collapse likely include other interactions such as intra-chain hydrogen bonding and
amide-solvent interactions (Holehouse and Pappu, 2018; Wuttke et al., 2014).
Interestingly, the cs values for the LCST transition correlated well with the hydrophobicity
78

of the amino acid substitution at P506 when all non-ionizable residues were considered
(Figure 2.10B). Polar substitutions also promoted aggregation (Figure 2.3E).
The polar groups in UBQLN2 likely modulate the UCST transition, as favorable
polymer-polymer interactions among polar and/or ionizable tracts in IDPs such as FUS
and hnRNPA1 are considered drivers of UCST transitions in biopolymers (Lin et al.,
2017; Molliex et al., 2015). An increase and decrease in the UCST part of coexistence
curves correspond to stronger and weaker polymer-polymer interactions, respectively.
Complicating matters, hydrophobic groups also modulate UCST, and the effects of
hydrophobic amino acid substitutions on the UCST transitions in UBQLN2 are certainly
complex. At P506, increased hydrophobicity moderately tracks with decreased cloud
point temperatures for the UCST transition (Figure 2.10A). Our observations are
opposite of what was seen in designed IDP polymers, for which UCST cloud points
increased with increasing hydrophobicity. (Quiroz and Chilkoti, 2015) Interestingly, our
turbidity data profile for hydrophobic substitutions at P497 are in better agreement with
Quiroz et al. (Quiroz and Chilkoti, 2015) We must acknowledge that prolines are
structure-disrupting amino acids. In addition, peptide bonds preceding prolines can
isomerize between cis and trans conformations. Therefore, the differences in observed
turbidity profiles for proline substitutions at different positions could be partially
explained by changes to backbone conformation and flexibility. These observations
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emphasize the heterogeneity of the phase transition behavior for the same type of
amino acid substitution even among the sticker positions.
Remarkably, Asp and Glu mutations at any of the five tested positions in UBQLN2
reduced phase separation, and significantly compressed coexistence curves for V538.
Importantly, these acidic mutations are also phosphomimetic substitutions. These data
highlight the potential impact of post-translational modifications such as phosphorylation
on modulating phase separation behavior. However, the effect is likely very dependent
on the electrostatics of the protein system involved (Monahan et al., 2017; Wang et al.,
2018).
Material properties of the dense phase are also modified by amino acid substitutions
(Kato et al., 2012; Molliex et al., 2015). The liquid-liquid phase diagram therefore
includes liquid-gel phase boundaries (Lin et al., 2017) as schematized in Figure 2.9.
Indeed, the sticker and spacer framework is one formalism that quantitatively addresses
gelation (Semenov and Rubinstein, 1998). We observed that hydrophobic and aromatic
amino acid substitutions only in sticker position P506 showed significantly slowed
droplet fusion kinetics (Figure 2.6), and those same mutants exhibited increased
oligomerization propensity (Figure 2.7). At least in the UBQLN2 system, material
properties of the dense phase appear linked to the propensity for UBQLN2 to
oligomerize. We also noted that mutations that increased the propensity of
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oligomerization promoted UBQLN2 LLPS, and led to slowed droplet fusion kinetics in
Dao et al., 2019. However this is not always the case, as spacer mutations significantly
slowed droplet fusion kinetics in the FUS family of proteins (Wang et al., 2018), and
physicochemical properties of spacers in multidomain proteins modulate the liquid-liquid
and liquid-gel phase boundaries (Harmon et al., 2017).
In summary, our work here provides a rich dataset to be used as a benchmark for
analytical and computational models of phase separation. While mean-field theories
such as Flory-Huggins approximate phase separation behavior for several systems
(Brady et al., 2017; Nott et al., 2015), sequence-dependent frameworks will be essential
to capture the nuances of phase-separating systems such as UBQLN2 (Lin et al.,
2018). The sticker and spacer framework has already been used to successfully
examine the underlying forces of phase separation in the FET family of RNA-binding
proteins (Wang et al., 2018). Unraveling the complexities of solvent-solvent, polymerpolymer, and polymer-solvent interactions will establish the molecular code of phase
separating systems.
In this work, we put forth UBQLN2 450-624 as a model system to study the
physicochemical molecular determinants of phase separation. We employed a battery
of spectrophotometric, microscopy and size exclusion chromatography experiments to
systematically elucidate how amino acid substitutions at different positions in the protein
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sequence modulate phase separation. Experimental phase diagrams revealed that we
can describe UBQLN2 as an associative polymer with stickers and spacers that drive
and modulate phase separation behavior. Single amino-acid substitution can
substantially shift coexistence curves in a residue type-dependent manner. It is our
expectation that our experimental data can be used to rigorously design and benchmark
analytical models and molecular simulations of phase separation. This work can be
used to elucidate effects of disease-linked mutations in phase-separating systems as
well as to design thermoresponsive biopolymers.
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Figure 2.9. Illustration of effects of UBQLN2 sticker and spacer substitutions on
temperature-concentration phase diagrams.
(A) Effects of spacer and different types of sticker substitutions on the shape of the
phase diagram. Amino acid substitutions in sticker regions move the location and shape
of the phase boundaries. However, high concentration arms are hypothetical and for
illustration purposes only. We hypothesize that the high concentration arms of some of
the sticker mutants also move as we observed changes to the material properties of the
dense phase. (B) Effects of mutations on phase diagrams and viscoelasticity. Grey and
yellow shapes represent regions where the dense phase is liquid-like and
gel/aggregate-like, respectively. (Left) Green arrow represents a condition where dense
phase is liquid. (Right) Green arrow represents a condition where dense phase is solidlike (i.e. gel-like consistency). This figure has been reproduced with permission from
(Yang et al., 2019) (Appendix II)
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Figure 2.10. Correlation between saturation concentration (cs) and hydrophobicity
(A) Correlation between saturation concentration (cs) and hydrophobicity for the UCST
arm (left) and LCST arm (right) for P506 mutants G, A, V, M, I, L and WT (P). The
hydrophobicity is based on z-scores of the Kyte-Doolittle scale (Kyte and Doolittle,
1982). (B) Correlation between saturation concentration c s and hydrophobicity for the
LCST arm of WT and all 19 substitutions to P506 (left) and hydrophobic, aromatic and
polar substitutions (excluding D, E, R, K, H and P) to P506 (right). The hydrophobicity is
based on the Hopps-Wood scale (Hopp and Woods, 1981). The cs values were
calculated from a linear fit to either the UCST or LCST arm of each mutant from Figure
2C. The cs values for the LCST and UCST arms of each P506 mutant were calculated
at 23 and 45 oC, respectively. Equations for linear fits are shown at the top of the
individual graph with Pearson correlation coefficient (R). This figure has been
reproduced with permission from (Yang et al., 2019) (Appendix II)
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2.4 Material and Methods
2.4.1 Subcloning, Protein Expression, and Purification
UBQLN2 mutants were generated from UBQLN2 450-624 using Phusion SiteDirected Mutagenesis Kit (Thermo Scientific). A tryptophan codon was added to the Cterminal end of all constructs to facilitate determination of protein concentration.
UBQLN2 450-624 and all the mutants were expressed and purified as described in (Dao
et al., 2018). Briefly, the constructs were expressed in E. coli Rosetta 2 (DE3) pLysS
cells in Luria-Bertani (LB) broth at 37°C overnight. Bacteria were pelleted, frozen, lysed,
then purified via a “salting out” process. NaCl was added to the cleared lysate to the
final concentration of 0.5 M - 1 M. UBQLN2 droplets were pelleted and then
resuspended in 6 M urea, 20 mM NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02%
NaN3 (pH 6.8). Leftover NaCl and urea were removed through HiTrap desalting column
(GE Healthcare). All the cysteine mutants were subjected to size exclusion
chromatography over a Superdex 75 HiLoad 16/600 column (GE Healthcare) or an
ENrich SEC 650 10 x 300 column (Biorad) to remove dimer contaminations. SDS-PAGE
gels were performed to confirm the purity of the proteins (Figure 2.3A). The identity and
molecular weight of each mutant was verified using electrospray mass spectrometry in
positive mode on a Shimadzu 8040 MS (Figure 2.3B). Purified proteins were frozen at
−80°C.
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2.4.2 Spectrophotometric Absorbance/Turbidity Measurements
Protein samples were prepared by adding protein (from stock to a final
concentration of 50 μM unless otherwise noted) to cold sodium phosphate buffer (pH
6.8, 20 mM NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3) containing 200
mM NaCl and were kept on ice for at least 5 minutes before the assay. Absorbance at
600 nm was recorded as a function of temperature by a Beckman DU-640 UV/Vis
spectrophotometer using a temperature ramp rate of 2°C/min increasing from 16°C to
60°C and then ramped down to 16°C. Net absorbance values were recorded after
subtracting the absorbance value of a buffer control. Results were averaged from data
collected using proteins from at least two separate preps and four trials for each (total n
≥ 8) (Figure 2.3C). Data were plotted using Mathematica (Wolfram Research).

2.4.3 Phase diagram measurements
For the LCST (lower critical solution temperature) phase transition, i.e. mapping the
phase boundary as temperature is increased, protein samples were prepared as
described for the turbidity measurements. For the UCST (upper critical solution
temperature) arm, protein samples were prepared by mixing protein and buffer/salt
solutions that were incubated at 63°C for at least 10 minutes. Absorbance at 600 nm
was recorded as a function of temperature by a Beckman DU-640 UV/Vis
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spectrophotometer using a temperature ramp rate of 2°C/min decreasing from 60°C to
16°C. Two trials (n = 2) were conducted using four to five different concentrations of
wild-type and mutant UBQLN2 450-624 proteins for each arm. The protein
concentrations were chosen to cover as wide a range as possible to allow observation
of phase separation during the temperature ramps but not at the starting temperatures
(16°C and 60°C for LCST and UCST arms, respectively). Cloud point temperatures
were determined by fitting a Four Parameter Logistic Regression model to the data
(Figure 2.5).
𝑦=𝑑+

𝑎−𝑑
𝑥 𝑏
𝑐

(Equation 1)

1+( )

Cloud point temperatures used were the points of inflection (c). Cloud point
temperatures were then used to define the coexistence curve as a function of protein
concentration. The temperature ramp rate was either 1°C or 2°C/min, whichever yielded
the most reproducible, consistent turbidity profiles and phase diagrams. Fitting and
plotting of data were done with Kaleidagraph (Synergy Software).

2.4.4 Bright-field Imaging of Phase Separation
UBQLN2 450-624 constructs were prepared to contain 100 μM protein in 20 mM
NaPhosphate, 200 mM NaCl, 0.1 mM TCEP,and 0.5 mM EDTA (pH 6.8). Samples were
added to MatTek glass bottom dishes that had been coated with 5% bovine serum
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albumin (BSA) to minimize changes as a result of surface interactions, and incubated at
37 oC. Phase separation was imaged on an ONI Nanoimager (Oxford Nanoimaging Ltd,
Oxford, UK) equipped with a Hamamatsu sCMOS ORCA flash 4.0 V3 camera using an
Olympus 100×/1.4 N.A. objective. Images were prepared using Fiji (Schindelin et al.,
2012) and FigureJ plugin (Mutterer and Zinck, 2013).

2.4.5 Droplet Fusion Assays
UBQLN2 450-624 constructs were prepared to contain 100 μM protein in 20 mM
NaPhosphate, and 0.5 mM EDTA (pH 6.8), with the exception of P506W at 25 μM
protein and P506E and V538E at 300 μM protein. Samples were added to MatTek glass
bottom dishes that had been incubated with 5% BSA (to minimize changes as a result of
surface interactions), and incubated at 37 oC. Phase separation was initiated with the
addition of NaCl to a final concentration of 200 mM. After 10 minutes of incubation,
droplet formation was imaged as time-lapsed sequences for three minutes on an ONI
Nanoimager (Oxford Nanoimaging Ltd, Oxford, UK) equipped with a Hamamatsu
sCMOS ORCA flash 4.0 V3 camera using an Olympus 100×/1.4 N.A. objective. Five
trials were performed for each mutant. Droplets chosen for analysis were of similar size
and ranged between 2 and 4 microns, except for V538E (8 microns) and P506E (5
microns). For each mutant, eight fusion events were chosen for analysis and saved as
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separate TIFF images including frames from the initial fusion event.
Relaxation times (time it takes for two fusing droplets to return to a round shape)
were determined by manually measuring the major axis (a) and the minor axis (b) in
pixels using Fiji software (Schindelin et al., 2012) and calculating the aspect ratio as
α=a/b. We monitored the fusion events in this way until the droplets reached their most
relaxed state, or until the aspect ratio was approximately equal to 1. The aspect ratio for
each fusion event was fit to an exponential decay curve in Matlab (Mathworks).
𝑦 = (𝛼0 )−𝜏∗𝑥 + 𝑐

(Equation 2)

where 𝛼0 is the initial aspect ratio, 𝑥 is time, and 1/𝜏 gives the characteristic
relaxation time.

2.4.6 Size Exclusion Chromatography
Purified UBQLN2 constructs at different concentrations (10 μM, 100 μM, 500 μM)
were subjected to chromatography over a ENrichTM SEC 650 10 x 300 column (Biorad)
on a Biorad NGC FPLC system. Experiments were conducted using 250 μL of protein at
ambient temperature using 1 mL/min flow rate in pH 6.8 buffer containing 20 mM
NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP with no added NaCl. Standard molecular
weights were determined by subjecting a sample of Gel Filtration Standard (BioRad
#1511901) over the column at the same condition.
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Chapter III:
Polyubiquitin Chain Linkage and Length Dependence on UBQLN2
Phase Separation

The work presented in this chapter is unpublished.

In this chapter, there were experimental contributions from Dr. Thuy Dao, on
experiments including subcloning, expression and purification of K63-linked, K11-linked
and M1-linked polyUb chains and HOTag-Ub, and microscopy data collection and
analysis. Solution small-angle X-ray scattering (SAXS) data were collected by The
Advanced Photon Source at Argonne National Laboratory.
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Abstract
Ubiquitin (Ub) is an essential signaling protein that drives many biological
processes in eukaryotic cells. Proteins destined for degradation are typically tagged with
ubiquitin or polyUb chains. Ubiquilin-2 (UBQLN2), a ubiquitin-binding shuttle protein in
cells, is involved in protein quality control (PQC) mechanisms including proteasomal
degradation and autophagy pathways, which are generally but not exclusively, signaled
by K48-linked and K63-linked polyUb chains, respectively. We recently showed that
UBQLN2 undergoes liquid-liquid phase separation (LLPS) in vitro, and the droplets are
disassembled when ubiquitin is added.
To study how polyUb chains of different length and linkages modulate UBQLN2
phase transitions, we enzymatically assembled polyUb chains of different linkages (K48,
K63, K11 and M1) and lengths (Ub2, Ub3 and Ub4). We observed LLPS by UV-Vis
spectrophotometry assays and microscopy, and obtained experimental phase diagrams.
Our data showed that mono-Ub drives the disassembly of UBQLN2 droplets. In
addition, compact Ub4 chains (K11, K48) largely drove disassembly of UBQLN2
condensates, whereas extended and flexible Ub4 chains (K63, M1) acted as scaffolds
to promote multi-component LLPS via heterotypic interactions with UBQLN2.
To examine the binding between UBQLN2 and polyUb chains on an atomic level,
nuclear magnetic resonance (NMR) spectroscopy experiments were performed. The
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results suggested that binding affinity (Kd) between UBQLN2 and polyUb chains is not
the key factor that affects how the chains modulate UBQLN2 phase behavior. Instead,
chain conformation and accessibility of the Ub interacting surface affect UBQLN2 phase
separation. These observations provide mechanistic insights to how UBQLN2 could
differentiate between proteasomal degradation and autophagy pathways via LLPS.
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3.1 Introduction
Cells must maintain protein homeostasis to survive and function properly. The
cellular homeostasis is normally monitored by a mechanism called protein quality
control (PQC) (Hipp, Kasturi, and Hartl 2019), which is important in facilitating protein
folding, responding to the accumulation of protein aggregates, and keeping proteome
balance. Proteome balance means proper protein folding and functions maintained by
the proteostasis network (Ciechanover and Kwon 2017; Zheng, Yang, and Castañeda
2020; Hutt and Balch 2010). Maintaining protein homeostasis is challenging due to
environmental stress, aging and the limited protein folding capacity in cell. Protein
folding takes place in the endoplasmic reticulum (ER), but due to the limited space and
amount of chaperones and folding enzymes, the functional capacity of ER is restricted
(Levine et al. 2005; Christis et al. 2010). Dysfunctional PQC and dysregulation of
homeostasis are associated with neurodegenerative diseases such as Amyotrophic
lateral sclerosis (ALS), Huntington’s disease (HD), Alzheimer’s disease (AD), and
Frontotemporal dementia (FTD) (Douglas and Dillin 2010; Renaud et al. 2019; Taylor,
Brown Jr, and Cleveland 2016). Functional PQC mechanisms ensure that proteins are
not misfolded in cells and that misfolded proteins are cleared in a timely manner.
However, targeting substrates for degradation in PQC pathways can be difficult because
of the crowded and highly complex nature of the cellular environment (Zheng, Yang, and
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Castañeda 2020). To solve the problem, cells employed shuttle proteins that have the
dual capability to interact with both the substrate and degradation machineries.
Shuttle proteins are usually defined by a UBL-UBA domain architecture, whereby
the UBL (Ubiquitin-Like) domain interacts with proteasomal receptors and the UBA
(Ubiquitin-Associated) domain interacts with ubiquitin or polyubiquitin (polyUb) chains
tagged on the substrate for degradation (X. Chen et al. 2019; Ko et al. 2004). Ubiquilins
(UBQLNs) are part of the UBL-UBA shuttle protein family, which suggests that they
chaperone misfolded proteins and facilitate degradation of substrates through multiple
pathways including the ubiquitin-proteasome system (UPS), autophagy, and
endoplasmic-reticulum-associated protein degradation (ERAD) pathways (Ko et al.
2004; Yun Lee, Arnott, and Brown 2013; Lim et al. 2009; El Ayadi et al. 2013). These
protein degradation pathways are essential for maintaining protein quality control in
cells (Figure 3.1). Misfolded small proteins and large aggregates mostly are cleared by
UPS and autophagy, respectively, signaled by different polyUb chains. However, the
functionality of UBL-UBA shuttle proteins is not completely understood due to the
number of shuttle proteins and diversity in their domain architectures. Significant gaps
of knowledge exist, including how Ub-binding shuttle proteins decide whether to target
ubiquitinated proteins to proteasome or autophagosome for degradation? Is the
decision-making done via interactions with polyUb chains of different linkages?
99

Ubiquitin (Ub) is a compact protein consisting of 76 amino acids. It has a L8-I44-V70
hydrophobic patch (Figure 3.1A) which is important for interacting with other proteins
(Pickart and Fushman 2004a). Ub can form polyUb chains, and both ubiquitin and
polyUb signal for many essential cellular processes in eukaryotes (Hicke and Dunn
2003; L. Sun and Chen 2004; Dikic and Dötsch 2009). Ub forms polyUb chain tag onto
the protein substrate. The C-terminus of one Ub is covalenty connected to the ε-amino
group of any of the seven lysines (K6, K11, K27, K29, K33, K48, K63) of the other Ub,
or the N-terminal methionine (M1) of the Ub, with the help of E1 ubiquitin-activating
enzyme, E2 ubiquitin-conjugating enzymes and E3 ubiquitin ligase enzymes (Pickart
and Fushman 2004a; Aalto et al. 2019). K48-linked and K63-linked polyUb chains are
the most abundant linkages of polyUb chains in eukaryotic cells (Zientara-Rytter and
Subramani 2019). K48-linked polyUb generally signals misfolded proteins to the
proteasome for degradation, while K63-linked polyUb play a role in autophagy (Pickart
2000) (Figure 3.1A). Because of the difference in positions of the lysines in Ub, each of
the lysine linkages presents unique structures (Figure 3.1B). Related to this work, M1and K63-linked Ub chains generally display open conformations, whereas K11- and
K48-linked Ub chains adopt compact conformations (Komander and Rape 2012;
Zientara-Rytter and Subramani 2019; Pickart 2000; Pickart and Fushman 2004a;
Castañeda, Dixon, et al. 2016; Castañeda et al. 2013). In addition, different linkages
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exhibit different dynamical properties, and signals for different cellular processes. For
instance, K6-linked polyUb chains are important in DNA repair (Wu-Baer, Ludwig, and
Baer 2010, 1). K11-linked polyUb chains, together with other regulatory proteins, play a
role in the protein degradation pathways including UPS (A. Williamson et al. 2009) and
ERAD (P. Xu et al. 2009). In addition, K11-linked polyUb chains participate in the cell
division process (Bremm and Komander 2011). K27-linked polyUb chains and K33linked polyUb chains are associated with innate immune system regulation (Arimoto et
al. 2010; J. Liu et al. 2014; Birsa et al. 2014). K29-linked polyUb chains play a role in
the regulation of mRNA stability (Fei et al. 2013; Zhou et al. 2013).
As shown in Chapter 2, UBQLN2 undergoes liquid-liquid phase separation (LLPS)
in vitro and is recruited to stress granules in cell (Dao et al. 2018; Yang et al. 2019).
Importantly, UBQLN2 droplets are disassembled when ubiquitin is added (Dao et al.
2018). Since ubiquitin commonly exists as polyUb chains in cells, which signal for
different cellular events, we hypothesized that polyUb chains of different length and
linkages differentially modulate UBQLN2 phase transitions. To test this, we
enzymatically assembled polyUb chains of different linkages (K48, K63, K11 and M1)
and lengths (Ub2, Ub3 and Ub4), observed LLPS by UV-Vis spectrophotometry assays
and microscopy, and obtained experimental phase diagrams. To study the interactions
between UBQLN2 and polyUb chains, we conducted nuclear magnetic resonance
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(NMR) spectroscopy and determined binding affinity (Kd). Our data suggested that chain
conformation and accessibility of the Ub interacting surface, not binding affinities
between UBQLN2 and polyUb chains, affect UBQLN2 phase separation. These
observations provide mechanistic insights to how UBQLN2 could differentiate between
proteasomal degradation and autophagy pathways via LLPS.

Figure 3.1. PolyUb chains signal for different cellur processes.
(A) Ribbon and ball conformation of ubiquitin (left). The yellow balls on ubiquitin
represent the hydrophobic path of the protein (L8, I44 and V70). On the right two major
protein degradation pathways are showed, UPS and autophagy. K48-linked polyUb
chains generally signal misfolded proteins to the proteasome for degradation, whereas
K63-linked polyUb chains generally signal for autophagy. (B) Cartoon structures
represent the conformations of K48-Ub4, K11-Ub4, K63-Ub4 and M1-Ub4. Each yellow
ball represents a Ub unit. Different linkages adopt different conformations.
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3.2 Results
3.2.1 Enzymatic assembly of polyUb chains
Towards our objectives, it is necessary to assemble polyUb chains of different
linkages for biochemical study. In cells, polyUb chains are formed on substrates. This
process is called ubiquitination, which occurs through sequential steps catalyzed by Ubactivating enzyme (E1), conjugating enzyme (E2), and ubiquitin ligase (E3) (Pickart and
Fushman 2004b). Here, we used an enzymatic assembly approach to construct polyUb
chains (Pickart and Fushman 2004b; Pickart and Raasi 2005; Varadan et al. 2002).
K48-linked polyUb chain assembly is shown in Figure 3.2A as an example. Two
enzymes are needed, specifically, E1 and E2 (Pickart and Raasi 2005; Varadan et al.
2002). The carboxyl terminus of ubiquitin forms a thioester bond with the active-site
cysteine of E1 via an ATP-dependent process, followed by ubiquitin transfer to a
cysteine residue at the active site of E2. The ubiquitin activating enzyme used was
mouse E1 and the ubiquitin conjugating enzyme was mammalian enzyme E2-25K,
which specifically assembles K48-linked polyUb chains (Haldeman et al. 1997).
Different E2s were used for the assembly of polyUb chains of different linkages.
K48-Ub2 was first assembled, then K48-Ub3 and K48-Ub4 (Figure 3.2A). To get the
pure dimer, chain-terminating mutant forms of Ub monomers were used. One Ub cannot
be conjugated to another Ub as K48 has been changed into arginine, while the other Ub
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cannot conjugate through its C-terminus because it carries an extra residue V77. By
using these blocked Ub monomers, pure K48R Ub-V77 Ub dimer can be made. To
make longer Ub chains, ubiquitin carboxyl-terminal hydrolase Yuh1 was added to
remove the amino acids after the natural G76 C-terminus, resulting in a K48R Ub-WT
Ub dimer, which presents a free C-terminal end that can be used to conjugate a third
Ub. By adding one Ub at a time, polyUb chains can be built. SDS-PAGE gel showed the
purity of the protein samples (Figure 3.2B).
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B

Figure 3.2. Enzymatic assembly of polyUb chains (K48, K63, K11 and M1)
(A) Schematic for synthesis of K48-linked Ub4. The yellow ball denotes Ub K48R, the
blue ball denotes Ub V77 and the green ball denotes WT Ub. By adding one Ub at a
time, polyUb chains can be built. SEC represents size exclusion chromatography and
HPSP represents high performance cation exchange chromatography. (B) 4%-15%
SDS-PAGE gel showed the purify of the protein samples.
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3.2.2 Increasing valency of polyUb chains by increasing number of Ub units
promotes UBQLN2 phase separation
As shown previously by our lab, mono-Ub disassembles UBQLN2 droplets, and
K48-linked polyUb chains modulate UBQLN2 droplet disassembly in a different manner,
that is to say, the amount of Ub needed for droplet disassembly is different (Dao et al.
2018). To systematically screen for the effects of polyUb chain on full-length UBQLN2
LLPS and to visualize how mono-Ub, K48 and K63-linked Ub2, K48 and K63-linked Ub3
and K48 and K63-linked Ub4 affect full-length UBQLN2 droplet formation, we conducted
microscopy at 30 °C by mixing different ratios of [Ub]:[UBQLN2] (Figure 3.3A). Mono-Ub
and polyUb chains all cleared UBQLN2 droplets at high [Ub]:[UBQLN2] ratios, but the
amount of Ub needed varied depending on the chain. Mono-Ub cleared UBQLN2
droplets by a [Ub]:[UBQLN2] ratio of 0.4:1, while neither of the Ub2 of different linkages
was able to clear the condensates at a [Ub]:[UBQLN2] ratio of 0.4:1. K48-linked Ub3
and Ub4 disassembled UBQLN2 droplets before [Ub]:[UBQLN2] ratio reached 2.4:1,
whereas UBQLN2 condensates with K63-linked Ub4 persisted at higher [Ub]:[UBQLN2]
ratios. From these data, we clearly see that the length of polyUb chains make a
difference in modulating the phase behavior of UBQLN2. As the number of Ub units is
increased in polyUb, the range of concentration that UBQLN2 phase separates
increased.
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In addition, how polyUb chains affect UBQLN2 LLPS also depends on the linkage of
the chain. K48-Ub4 cleared the UBQLN2 droplets at a [Ub]:[UBQLN2] ratio of 2.4:1,
while K63-Ub4 didn’t fully clear the condensates until a [Ub]:[UBQLN2] ratio > 4:1 was
reached. Similar observations were seen for Ub3, which indicated that K63-linked
polyUb chains (Ub3 or Ub4) promoted the phase behavior of UBQLN2 over a much
wider [Ub]:[UBQLN2] range compared with K48-Ub3 or Ub4.
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Figure 3.3. Length and linkage dependent effects of polyUb chains on UBQLN2
LLPS.
(A) Fluorescence microscopy showing enhancement or inhibition UBQLN2 droplet
formation at increasing ratios of K48- and K63-linked polyUb chains of different lengths
at 50 µM UBQLN2 in 20 mM NaPhosphate and 200 mM NaCl (pH 6.8) at 30 ºC. For
direct comparison among different chain lengths, [Ub]:[UBQLN2] reflects the ratio
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between Ub monomers and UBQLN2 molecules. Solution is spiked with 20 nM Alexa
Fluor 647-labeled UBQLN2. Scale bar, 5 µm. (B) Representative results from
spectrophotometric turbidity assay as a function of temperature comparing the effects of
varying amounts K48- and K63-linked polyUb chains of different lengths on UBQLN2
LLPS at 30 μM UBQLN2 in 20 mM NaPhosphate and 200 mM NaCl (pH 6.8). (C)
Temperature−Component phase diagrams showing the changes in LCST phase
transition cloud-point temperatures as a function of [Ub]:[UBQLN2] ratios for different
Ub chains at different UBQLN2 concentrations. The black dashed lines denote
biologically relevant temperature 37 ºC, at which UBQLN2 at lower concentrations can
still undergo LLPS with K63-Ub4.
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3.2.3 K48- and K63-linked Ub2 modulate UBQLN2 LLPS in a similar way as monoUb, while K48- and K63-linked Ub4 affect UBQLN2 LLPS differently
To systematically screen for the effects of polyUb chains of different lengths (monoUb, Ub2, Ub3 and Ub4) and different linkages (K48 and K63) on UBQLN2 LLPS, we
monitored the change of absorbance at 600 nm between 16 °C and 60 °C of samples
containing 30 M UBQLN2 and varying amounts of polyUb chains. We previously
showed that high and low A600 values correlate with UBQLN2 droplet formation and
droplet clearance, respectively (Dao et al. 2018; Yang et al. 2019). As shown in (Dao et
al. 2018), UBQLN2 phase separates with increasing temperature, thus exhibiting a
lower critical solution temperature (LCST) phase transition. To account for different
lengths of Ub chains in this experiment, we monitored UBQLN2 LLPS as a function of
[Ub]:[UBQLN2] ratio (e.g. 50 μM Ub2 is equal to 100 μM Ub). Consistent with our prior
results, increasing amounts of mono-Ub and K48-Ub2 reduced and eventually
eliminated UBQLN2 phase separation (Figure 3.3A, B and (Dao et al. 2018)). The
turbidity data for the addition of K63-Ub2 to UBQLN2 were very similar to those of K48Ub2 and mono-Ub, suggesting the effects of each Ub dimer on LLPS are equivalent to
those of two monomers (Figure 3.3B). Intriguingly, addition of K48-Ub4 and K63-Ub4
did not lead to the same trend. At [Ub]:[UBQLN2] ratios of 0.04:1, 0.08:1, 0.2:1 and
0.4:1, LLPS was slightly enhanced when temperature was below 36 ℃ with K48-Ub4
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addition, however, the same [Ub]:[UBQLN2] ratios with K63-Ub4 addition enhanced
UBQLN2 phase separation significantly.
To quantitatively compare the effects of Ub and chains on phase transitions of
UBQLN2, we obtained temperature-component phase diagrams for different
[Ub]:[UBQLN2] ratios at different UBQLN2 concentrations (Figure 3.3C). We determined
Tcp(infl), the cloud point temperature at the inflection point of the transition, from
temperature-ramping turbidity assays to obtain the LCST transitions for UBQLN2
solutions, as done previously in Chapter 2 (Yang et al. 2019). Tcp at different
[Ub]:[UBQLN2] ratios were used to map out the coexistence curve. The protein solution
exists as two phases in the area above the coexistence curve and as one phase below
the curve.
When UBQLN2 concentration was low (12.5 μM), K63-Ub4 promoted the phase
behavior towards physiological temperatures. However, no similar trend was observed
for K48-Ub4 at 12.5 μM of UBQLN2 (Figure 3.3C). We saw trends for K48-Ub4 in the
following plots when UBQLN2 concentration was higher than 12.5 μM. Tcp was as low
as 16 ℃ at [Ub]:[UBQLN2] ratios of 0.4:1 and 0.8:1 for K63-Ub4 addition, whereas Tcp
was around 32 ℃ and 36 ℃ when [Ub]:[UBQLN2] ratios were 0.4:1 and 0.8:1 for K48Ub4 addition. As the ratios of [Ub]:[UBQLN2] further increased, phase separation of
UBQLN2 was eventually inhibited. Together, these data suggested that K63 linkages
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drive the phase behavior over a much broader temperature range and [Ub]:[UBQLN2]
range.
From the phase diagrams shown in Figure 3.3C, as [Ub]:[UBQLN2] ratio increased,
we observed a highly similar, roughly linear increase in T cp for mono-Ub or Ub2 addition
at 20 μM, 30 μM and 40 μM UBQLN2, consistent with individual Ub units binding to the
UBQLN2 UBA domain (Dao et al. 2018). In contrast, under the same concentrations of
UBQLN2 (20 μM, 30 μM and 40 μM), when K48-Ub4 was added to UBQLN2, a small
decrease in Tcp was observed, whereas K63-Ub4 was added to UBQLN2, a substantial
decrease in Tcp was observed. The lowest Tcp’s occurred around a [Ub]:[UBQLN2] ratio
of 0.4:1 for K48-Ub4 and 0.8:1 for K63-Ub4. In other words, K48-Ub4 addition promoted
UBQLN2 phase separation until the [Ub]:[UBQLN2] ratio reached 0.4:1, while K63-Ub4
addition promoted UBQLN2 LLPS over a broader range of [Ub]:[UBQLN2] ratio -- phase
separation was enhanced until the [Ub]:[UBQLN2] ratio reached 0.8:1. As the ratio
further increased, Tcp increased for both linkages of Ub4. These data suggested that
small amounts of Ub4 chains, through simultaneous binding to multiple UBA units, bring
the UBQLN2 molecules closer together and provide additional multivalency that further
promotes LLPS. However, as Ub4 concentrations increase, there are not enough
UBQLN2 molecules for Ub4 molecules to bind simultaneously, leading to inhibition of
phase separation. The phenomena described above is known as a reentrant phase
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transition, where the coexistence of LCST phase boundaries create a window-like
behavior of mutual miscibility (Banerjee et al. 2017; Choi, Dar, and Pappu 2019).
However, what causes the difference in how K48-linked Ub4 and K63-linked Ub4
modulate UBQLN2 LLPS? Moreover, what are the implications to different linkages of
polyUb chains in cells? From previous work we learned that UBQLN2 LLPS is driven by
weak multivalent interactions among its domains, and Ub binding may affect some of
these interactions (Dao et al. 2018). We hypothesized that the difference in effects of
polyUb chains on UBQLN2 LLPS could be attributed to different binding affinity (Kd) for
the chains, and/or conformation and flexibility of the polyUb chain.
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3.2.4 Phase diagram of UBQLN2 450-624 with Ub4 chains is similar to that of fulllength protein
UBQLN2 450C (residues 450-624) is the minimum length construct of UBQLN2 that
undergoes LLPS (Dao et al. 2018). As shown previously by our lab, this construct only
contains ~175 residues and is significantly smaller than full-length UBQLN2; these
properties make it easier to study by protein NMR. To explore if polyUb chains affect
UBQLN2 450C LLPS in a similar way as FL protein, I conducted UV-Vis
spectrophotometry assays under the same experimental conditions as FL UBQLN2 and
mapped out the phase diagrams (Figure 3.4). Similar as FL UBQLN2, LLPS of UBQLN2
450C was promoted at low [Ub]:[UBQLN2 450C] ratios when K63-Ub4 was added, and
phase separation was eliminated at high ratios. K48-Ub4 affected the phase behavior of
UBQLN2 450C in a similar pattern, by enhancing it slightly before eliminating it. The
[Ub]:[UBQLN2 450C] ratio of K48-Ub4 needed for fully disassembling UBQLN2 droplets
was much lower than the ratio of K63-Ub4, just as seen for FL UBQLN2. These data
suggested that polyUb chains interact with FL UBQLN2 similarly as 450C. Therefore,
UBQLN2 450C can be used as a proxy for FL UBQLN2 in subsequent NMR
experiments to study the effects of different polyUb chains.
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Figure 3.4. Temperature−Component phase diagrams showing the changes in LCST
phase transition cloud-point temperatures as a function of [Ub]:[UBQLN2/450C] for K48Ub4 and K63-Ub4 in 20 mM NaPhosphate and 200 mM NaCl (pH 6.8). The
concentration of FL UBQLN2 was 30 μM and 450C was 100 μM. The red solid line
denotes the phase boundary of FL UBQLN2 with the addition of K48-Ub4 while the red
dashed lines denote the phase boundary of 450C with the addition of K48-Ub4. The
blue solid line denotes the phase boundary of FL UBQLN2 with the addition of K63-Ub4
while the blue dashed lines denote the phase boundary of 450C with the addition of
K63-Ub4. Phase diagram of UBQLN2 450C with Ub4 chains is similar to that of FL
UBQLN2.
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3.2.5 UBQLN2 CSPs and binding affinity for K48-linked and K63-linked polyUb
chains are similar
The data presented in Chapter 3.2.3 suggested that the extended K63-linked
polyUb chains promote UBQLN2 phase separation, while compact K48-linked polyUb
chains do not. To examine whether UBQLN2 preferentially binds to one polyUb chain
linkage over another, we performed nuclear magnetic resonance (NMR) titration
experiments. NMR is a technique widely used in protein studies to monitor how proteins
interact with ligands on a residue-by-residue basis. Heteronuclear multiple quantum
coherence (HMQC) SOFAST experiments were performed with

15N

labeled UBQLN2

450C. Mono-Ub, K48-linked Ub2, Ub4 and K63-linked Ub2, Ub4 were titrated into a
sample of 50 μM 15N labeled UBQLN2 450C, respectively. We followed chemical shifts
at the end of titration, which is the [mono-Ub]:[UBQLN2 450C] ratio of 3:1;
[Ub2]:[UBQLN2 450C] ratio of 2:1 and [Ub4]:[UBQLN2 450C] ratio of 1:1 (Figure 3.5).
Chemical shift perturbations (CSP) indicate changes in the chemical shifts of a protein
when a ligand is added (M. P. Williamson 2013). Large shifts likely reflect sites where
binding interactions occur, while small shifts or no shift indicate that these residues are
not involved in ligand binding. Figure 3.5A showed that, in general, the CSPs of K48Ub4 and K63-Ub4 at the end point were similar, indicating that the interactions between
UBQLN2 450C and the Ub4 are similar across the two types of polyUb chains. In
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addition, the resonances in the UBA domain have high CSPs, resulting from binding of
Ub4 with UBA domain. Besides that, K63-Ub4 titration resulted in notable higher shifts
compared with K48-Ub4 for residues 550-570, which are in the intrinsically disordered
linker region between PXX domain and UBA domain. Previous data from our lab
showed that residues 550-570 have higher helical propensity (Dao et al. 2018).
Furthermore, the titration curves of K48-Ub4 and K63-Ub4 CSPs exhibited different
trajectory patterns (Figure 3.5B). K48-Ub4 titration showed a sigmoidal trend while K63Ub4 titration curves were almost flat at the endpoint.
At any titration point, the observed CSP can be represented as:
∆𝛿 = Δδ𝑏𝑜𝑢𝑛𝑑 × 𝑃𝑏𝑜𝑢𝑛𝑑
Where Δδbound is the difference in the chemical shift between the free and fully
bound states for a given amide resonance, Pbound is the relative population of the bound
state of UBQLN2 under observation.
As only a single Ub can bind to a UBQLN2 molecule, we employed a single-site
binding model to determine the binding affinity. Concentrations of Ub ligand were
adjusted by the number of Ub units in the polyUb chain such that 50 µM Ub4 was equal
to 200 µM Ub. After this correction, we used the single-site binding model:

𝑃𝑏𝑜𝑢𝑛𝑑 =

([𝑃𝑡 ] + [𝐿𝑡 ] + 𝐾𝑑 ) − √([𝑃𝑡 ] + [𝐿𝑡 ] + 𝐾𝑑 )2 − 4[𝑃𝑡 ][𝐿𝑡 ]
2[𝑃𝑡 ]

Where [Pt] and [Lt] are the UBQLN2 and Ub concentrations, respectively, and Kd is
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the dissociation equilibrium constant. Data fitting for each amide was performed using
an in-house MATLAB program. Only residues with a CSP > 0.03 ppm at the titration
endpoint were considered for Kd determination. Reported Kd values were averages of
residue specific Kd values with errors reflecting standard deviation of these values
(Table 3.1).
We found that binding affinities for K48-Ub2 and K63-Ub2 were similar. However,
K48-Ub4 has a Kd = 121 μM ± 32 μM, which is higher than the binding affinity between
K63-Ub4 and 450C. As shown in Figure 3.5B, K48-Ub4 titration showed a sigmoidal
behavior while K63-Ub4 titration curves didn’t, indicating that single-site binding model
is not a perfect choice for K48-Ub4 and UBQLN2 binding. As the K48-Ub4 titration
curves showed sigmoidal behavior while K63-Ub4 titration curves didn’t, we postulate
that the chain conformational change upon binding may cause the difference in the
titration trajectories. Here, we hypothesized that compact K48-linked polyUb chains
need to “open” before interacting with UBQLN2, whereas extended K63 chains directly
bind to UBQLN2.
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Figure 3.5. CSPs and titration curves of CSPs for residues in 15N UBQLN2 450C.
(A) CSPs as a function of residue number for the residues in 50 μM 15N UBQLN2 450C
titrated with unlabeled K48-Ub4 (red) and K63-Ub4 (blue) at 1:1 stoichiometry (Ub4:
UBQLN2 450C) in 20 mM NaPhosphate (pH 6.8) at 25 ℃. CSPs showed that residues
in the UBA domain and the linker region (550-570) upstream of UBA are affected by
Ub4 binding. (B) Titration curves of CSPs in 50 μM 15N UBQLN2 450C. Residues in the
linker region upstream of UBA (550-570) were highlighted in red. Generally, K48-Ub4
and K63-Ub4 presented similar CSPs and the end point. However, K48-Ub4 titration
showed a sigmoidal trend.
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Titration

Average Kd (µM) ±
SD (µM)

15N

450C + mono-Ub

3.3 ± 0.9

15N

450C + K48-Ub2

15 ± 4.8

15N

450C + K63-Ub2

9 ± 2.7

15N

450C + K48-Ub4

121 ± 36

15N

450C + K63-Ub4

13 ± 7.8

Chain conformation illustration

Table 3.1. Summary of UBQLN2 450C + K48-linked and K63-linked polyUb chains
binding affinities.
Unlabeled mono-Ub, K48-Ub2, K63-Ub2, K48-Ub4 and K63-Ub4 were titrated into a
sample of 50 μM 15N labeled UBQLN2 450C. Data fitting for each amide was performed
using an in-house MATLAB program, assuming a single-site (1:1 stoichiometry) binding
model. Only residues with CSP > 0.03 ppm at the titration endpoint were considered for
Kd determination. Reported Kd values were averages of residue specific Kd values, with
errors reflecting standard deviation of these values. The Kd values of 18 residues were
averaged for mono-Ub, 20 residues for K48-Ub2, 18 residues for K63-Ub2, 18 residues
for K48-Ub4 and 15 residues for K63-Ub4.
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Mono-Ub

K48-Ub2

K48-Ub4

K63-Ub2

K63-Ub4

Figure 3.6. Sample titration curves for residues selected for Kd determination.
Unlabeled mono-Ub, K48-Ub2, K63-Ub2, K48-Ub4 and K63-Ub4 were titrated into a
sample of 50 μM 15N labeled UBQLN2 450C. Data fitting for each amide was performed
using an in-house MATLAB program. Lines represent fit to single-site 1:1 binding model.
121

3.2.6 The compact K48-Ub4 needs to ‘open’ before binding receptors
To test whether compact K48-Ub4 needs to “open” before interacting with UBQLN2,
we conducted HMQC-SOFAST experiments of mono-Ub and proximal labeled K48-Ub4
or K63-Ub4 to explore the self-interacting sites of Ub4. The Ub at the end of the chains,
whose lysine side chain participate in the isopeptide linkage is termed ‘proximal’, while
the Ub that contributes its C-terminus in the linkage is termed ‘distal’ (Figure 3.7A). We
calculated the CSPs between mono-Ub and proximal Ub of the Ub4, and compared
between the two linkages (Figure 3.7B and C). CSPs showed that residues 5-15, 42-48,
65-75 exhibited notable chemical shifts in proximal labeled K48-Ub4. These residues
are located in the hydrophobic patch (L8, I44, V70) of ubiquitin that is known to interact
with the UBA domain of UBQLN2, while only residues 60-70 exhibited high chemical
shifts in proximal labeled K63-Ub4. These observations suggested that K48-Ub4 selfinteracts through its hydrophobic patch (L8, I44, V70) to form the compact structure (Ye
et al. 2012; Eddins et al. 2007) while K63-Ub4 adopts an extended structure without
having much self-interaction. When Ub4 interacts with UBQLN2, the Ub unit of K63-Ub4
binds to UBQLN2 directly, mainly through the UBA domain, while K48-Ub4 must open
its compact structure before binding to UBQLN2, particularly as the UBA-binding
hydrophobic patch is sequestered in the K48-Ub4 interface (Figure 3.7B, D).
More experiments are needed to investigate the relationship between polyUb
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chains’ conformations and their effect on the phase behavior of UBQLN2.

Figure 3.7. NMR Characterization of K48-Ub4 and K63-Ub4.
(A) Cartoon illustration of proximal Ub in the Ub4. The Ub at the end of the chains,
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whose lysine side chain participate in the isopeptide linkage is termed “proximal”. (B)
Representative structures of K48-Ub4 (left) and K63-Ub4 (right). The yellow balls
represent the hydrophobic patch of Ub (L8, I44 and V70) PDB ID: K48 (2O6V); K63
(3HM3). (These structures cannot represent the full conformational ensembles of these
polyUb chains). Ub hydrophobic patches are readily accessible in K63-Ub4, but not
K48-Ub4. The proximal Ub is labeled in cyan. (C) Chemical shift perturbations (CSPs) of
50 μM proximal-Ub unit in K48-Ub4 (left) and K63-Ub4 (right) versus mono-Ub in 20 mM
NaPhosphate (pH 6.8) at 25 ℃. CSPs showed that residues in 5-15, 42-48, 65-75
exhibited high chemical shifts in prox-K48-Ub4, while only residues in 60-70 exhibited
high chemical shifts in prox-K63-Ub4. K48-Ub4 self-interacts through its hydrophobic
patch to form the compact structure while K63-Ub4 adopts an extended structure. (D)
Cartoon illustration of our hypothesis of how K48-Ub4 and K63-Ub4 interact with
UBQLN4. Each Ub in K63-Ub4 binds to UBQLN2 directly, mainly through the UBA
domain. The Ub units of K48-Ub4 interact with UBQLN2, but K48-Ub4 needs to “open”
before binding to UBQLN2.
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3.2.7 Extended and flexible polyUb chains promote UBQLN2 LLPS whereas
compact polyUb chains inhibit LLPS
From the previous experiments, it is demonstrated that polyUb chain conformational
change upon binding UBQLN2 (K48-Ub4 opens before binds to UBQLN2 while K63Ub4 directly binds) could be responsible for the difference in the titration trajectories. We
postulate that chain conformation and accessibility of the Ub interacting surface might
contribute to the differences that these polyUb chains exert in modulating UBQLN2
LLPS. To examine whether conformations of polyUb chains and the accessibilities of
these hydrophobic patches affect how the chains modulating UBQLN2 LLPS, we
enzymatically assembled Ub4 of other linkages, specifically K11 and M1; besides these,
we also assembled HOTag-Ub (homo-oligomeric tag), which is a small helical domain
that forms tetramers in solution (Zhang et al. 2018). M1-linked polyUb chains shares a
similar structure as K63-linked polyUb chains, which generally display open
conformations, whereas K11- and K48-linked Ub chains share similar structures, where
they all adopt compact conformations (Komander and Rape 2012; Zientara-Rytter and
Subramani 2019; Pickart 2000; Pickart and Fushman 2004a; Castañeda, Dixon, et al.
2016; Castañeda et al. 2013). SDS-PAGE gel showed the purity of the protein samples
(Figure 3.2B).
To visualize the effect of different Ub4 on UBQLN2 phase behavior and study how
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droplet formation is affected by the addition of Ub4 chains, we conducted microscopy
experiments. As previous studies showed, the K63-linked polyUb chains lack welldefined quaternary structures in solution, indicating they adopt an array like "beads on a
string", however, K48-linked polyUb chains adopt predominantly compact conformations
(Varadan et al. 2004; Tenno et al. 2004; Ye et al. 2012). Study on K11-linked polyUb
chains showed that this linkage adopts a more compact conformation ompared with
K63- or M1-linked Ub chains. Dynamics study showed that the conformation of K11linked Ub chains are not rigidly locked, suggesting a more flexible structure than K48linked polyUb chains (Castañeda et al. 2013; Komander and Rape 2012; ZientaraRytter and Subramani 2019; Ye et al. 2012; Blount, Johnson, and Todi 2020). M1linkage, which connects through the first Met, results in a linear chain that exhibits even
more flexibility than K63-linked polyUb chains (Ye et al. 2012; Komander and Rape
2012). Ubiquitin units in the HOTag-Ub are not directly connected, but through a
substrate and a G10 linker in the middle. The linkers between the Ub units increase
flexibility of the constructs (Zhang et al. 2018). The flexibility of polyUb chains increases
in the order: K48, K11, K63, M1-linked polyUb chains and HOTag-Ub (Figure 3.8A).
Solution small-angle X-ray scattering (SAXS) data report on the conformation of Ub4
chains (Figure 3.8C). The pairwise distance distribution (P(r)) data indicate that K63-,
M1-linked and HOTag-Ub chains adopt extended conformations, while K48-linked Ub
126

chains exhibit a compact conformation.
Microscopy results showed that K11-Ub4 affected droplet formation similarly as
K48-Ub4: the droplets were completely eliminated by a [Ub]:[UBQLN2] ratio of 2.4:1,
whereas droplet formation was promoted with K63-Ub4 and M1-Ub4 addition (Figure
3.8B). M1-Ub4 extended the regime where we see phase behavior of UBQLN2, out to
even higher [Ub]:[UBQLN2] ratios than what we saw for K63-Ub4, suggesting that the
more extended chains (M1, K63) can promote the phase behavior of UBQLN2, whereas
the compact chains (K11, K48) inhibit the ability of UBQLN2 to phase separate.
HOTag-Ub enhanced the UBQLN2 phase behavior over much larger concentration
range than M1- or K63-Ub4, and far more than K11- or K48-Ub4. Figure 3.8B showed
that the regime over which we saw the droplets extended to a far greater range.
Together, these data supported our initial hypothesis on how polyUb chain conformation
and accessibility of the Ub modulate UBQLN2 LLPS.
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Figure 3.8. increaseing Ub flexibitly and accesibilty of polyUb chains promotes
UBQLN2 LLPS.
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(A) Yellow cartoon structures illustrate one major solution conformation of each polyUb
chains. The structures are arranged from the most compact (left) to the most flexible
(right). (B) Fluorescence microscopy showing enhancement or inhibition of UBQLN2
droplet formation at increasing ratios of K11-, K48- K63 and M1-linked Ub4 chains as
well as of tetrameric HOTag-Ub at 50 µM UBQLN2 in 20 mM NaPhosphate and 200 mM
NaCl (pH 6.8) at 30 ºC. [Ub]:[UBQLN2] reflects the ratio between Ub monomers and
UBQLN2 molecules. Solution is spiked with Alexa Fluor 647-labeled UBQLN2. Scale
bar, 5 µm. (C) Solution small-angle X-ray scattering (SAXS) data report on the
conformation of Ub4 chains. Data were collected using 7 mg/mL protein in pH 6.8, 20
mM NaPhosphate buffer, 20 ºC.
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3.2.8 The extended conformations of polyUb chains provide a multivalent scaffold
to promote UBQLN2 LLPS
We quantified the phase behavior of UBQLN2 further by making the temperaturecomponent phase diagrams, by performing the same spectrometry turbidity assays as
we showed in Chapter 3.2.3. M1-linked polyUb chains promoted UBQLN2 phase
separation similarly as K63-linked polyUb chains. By contrast, compact K48-Ub4
modulated UBQLN2 LLPS differently from K63 or M1-Ub4. HOTag-Ub, which exhibited
the most flexibility in solution, enhanced UBQLN2 phase separation dramatically (Figure
3.9A). In addition, the temperature-component phase diagrams presented trends which
were consistent with microscopy data. The cloud point temperature T cp decreased as
more Ub4 chains of all linkages were initially titrated in, causing a downward trend on
the phase diagram (Figure 3.9B). Eventually the cloud point temperature Tcp increased
because the polyUb chains drove the disassembly of the condensates (Figure 3.9B). As
the flexibility of Ub chains increased, the phase boundaries were increased to a higher
[Ub]:[UBQLN2] ratio, suggesting that the extended conformations of polyUb chains
provided a multivalent scaffold to promote UBQLN2 LLPS. That is to say, the extended
polyUb chains could provide the structural support for a UBQLN2/polyUb condensate to
form, by bringing multiple UBQLN2 molecules closer together and providing multiple
binding sites between Ub4 and UBQLN2.
130

To verify that the binding affinities between UBQLN2 and the Ub4 of different
linkages are similar, additional NMR spectroscopy titration experiments were performed.
Similar as the experiments we carried out in Figure 3.3, K48-, K11-, K63-, M1-Ub4 and
HOTag-Ub were titrated into a sample of 50 μM 15N labeled UBQLN2 450C,
respectively. We used MATLAB to determine the binding affinity between these chains
and UBQLN2, using a single-site binding model (one Ub unit binds to one UBQLN2
450C molecule) (Figure 3.10). In addition, we used the concentration of [Ub] instead of
[Ub4] for the Kd fitting since UBQLN2 is interacting with each Ub unit in Ub4. The results
showed that K11-Ub4 had similar CSPs as K48-Ub4, with sigmoidal fitting curves,
suggesting similar confirmation change of Ub4 chains upon binding. UBQLN2 has
similar binding affinities for Ub4 chains excerpt for K48-Ub4 (Table 3.2). As discussed in
section 3.2.6, K48-Ub4 interacts with UBQLN2 likely by opening its compact structure
before binding to UBQLN2. Together, these data revealed that chain conformation and
accessibility of the Ub-interacting surface, not binding affinities between UBQLN2 and
chains affect UBQLN2 phase separation.
As our data suggested, the extended conformations of polyUb chains provide a
multivalent scaffold to promote UBQLN2 LLPS. By inference, we expect that polyUb
chains to be inside the droplets. To test whether polyUb chains are inside the droplets or
not, we fluorescently tagged the polyUb chains and UBQLN2. As shown by Figure 3.9C,
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at low ratios of [Ub] to [UBQLN4] (0.1 to 1), K48-Ub4 exhibited a very minor
enhancement inside the droplet versus outside when UBQLN2 always resided inside
the droplets. However, when we tested K63Ub, M1-Ub4 and HOTag-Ub, the amount of
Ub4 found inside the droplets changed. As discussed in section 3.2.7, K63-Ub4 and M1Ub4 adopt open conformations with more flexibility than K48-Ub4; HOTag-Ub exhibits
the most flexibility. The data showed that more Ub4 were found inside the condensates
when we increase the flexibility of the chains. Notably, of all chains, HOTag-Ub was
found the most inside than outside the droplets. As we increase stoichiometric ratios of
Ub:UBQLN2, by titrating in more polyUb chains, K48-Ub4 no longer has a preference
for being inside or outside the condensates. However, chains with more extended
conformations (K63, M1 and HOTag-Ub) tend to stay inside the droplets more than K48Ub4. There is an increase in the dilute phase of polyUb chains compared with low ratios
of Ub to UBQLN4 due to more polyUb chains being titrated into the system.
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Figure 3.9. Mapping the effects of polyUb chains on UBQLN2 phase diagrams.
(A) Representative results from spectrophotometric turbidity assay as a function of
temperature comparing the effects of varying amounts K48- and K63-, and M1-linked
Ub4 and HOTag-Ub on UBQLN2 LLPS at 30 μM UBQLN2 in 20 mM NaPhosphate and
200 mM NaCl (pH 6.8). (B) Temperature−Component phase diagrams showing the
changes in LCST phase transition cloud-point temperatures as a function of
[Ub]:[UBQLN2] for Ub4 of different linkages at 30 µM UBQLN2. (C) Fluorescence
microscopy showing the distribution of Ub chains (spiked with Dylight 488-labeled
chains) inside and outside droplets containing 50 μM UBQLN2 (spiked with Alexa Fluor
647-labeled UBQLN2) at 0.1 to 1 and 1 to 1 ratios of Ub to UBQLN2. Scale bar, 5 µm.

133

Titration

Average Kd (µM) ±
SD (µM)

15N

450C + K48-Ub4

121 ± 36

15N

450C + K11-Ub4

40 ± 16

15N

450C + K63-Ub4

13 ± 7.8

15N

450C + M1-Ub4

30 ± 7.1

450C + HOTag-Ub

16 ± 4.8

15N

Chain conformation illustration

Table 3.2. Summary of the binding affinities between UBQLN2 450C and Ub4 of
different linkages.
Unlabeled Ub4 of different linkages were titrated into a sample of 50 μM 15N labeled
UBQLN2 450C. Data fitting for each amide was performed using an in-house MATLAB
program, assuming a single-site binding model (Ub bind to UBQLN2 450C at 1:1). Only
residues with CSP > 0.03 ppm at the titration endpoint were considered for Kd
determination. Reported Kd values were averages of residue specific Kd values with
errors reflecting standard deviation of these values. The Kd values of 18 residues were
averaged for K48-Ub4, 15 residues for K63-Ub4, 17 residues for M1-Ub4, 16 residues
for K11-Ub4 and 16 residues for HOT-tag Ub. Overall, except for K48-Ub4, binding
affinities between UBQLN2 450C and different Ub4 are similar.
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K48-Ub4

K11-Ub4

M1-Ub4

K63-Ub4

HOTag-Ub

Figure 3.10. Sample titration curves for residues selected for Kd determination.
Unlabeled Ub4 of different linkages were titrated into a sample of 50 μM 15N labeled
UBQLN2 450C. Data fitting for each amide was performed using an in-house MATLAB
program. Lines represent fit to single-site 1:1 binding model.
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3.2.9 UBQLN2 oligomerization doesn’t affect its binding to different polyUb
chains
To ascertain the molecular reasons for the differential effects of polyUb chains on
UBQLN2 LLPS we asked: first, do the binding affinities between UBQLN2 and different
polyUb chains make a difference in modulating UBQLN2 LLPS? Second, since
UBQLN2 interacts with ubiquitin by its UBA domain, is there a difference between
polyUb chains binding to UBA, and does it affect UBQLN2 phase behavior? Third, as
shown previously by the lab, UBQLN2 self-interacts and drives the phase separation of
the protein, does its oligomerization property affect the binding of different polyUb
chains?
To answer these questions, we employed NMR experiments and provided answers.
The titration experiments between 15N labeled UBQLN2 450C and polyUb chains
suggested that binding affinity is not the key of polyUb chains modulating UBQLN2
phase separation, whereas the binding modes matter, which means that polyUb chain
undergoes conformational change upon binding UBQLN2 (K48-Ub4 opens before binds
to UBQLN2 while K63-Ub4 directly binds). Additionally, by NMR titration experiments,
we showed that polyUb chains of different linkages do not exhibit binding preference for
UBQLN2 UBA domain (Figure 3.11A). NMR titration experiments were performed by
titrating unlabeled K48-Ub4 and K63-Ub4 into 50 μM 15N UBQLN2 487C sample, which
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has been previously shown in (Dao et al. 2018) to lack the ability to oligomerize or
undergo phase separation. Similar binding affinities (K48-Ub4, Kd = 48 ± 29 μM; K63Ub4, Kd = 18 ± 14 μM) indicate that UBQLN2 oligomerization doesn’t affect its binding to
different polyUb chains (Figure 3.11B).
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A

B

Kd = 21 μM ± 8.0 μM

Kd = 56 μM ± 17 μM

UBA + K48-Ub4

UBA + K63-Ub4

Kd = 48 μM ± 29 μM

Kd = 18 μM ± 14 μM

487C + K48-Ub4

487C + K63-Ub4

Figure 3.11. Sample titration curves for residues selected for Kd determination.
(A) Unlabeled K48-Ub4 and K63-Ub4 were titrated into a sample of 50 μM 15N labeled
UBQLN2 UBA. Data fitting for each amide was performed using an in-house MATLAB
program. Lines represent fit to single-site 1:1 binding model. Kd of K48-Ub4 titrate into
UBA is 21 μM ± 8.0 μM, which is the average of 25 residues. Kd of K63-Ub4 titrate into
UBA is 56 μM ± 17 μM, which is the average of 26 residues. (B) Unlabeled K48-Ub4
and K63-Ub4 were titrated into a sample of 50 μM 15N labeled UBQLN2 487C. Data
fitting for each amide was performed using an in-house MATLAB program. Lines
represent fit to single-site 1:1 binding model. Kd of K48-Ub4 titrate into 487C is 48 μM ±
29 μM, which is the average of 18 residues. Kd of K63-Ub4 titrate into 487C is 18 μM ±
14 μM, which is the average of 18 residues.

138

3.3 Discussion and Conclusions
In this study, we demonstrated that ubiquitin and polyubiquitin regulate UBQLN2’s
phase behavior. UBQLN2 undergoes LLPS under physiological conditions in vitro, and
mono-ubiquitin drives the disassembly of UBQLN2 droplets (Dao et al. 2018). We
systematically studied the effects of different polyUb chains on UBQLN2 phase behavior
and revealed that chain conformation and accessibility of the Ub interacting surface, not
binding affinities between UBQLN2 and chains, affect UBQLN2 phase separation.
We have demonstrated that both the length and linkage of the chains make a
difference in modulating UBQLN2 phase behavior. When we increase the number of Ub
units, we increase the multivalency of the polyUb chains, thereby broadening the
[Ub]:[UBQLN2] range of phase separation of UBQLN2, which indicates that the phase
separation is driven over a much broader range of concentration as the valency of
polyUb chains increases. Conformation of the chains matters when it comes to
regulating UBQLN2 LLPS. K48- and K11-linked polyUb chains are structurally compact
in solution (Eddins et al. 2007; Ye et al. 2012; Castañeda, Chaturvedi, et al. 2016;
Castañeda et al. 2013), and they largely drive disassembly of UBQLN2 condensates
when added to UBQLN2 liquid droplets. However, K63- and M1-linked polyUb chains
exhibit more extended conformations, and Ub units from the HOTag-Ub are most
extended and have the most flexibility. Importantly, these chains can act as a scaffold to
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bring UBQLN2 and Ub molecules together, as a result, promote multi-component LLPS
via heterotypic interactions.
Phase diagrams allow us to evaluate the effects of different polyUb chains on
UBQLN2 LLPS. We showed previously that ubiquitin drives disassembly of UBQLN2
droplets (Dao et al. 2018), which is the result of polyphasic linkage, suggesting that
ligand binding changes the equilibrium between phases, specifically the phaseseparated states and miscible states. (Wyman and Gill 1980; Ruff, Dar, and Pappu
2021; Dao and Castañeda 2020). As shown in Figure 3.3C, polyUb chain binding to
UBQLN2 shifts phase boundaries for UBQLN2 phase separation. The UBQLN2
concentration needed for LLPS is increased to higher values as polyUb chain are
titrated into UBQLN2 solution.
Our phase transition data (Figure 3.3C) illustrates a transition from LLPS driven by
homotypic interactions to a system where LLPS is driven by heterotypic interactions
between UBQLN2 and Ub4. LLPS driven by homotypic interactions occurs when a
single macromolecular component phase separates in response to physicochemical
changes. UBQLN2 undergoes LLPS with increasing temperature, driven by the selfinteractions among the sticker regions. When polyUb chain was added to the system,
UBQLN2 LLPS transients from homotypic interaction-driven to heterotypic interactiondriven, since both UBQLN2 and polyUb chains are involved in the phase separation
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behavior of UBQLN2.
The implications of this work are that polyUb chains of different linkages can
substantially alter the driving forces of phase-separating systems. It has been
demonstrated that UBQLN2 is recruited to stress granules in cells (Dao et al. 2018), and
associates with stress granule components and might be involved in the assembly and
disassembly of SGs (Alexander et al. 2018). As UBQLN2 undergoes LLPS in vitro and
its phase behavior is tuned by polyUb binding, we hypothesize that UBQLN2
functionality in stress granules and protein degradation pathways is modulated by its
LLPS properties. As a result, variables affecting UBQLN2 LLPS behaviors, including
polyUb binding, will affect its biological functions.
This study provides implications for the link between UBQLN2 LLPS and the
functions of different polyUb chains inside cells. PolyUb chain engagement with UBLUBA shuttle proteins modulates LLPS outcomes. Via LLPS with polyUb chains, UBLUBA shuttle proteins may direct substrates to different PQC outcomes, including
proteasomal degradation and autophagy. Interestingly, previous studies have already
shown the link between UBL-UBA shuttle protein interacting with polyUb chains and
different PQC outcomes (Yasuda et al. 2020; D. Sun et al. 2018; Zaffagnini et al. 2018;
Dao and Castañeda 2020). Interactions between UBQLN2 and Ub or polyUb chains
disassemble UBQLN2-containing condensates, suggesting a mechanism whereby
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UBQLN2 shuttles ubiquitinated substrates out of the condensates (Dao and Castañeda
2020). Autophagy adaptor p62, an UBL-UBA protein, condenses with K63-linked polyUb
chains to produce an autophagosome precursor, which then recruits other components
to construct the autophagosome (Zaffagnini et al. 2018). In addition, proteasomal
shuttle protein hHR23B prefers to interact with K48-linked polyUb chains to form stressinduced nuclear foci, which may drive the substrate to the proteasome for degradation
(Yasuda et al. 2020). Notably, UBQLN2 can phase separate alone, but p62 and
hHR23B only phase separate when mixed with polyUb chains (Yasuda et al. 2020; D.
Sun et al. 2018; Zaffagnini et al. 2018).
Collectively, our results are consistent with the previous knowledge that
monoubiquitin and K48-linked polyUb chains disassemble UBQLN2 droplets but in
different manners (Dao et al. 2018). We expand this knowledge by revealing how
polyUb chains of different linkages and length modulate UBQLN2 condensate
formation, and by relating to polyUb’s various functionalities in cells. These findings
demonstrate that conformational flexibility of polyUb chains, and valency of Ub units
contribute to phase separation behavior in multi-component UBQLN2 LLPS systems.
Particularly, compact polyUb chains (K11, K48) inhibit the ability of UBQLN2 to phase
separate, while extended and more flexible polyUb chains (K63, M1) promote multicomponent LLPS. Meanwhile our study provides a link between UBQLN2 LLPS
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properties and its functions in different protein degradation pathways, including
proteasomal degradation and autophagy.
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3.4 Material and Methods
3.4.1 Subcloning, Protein Expression, and Purification
Wildtype, K48R, K63R and K11/63R Ub were expressed and purified as detailed
elsewhere (Beal et al., 1996; Castañeda et al., 2016). The gene encoding mouse E1
was a kind gift from Jorge Eduardo Azevedo (Addgene plasmid 32534, (Carvalho et al.,
2012)). E1, Mms2 and GST-Ubc13 were expressed in Escherichia coli NiCo21 (DE3)
cells in Luria-Bertani (LB) broth at 16 ℃ overnight. GST-E2-25K in pGEX-4T2 and GSTUbe2s-UBD in pGEX6P1 were expressed in Escherichia coli Rosetta 2 (DE3) pLysS
cells in Luria-Bertani (LB) broth at 16 ℃ overnight. Bacteria were pelleted, frozen, then
lysed via freeze/thaw method in 50 mM Tris, 1 mM EDTA (pH 8), 1 mM PMSF, 1 mM
MgCl2, and 0.2 mg/mL DNase I. E1 and Mms2 were purified via Ni2+ chromatography.
GST-E2-25K, GST-Ubc13, and GST-Ube2s-UBD were purified via GST
chromatography. All proteins were concentrated, and buffer exchanged into 50 mM Tris
and 1 mM EDTA (pH 8) and stored at 80 ℃ for subsequent use in the production of K48and K63-linked polyUb chains, as described in (Raasi and Pickart, 2005). K11-linked
Ub4 were produced as described in (Bremm et al., 2010). Briefly, ubiquitin WT was
reacted with 1000 nM E1 and 10 μM GST E2-25K in the presence of 10 mM ATP, 0.3
mM TCEP in Tris buffer at pH 8 for 3 hours at 37 ℃. This procedure generates
polyubiquitin (polyUb) chains of different length.
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HOTag-Ub were expressed in Escherichia coli NiCo21 (DE3) cells in Luria-Bertani
(LB) broth at 37 ℃ overnight. Bacteria were pelleted, frozen, then lysed via freeze/thaw
method in 50 mM Tris, 1 mM EDTA (pH 8, 1 mM PMSF, 1 mM MgCl2, and 0.2 mg/mL
DNase I. The cleared lysate was then loaded onto anion exchange column and eluted
with a gradient between 20 mM Hepes, 0.02% NaN3 (pH 7) and 20 mM Hepes (pH 7), 1
M NaCl, 0.02% NaN3. Fractions containing HOTag6-G10-Ub were dialyzed, loaded
onto cation exchange column and eluted with a gradient between 50 mM ammonium
acetate (pH 4.5) and 50 mM ammonium acetate, 1 M NaCl (pH 4.5). Purified HOTag6G10-Ub was then concentrated, and buffer exchanged into 20 mM NaPhosphate, 0.5
mM EDTA, 0.1 mM TCEP, 0.02% NaN3 (pH 6.8).
Full-length UBQLN2 and UBQLN2 450-624 were expressed and purified as
described by Dao et al, 2018.(Dao et al. 2018) Briefly, the constructs were expressed in
E. coli Rosetta 2 (DE3) pLysS cells in Luria-Bertani (LB) broth at 37°C overnight.
Bacteria were pelleted, frozen, lysed, then purified via a “salting out” process. NaCl was
added to the cleared lysate to the final concentration of 0.5 M - 1 M. UBQLN2 droplets
were pelleted and then resuspended in 6 M urea, 20 mM NaPhosphate, 0.5 mM EDTA,
0.1 mM TCEP, 0.02% NaN3 (pH 6.8). Leftover NaCl and urea were removed through
HiTrap desalting column (GE Healthcare). Purified proteins were frozen at -80°C.
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3.4.2 Spectrophotometric Absorbance/Turbidity Measurements
Protein samples were prepared by mixing protein solution containing UBQLN2 and
polyUb (the concentrations of the protein stock solutions were doubled compared with
the sample concentrations) and cold sodium phosphate buffer (pH 6.8, 20 mM
NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3) containing 400 mM NaCl at
1:1 stoichiometry. The protein concentrations were chosen to cover as wide a range as
possible to allow observation of phase separation during the temperature ramps. All the
solutions were kept on ice for at least 5 minutes before mixing. Absorbance at 600 nm
was recorded as a function of temperature by a Cary 3500 UV-Vis spectrophotometer
using a temperature ramp rate of 1 °C/min increasing from 16 °C to 60 °C (4°C to 60 °C
range was screened in some cases). Net absorbance values were recorded after
subtracting the absorbance value of a buffer control. At least two trials (n = 2) were
conducted to ensure reproducibility. Data were plotted using Mathematica (Wolfram
Research).

3.4.3 Phase diagram measurements
For the LCST (lower critical solution temperature) phase transition, i.e. mapping the
phase boundary as temperature is increased, protein samples were prepared as
described for the turbidity measurements. Cloud point temperatures were determined by
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fitting a Four Parameter Logistic Regression model to the data (Figure S3).
𝑦=𝑑+

𝑎−𝑑
𝑥 𝑏
𝑐

(Equation 1)

1+( )

Cloud point temperatures used were the points of inflection (c).
Cloud point temperatures were used to define the coexistence curve as a function of
ligand:protein ratio (ligand refers to polyUb chains and protein refers to UBQLN2).
Fitting and plotting of data were done with Mathematica (Wolfram Research) and
Kaleidagraph (Synergy Software).

3.4.4 Bright-field Imaging of Phase Separation
Samples were prepared to contain 55 μM UBQLN2 and different amounts of Ub and
Ub chains in 20 mM NaPhosphate, 200 mM NaCl, 0.1 mM TCEP, and 0.5 mM EDTA
(pH 6.8). Samples were added to Eisco Labs Microscope Slides, with Single Concavity,
and covered with MatTek coverslips that had been coated with 5% bovine serum
albumin (BSA) to minimize changes as a result of surface interactions, and incubated
coverslip-side down at 30 oC for 10 min. Phase separation was imaged on an ONI
Nanoimager (Oxford Nanoimaging Ltd, Oxford, UK) equipped with a Hamamatsu
sCMOS ORCA flash 4.0 V3 camera using an Olympus 100×/1.4 N.A. objective. Images
were prepared using Fiji (Schindelin et al., 2012) and FigureJ plugin.

3.4.5 NMR Titration Experiments
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Unlabeled protein ligand was titrated into 50 µM samples of 15N protein. Proteins
were prepared in 20 mM NaPhosphate buffer (pH 6.8), 0.5 mM EDTA, 0.02% NaN 3, and
5% D2O. 1H-15N SOFAST-HMQC was used for UBQLN2 constructs and polyUb
titrations. All NMR experiments were performed on a Bruker 800-MHz instrument
(SUNY-ESF) at 25 °C. 1H-15N SOFAST-HMQC experiments were acquired using
spectral widths of 16 and 30 ppm in the direct 1H and indirect 15N dimensions, and
corresponding 2048 and 160 total points, respectively. NMRPipe (Delaglio et al. 1995)
was used to process the all the NMR data, and peak analyses were performed using
CCPNMR (Vranken et al. 2005).
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Chapter IV:
Study of UBQLN4 Phase Separation Properties

The work presented in this chapter is unpublished.
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Abstract
Ubiquilin-4 (UBQLN4), which is a member of the UBQLN family, serves as a shuttle
protein in cells because of its UBL-UBA architecture. Like UBQLN2, UBQLN4 is
involved in diverse protein quality control (PQC) pathways, including the ubiquitin–
proteasome system (UPS), autophagy and endoplasmic-reticulum-associated protein
degradation (ERAD), as well as DNA/RNA metabolism, cell differentiation/development
and DNA damage response. Our lab discovered that UBQLN2 undergoes liquid-liquid
phase separation (LLPS) under physiological condition. Since UBQLN4 sequence is
56% identical to UBQLN2 and UBQLN4 shares similar domain structures as UBQLN2,
we hypothesized that UBQLN4 undergoes LLPS as well. To test whether UBQLN4
phase separates and to understand the molecular rules that govern UBQLN4 phase
behavior, we designed various UBQLN4 deletion constructs. To date, we have
successfully expressed UBQLN4 full-length (FL), 86-601 (86C), 262-601 (262C), 393601 (393C) and 464-601 (464C) and has purified UBQLN4 FL and 86C.
We observed LLPS by UV-Vis spectrophotometry assays and obtained preliminary
experimental phase diagram. Our data showed that UBQLN4 undergoes LLPS in vitro
and ubiquitin binding disrupts its LLPS. Both UBQLN4 FL and 86C construct phase
separate in the same pattern. However, the phase behaviors of UBQLN4 constructs are
different from the equivalent UBQLN2 constructs, suggesting that the domains involved
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in self-interactions that promote LLPS might be different between UBQLN4 and
UBQLN2. Data from this work suggested that UBL domain of UBQLN4 doesn’t affect its
phase behavior drastically, but more experiments are needed to map the interactions
between UBQLN4 domains and how they affect UBQLN4 LLPS.
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4.1 Introduction
The UBQLN family consists of 5 protein members (UBQLN1-4 and UBQLNL), which
belong to the UBL-UBA proteins by containing a ubiquitin-like (UBL) domain at the Nterminus and a ubiquitin-associated domain (UBA) at the C-terminus (Figure 1.2).
UBQLN1, 2 and 4 are widely expressed in all tissues (Marín 2014). Notably, UBQLN4 is
generally evenly expressed in the nucleus, cytoplasm and endoplasmic reticulum (ER)
(Jachimowicz et al. 2019), whereas UBQLN2 is cytoplasmic in general, but is also found
in nucleus depending on the cell states (Mah et al. 2000; Kleijnen et al. 2000).
Similar to UBQLN2, UBQLN4 is also a multifaceted protein involved in diverse
protein quality control (PQC) pathways, including the ubiquitin–proteasome system
(UPS), autophagy and endoplasmic-reticulum-associated protein degradation (ERAD)
(Yun Lee, Arnott, and Brown 2013; Suzuki and Kawahara 2016). As discussed in
section 1.1.3 and 3.1, the UPS is a crucial protein degradation system in eukaryotes. Its
proper function requires the ATP-dependent substrate ubiquitination, which is a posttranslational modification that covalently attaches mono- or polyUb chains onto protein
substrates at lysine residues, or to the N-terminal amino group (Bence, Sampat, and
Kopito 2001; Adams 2003). The mono-Ub or polyUb chains act as signaling tags for
these cellular degradation pathways. Shuttle proteins facilitate cargo transporting, due
to their dual capability to interact with both ubiquitin and degradation machineries via
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the UBA and UBL domain, respectively. Because of the conserved structures among
UBQLNs, UBQLN4 is also considered as a shuttle protein like UBQLN2 (Ko et al. 2004).
In particular, UBQLN4 can shuttle nuclear proteins to the cytosol for degradation
through the nuclear pore (Hirayama et al. 2018). Disease-linked mutations in UBQLN4
affect the UPS functions, such as UBQLN4 D90A (Edens et al. 2017). The position of
the mutation is near UBL domain but not at the binding interface of UBL and
proteasome, as a result, it might decrease UBQLN4 binding to the proteasome but not
completely eliminate it (Zheng, Yang, and Castañeda 2020).
Autophagy is another major degradation pathway for maintaining PQC in cells.
Different from degrading small molecules by UPS, autophagy generally is responsible
for clearing macromolecules including protein aggregates, RNA, and organelles (Glick,
Barth, and Macleod 2010). Three types of autophagy, specifically macro-autophagy,
micro-autophagy and chaperone-mediated autophagy (CMA) all rely on the lysosome to
function, which provides an acidic environment to degrade the substrates (Glick, Barth,
and Macleod 2010). Both UBQLN2 and UBQLN4 can bind to macro-autophagy or
autolysosome component microtubule-associated protein light chain 3 (LC3) and
facilitate the maturation of LC3-II, which initiates the formation and elongation of the
autophagosome (Yun Lee, Arnott, and Brown 2013; J. J. Wu et al. 2020). In addition,
UBQLN2 interacts with proton pump, V-ATPase, stabilizes it and promotes lysosome
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acidification (J. J. Wu et al. 2020; Şentürk, Mao, and Bellen 2019), while UBQLN4 is
involved in autophagy via interaction with UBQLN1. UBQLN4 mediates the interaction
between UBQLN1 and autophagosomes by recruiting UBQLN1 to LC3. (Yun Lee,
Arnott, and Brown 2013; Rothenberg et al. 2010).
Additionally, UBQLN4 assists in endoplasmic reticulum-associated degradation
(ERAD), which is also a critical protein degradation pathway. ERAD gets rid of the
protein substrates that fail to fold into their native conformation in the ER, or the
transmembrane proteins that fail to integrate into ER. UBQLNs can form complexes with
the ERAD adaptors, facilitate the ERAD substrate extraction, and act as the shuttle
proteins to translocate the substrate to the proteasome for degradation. Specifically,
UBQLN2 facilitates ERAD substrate extraction by interacting with an ERAD adapter,
UBXD8 (Y. Xu et al. 2013; Xia et al. 2014). Moreover, UBQLN2 is involved in ER-Golgi
trafficking (Halloran et al. 2020). However, UBQLN4 is involved in ERAD in a different
manner than UBQLN2. It shuttles misassembled ER-localized proteins to cytoplasm for
degradation, by recognizing their exposed hydrophobic transmembrane domains
(Suzuki and Kawahara 2016). UBQLN4 also binds to a nonenveloped polyomavirus,
Simian Virus 40 (SV40) by interacting with the structural coat protein VP1, captures the
virus at the ER, and facilitates the transportation of the virus through the ER into the
cytoplasm (X. Liu and Tsai 2020; Zheng, Yang, and Castañeda 2020). Notably, UBQLN4
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interacts with the transmembrane proteins and virus through its STI1-II domain, which is
important for the interaction between the client protein and UBQLN4 (Suzuki and
Kawahara 2016; X. Liu and Tsai 2020).
Besides PQC, UBQLN4 also participates in DNA/RNA metabolism, cell
differentiation/development and DNA damage response. It has been shown that
UBQLN4 regulates motor axon morphogenesis (Edens et al. 2017), mediates cell
differentiation and apoptosis by activating ERK pathway (ERK is extracellular signalregulated kinases, which play a role in signaling cascades and transmits extracellular
signals to intracellular targets) (Huang et al. 2018). Additionally, UBQLN4 balances
between two major DNA damage repair pathways: the faster but error-prone
nonhomologous end joining (NHEJ), and the slower but more accurate homologous
recombination repair (HHR) pathway (Mao et al. 2008). During the DNA damage repair
process, UBQLN4 is recruited to the damage site where it undergoes phosphorylation,
then mediates the Ub-dependent degradation of a HHR regulator, MRE11 (Jachimowicz
et al. 2019). Importantly, UBQLN4 has been shown to function as a tumor suppressor in
several cancers, and dysregulation or mutation of UBQLN4 is related to
neurodegenerative diseases and cancers, including ALS, breast cancer and ovarian
cancer (Edens et al. 2017; Jantrapirom et al. 2020). Overexpression of UBQLN4 is
associated with poor overall survival rate of hepatocellular carcinoma (HCC) patients,
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as well as the induction of cellular senescence and cell cycle arrest in gastric cancer
cells (Yu et al. 2020; Huang et al. 2019).
Liquid-liquid phase separation (LLPS) is an essential biophysical mechanism in
many cellular processes, including stress response. As stated in the previous chapters,
UBQLN2 is recruited to stress granules in vivo and undergoes LLPS in vitro (Dao et al.
2018). Since UBQLN4 is 56% identical to UBQLN2, does UBQLN4 phase separate? If
so, does it mimic the phase behavior of its paralog UBQLN2? First, UBQLN4 shares
similar domain structures as UBQLN2, with the only difference that UBQLN4 lacks the
PXX region (Figure 1.2). Given the fact the UBQLN2 still undergoes phase separation
without the PXX region (Dao et al. 2018), we believed that UBQLN4 has a high
propensity to phase separate. Besides that, UBQLN1, UBQLN2 and UBQLN4 form
homodimers (Yun Lee, Arnott, and Brown 2013; Dao et al. 2019; Ford and Monteiro
2006), and both UBQLN1 and UBQLN2 can form heterodimers with UBQLN4 (Yun Lee,
Arnott, and Brown 2013). It is believed that multivalent interactions promote selfassembly and oligomerization, which is the pre-requisite for LLPS. Furthermore,
UBQLN2 and UBQLN4 all localize into puncta in cells (Mah et al. 2000; Regan-Klapisz
et al. 2005). Based on these observations, we propose that UBQLN4 possesses the
ability to phase separate.
Will UBQLN4 undergo phase separation in a similar way as UBQLN2? Recently it
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has been shown that UBQLN4 displays heightened aggregation propensity over the
other UBQLNs, and is more prone to self‐assemble into aggregates in vitro (Gerson et
al. 2021). According to PONDR-FIT calculations, the STI1-II region (the main domain
driving the self-assembly and oligomerization in UBQLN2) of UBQLN4 is the least prionlike and the least disordered among all the UBQLNs (Zheng, Yang, and Castañeda
2020). All these information indicate that UBQLN4 may phase separate in a different
manner than UBQLN2.
The phase behavior of UBQLN4 is largely unknown, as well as the sequence and
structural basis for the phase behavior of the protein. In this chapter, we first postulated
that UBQLN4 undergoes phase separation and the LLPS behavior is temperature
dependent. To test this hypothesis, we successfully expressed and purified full-length
UBQLN4. Preliminary data suggest that the LLPS behavior of full-length UBQLN4 is
concentration and temperature dependent, but in a different manner compared with fulllength UBQLN2.
To dissect the phase separation behaviors of UBQLNs, we carried out this project
with the overall goals to understand how UBQLN4 phase separates and to decipher the
underlying mechanisms that cause the discrepancies in the phase behaviors of
UBQLN4 and UBQLN2. To achieve these goals, I successfully designed, cloned,
expressed and purified various UBQLN4 C-terminal deletion constructs, which are
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equivalent to UBQLN2 C-terminal deletion constructs the lab has already studied. I
collected preliminary turbidity assay data and compared the temperature-dependent
LLPS behavior of UBQLN4 and UBQLN2. We found that the phase behavior of a
UBQLN4 C-terminal deletion construct follows a different temperature-dependent trend
compared to its UBQLN2 equivalent. More stringent studies are needed to unravel the
differences in LLPS properties of UBQLN4 and UBQLN2.

4.2 Results
4.2.1 UBQLN4 undergoes LLPS in vitro
Since UBQLN2 undergoes LLPS without the PXX region and shares similar domain
structure as UBQLN4 (Figure 4.1A), we hypothesized that UBQLN4 has a high
propensity to phase separate (Dao et al. 2018; Zheng, Yang, and Castañeda 2020). To
test our hypothesis, we expressed and purified full-length (FL) UBQLN4. Previously, the
lab successfully expressed and purified UBQLN2 FL in E. coli cells (Dao et al. 2018).
However, expressing and purifying UBQLN4 turned out to be more challenging.
UBQLN4 FL was expressed in Rosetta 2 cells, and was purified by “salting out” process,
please see section 4.4.2 for purification process. We further purified the protein with
cation exchange column and size exclusion chromatography (SEC). SDS-PAGE gel
showed > 95% purity of the protein samples (Figure 4.1B). Mass spectrometry (MS)
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was used to verify the identity and molecular weight (MW) of the protein samples
(Figure 4.1C).
To test if UBQLN4 phase separates, we conducted turbidity assays by monitoring
the change of A600 values between 16 °C and 60 °C of samples containing 25 μM, 35
μM or 50 μM protein and a fixed buffer composition. Section 2.2.1, 3.2.3 and previous
work from our lab showed that high and low A600 values correlate with UBQLN2 droplet
formation and droplet clearance, respectively (Dao et al. 2018; Y. Yang et al. 2019). It is
worth mentioning that, in the previous chapters (Chapter 2 and 3), we used pH 6.8
NaPhosphate buffer with 200 mM NaCl in the samples for turbidity assays, however, we
used pH 7 HEPES buffer with 400 mM NaCl in the turbidity assays here (Figure 4.1D
and E), since we noticed that HEPES buffer improved the solubility of the protein when
we concentrated it. As hypothesized, UBQLN4 FL phase separates with increasing
temperature and increasing concentration. The cloud point temperature of 50 μM and
35 μM UBQLN4 FL was around 34 °C and 44 °C, respectively. At 25 μM, the protein
started to phase separate at the end of the assay when temperature almost reached 60
°C.
To study droplet morphology of UBQLN4, we used bright field microscopy to monitor
the shape and size of the droplets. LLPS was induced with 400 mM NaCl, and all
samples were incubated in 37 °C for 15 minutes before imaging. Droplets were round
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and grew in size over time as a result of droplet fusion, which suggested liquid-like
behavior for UBQLN4 FL. (Figure 4.1 F).
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Figure 4.1. UBQLN4 FL undergoes LLPS in vitro.
(A) Domain architecture of UBQLN4 FL. (B) SDS-PAGE gel showed the purity of the
protein, including 2 stocks of UBQLN4 FL. The molecular weight of UBQLN4 FL is
63852 Da. (C) Electrospray ionization mass spectrometry (ESI-MS) of UBQLN4 FL. Due
to the low resolution of ESI-MS and the big size of UBQLN4 FL, the molecular weight
showed by MS (31853 Da) was lower than the calculated value (63852 Da). When
double the showed molecular weight (31853 Da), we get 63706 Da, which is 146 Da
less than the calculated molecular weight (63852 Da). The 146 Da difference arises
from the loss of the first methionine in the sequence, whose molecular weight is 149 Da.
(D) Average turbidity assays as a function of temperature comparing LLPS of UBQLN4
FL using 50 μM, 35 μM or 25 μM protein in 20 mM HEPES and 400 mM NaCl (pH 7).
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Each concentration was performed at least twice to ensure reproducibility (UBQLN4 FL
assay was repeated 6 times at 50 μM concentration; UBQLN4 FL assay was repeated 2
twice at 35 μM and 25 μM concentrations). (E) Raw turbidity assay data of UBQLN4 FL
as shown in (D). Error bars represent standard deviation. (F) Bright field microscopy of
UBQLN4 FL over 15 minutes of incubation at 37 °C using 70 μM protein in 20 mM
HEPES (pH 7) buffer, in presence of 400 mM NaCl. Scale bar, 5 μm.
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4.2.2 UBQLN4 FL phase separates in a different manner than UBQLN2 FL
To test whether UBQLN2 and UBQLN4 phase separates in a similar way, we
purified UBQLN2 FL according to the method described in our previously published
papers (Dao et al. 2018; Y. Yang et al. 2019). Turbidity assays were conducted by
monitoring the change of A600 values between 16 °C and 60 °C of samples containing
20 μM or 35 μM of UBQLN2 FL at a fixed buffer composition (Figure 4.2C and B, left).
To clearly compare the LLPS properties of UBQLN4 FL and UBQLN2 FL, we overlayed
the turbidity curves of the same concentration (35 μM) for both proteins under identical
buffer conditions (Figure 4.2B, right). In addition, temperature-concentration phase
boundaries of UBQLN4 FL and UBQLN2 FL were mapped out by using two
concentrations of UBQLN4 FL (35 μM and 50 μM) and two concentrations of UBQLN2
FL (20 μM and 35 μM) (Figure 4.2D). Cloud point temperatures were determined by
fitting a Four Parameter Logistic Regression model to the data (Figure 4.2F) (see
section 4.4.4 for details).
Despite high sequence similarities, UBQLN4 FL and UBQLN2 FL showed different
temperature-dependent LLPS behavior at same conditions. The concentrations required
for phase separation of UBQLN2 FL was lower than that of UBQLN4 FL. Specifically, 35
μM of UBQLN2 FL phase separates at 32 ºC, whereas UBQLN4 FL with the same
concentration doesn’t phase separate until the temperature reaches 44 ºC. The phase
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diagram provides us a clear comparison between UBQLN4 and UBQLN2 (Figure 4.2D).
The phase boundary of UBQLN2 FL is on the left of UBQLN4 FL, suggesting that the
concentration required for UBQLN2 to phase separate is lower than UBQLN4.
Furthermore, to study the oligomerization propensity of UBQLN4 and to compare
between UBQLN2 FL and UBQLN4 FL, we performed size exclusion chromatography
(SEC) under non-phase separating conditions and collected some preliminary data
(Figure 4.2E). Recent work from our lab showed that UBQLN2 oligomerizes and this
property is the pre-requisite for UBQLN2 to phase separate (Dao et al. 2018). The data
showed that UBQLN2 FL eluted earlier than UBQLN4 FL. Several possibilities include
the proline-rich region that is present in UBQLN2. This segment may be in an extended
conformation, which increases the hydrodynamic radius of the protein. A second
possibility is a difference in oligomerization propensity of UBQLN2 and UBQLN4. SEC
data under different concentrations are needed to figure out the oligomerization
propensity of the proteins.
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Figure 4.2. UBQLN4 FL and UBQLN2 FL phase separate differently
(A) Domain architecture of UBQLN2 FL and UBQLN4 FL. (B) Left: raw turbidity assay
data of UBQLN2 FL as shown in (C). Middle: raw turbidity assay data of UBQLN4 FL as
shown in (C). Right: overlay of raw turbidity assay data of 35 μM UBQLN2 FL and 35
μM UBQLN4 FL as shown in (C). Error bars represent standard deviation. (C) Average
turbidity assays as a function of temperature comparing LLPS of UBQLN4 FL and
UBQLN2 FL under different concentrations in 20 mM HEPES and 400 mM NaCl (pH 7).
Each concentration was performed at least twice to ensure reproducibility (UBQLN4 FL
assay was repeated 6 times at 50 μM; UBQLN4 FL assay was repeated twice using 35
μM and 25 μM protein concentrations; UBQLN2 FL assay was repeated twice using 35
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μM and 20 μM). Error bars represent standard deviation. (D) Temperature-concentration
phase boundaries for UBQLN4 FL (purple) and UBQLN2 FL (red). (E) SEC of UBQLN2
FL and UBQLN4 FL at 10 μM in 20 mM HEPES (pH 7) without NaCl. (F) Representative
fitting curves of Four Parameter Logistic Regression model, which was used to
determine could point temperatures of the protein samples under different
concentrations. Blue dots are the raw data points and red line is the fitting curve. Fitting
was done in MatLab.
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4.2.3 Expression and purification of UBQLN4 deletion constructs
To dissect the why UBQLN4 and UBQLN2 exhibit different phase behavior, we
aimed to determine the domains important for UBQLN4 LLPS. For this part, we
designed different domain deletion constructs and studied their phase separation
behavior. Towards our objective, we constructed C-terminal constructs UBQLN4 86–601
(which contained all the domains except for UBL), UBQLN4 262–601 (which contained
all the domains except for UBL and STI1-I), UBQLN4 393–601 (which contained the
entire C-terminal STI1-II region and UBA domain), and 464–624 (which is the equivalent
construct of UBQLN2 450C, the minimum length of UBQLN2 that undergoes LLPS)
(Figure 4.3A). I successfully expressed UBQLN4 86C, 262C, 393C and 464C (with Histag) constructs and have successfully purified UBQLN4 86C (Figure 4.3B). However,
further modification to purification strategies is needed for UBQLN4 262C, 393C and
464C.
Similar as UBQLN4 FL, UBQLN4 86C was expressed in Rosetta 2 cells and was
purified by “salting out” process, please see section 4.4.2 for purification process. The
protein was further purified by cation exchange column and SEC. SDS-PAGE gel
showed > 95% purity of the protein samples (Figure 4.3B). Mass spectrometry (MS)
was used to verify the identify and molecular weight of the protein samples (Figure
4.3G).
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We originally attempted to express UBQLN4 262C in Rosetta 2 cells, but no protein
expression was observed. Therefore, we transformed the DNA into NiCo21(DE3) cells,
and this resulted in decent expression. Similar as UBQLN4 FL and 86C, 262C was
lysed in the same Tris lysis buffer and purified by the same process. Because SDSPAGE gel showed contaminations (Figure 4.1D), we further purified the construct with
cation exchange column by eluting the protein with an increasing salt gradient, and
SEC. The chromatography purification showed no improvement (Figure 4.1E).
We originally tried to express UBQLN4 393C in Rosetta 2 cells using LB media, but
no protein expression was observed. Similarly, we transformed the DNA into
NiCo21(DE3) cells, however, this attempt did not result in any detectable expression.
Since Terrific broth (TB) has been shown to enhance the expression of tricky proteins in
E. coli (Rosano and Ceccarelli 2014), we used TB media instead of LB media for
expressing 393C. Luckily, the Rosetta 2 cells grow and express 393C well in TB media.
Similar as UBQLN4 FL, 86C and 262C, 393C was lysed in Tris lysis buffer and NaCl
was added to lysate supernatant to induce phase separation, however, no phase
separation was observed. Results from an SDS-PAGE gel of both the lysate
supernatant and the pellet suggested that the 393C protein was in the pellet instead of
the supernatant (Figure 4.3C). One possible reason may be that 393C phase separates
under low salt concentration. In addition, it is also possible that poor solubility of the
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protein pushed it out of the supernatant. To improve protein solubility, I used GoldBio
lysis buffer, which contains organic detergents to improve protein solubility and enhance
the extraction of the protein. I used the GoldBio lysis buffer to resuspend the pellet, and
“salting out” process was used to carry out the purification protocol, nevertheless, SDSPAGE gel showed contaminations (Figure 4.3D). SEC was used to further purify the
protein, but this did not improve purification (Figure 4.1E).
UBQLN4 464C was expressed in Rosetta 2 cells using Lysogeny broth (LB) media,
but no protein expression was observed. Transformation of the DNA into NiCo21(DE3)
cells did not improve expression. Moreover, TB media did not help with cell growth and
protein expression either. As a result, all the attempts we tried to modify expression
failed. However, another UBQLN4 464C construct, which has a 6xcHis tag at the end of
C-terminus, showed expression in Rosetta 2 cells with Lysogeny broth (LB) media. Tris
lysis buffer was used to lyse the cells, and the same “salting out” process was adopted
to purify the protein. As shown by SDS-PAGE gel (Figure 4.1D), the protein was not
pure. SEC failed to purify the protein (Figure 4.1F). Further purification process is
needed. It might be worthwhile to purify the protein by Ni-NTA Column since the protein
has an affinity tag.
Together, different expression conditions were optimized to obtain the best
expression of the constructs (Table 4.1). Expression of UBQLN4 464C needs to be
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tackled, moreover, further purification of UBQLN4 262C, 393C and 464C are needed.

UBQLN4 construct

Cells

Media

Expression
temperature (°C)

FL

Rosetta 2

LB

37

86C

Rosetta 2

LB

37

262C

NiCo21(DE3)

LB

37

393C

Rosetta 2

TB

37

464C

Rosetta 2

LB

37

Table 4.1. Optimal expression conditions for UBQLN4 deletion constructs.
Proteins were expressed in E. coli cells, including Rosetta 2 cells and NiCo21(DE3)
cells. Lysogeny broth (LB) media or terrific broth (TB) media are used for protein
expression. All the constructs were expressed at 37 °C.
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Figure 4.3 Expression and purification of UBQLN4 deletion constructs used in
this study.
(A) Domain architecture of UBQLN4 and UBQLN2 equivalent deletion constructs. The
molecular weights of the proteins are: UBQLN4 FL, 63852 Da; 86C, 54478 Da; 262C,
36209 Da; 393C, 22385 Da; 464C (with 6 x His), 15355 Da. (B) SDS-PAGE gel showed
the purity of UBQLN4 86C, including 2 stocks. The molecular weight of UBQLN4 86C is
54478 Da. (C) SDS-PAGE gel showed that UBQLN4 393C was in the pellet instead of
supernatant after being lysed by Tris lysis buffer (sup represents supernatant; pel
represents pellet). (D) SDS-PAGE gel showed expression of UBQLN4 262C, 393C and
464C, but further purification is needed. (E) SDS-PAGE gel showed the purification of
UBQLN4 262C by cation exchange column (left) and SEC (right), and the result
indicated that purification methods need to be improved. (F) SDS-PAGE gel showed the
purification of 393C (left) and 464C (right) by SEC. The result indicate that SEC cannot
separate the desired protein from the contamination. (G) Electrospray ionization mass
spectrometry (ESI-MS) of UBQLN4 86C. Due to the low resolution of ESI-MS and the
big size of UBQLN4 86C, the first molecular weight showed by MS (27236 Da) was
lower than the calculated value (54478 Da). When doubled, the observed molecular
weight was 54472 Da, which is similar to the calculated molecular weight (54478 Da).
177

4.2.4 UBQLN4 86C phase separates in a different manner than UBQLN2 109C
To test whether UBQLN4 86C and UBQLN2 109C phase separate in a similar way,
we conducted turbidity assays by monitoring the change of A600 values between 16 °C
and 60 °C of samples containing 50 μM, 35 μM or 25 μM of UBQLN4 86C and 20 μM or
10 μM of UBQLN2 109C at a fixed buffer composition (Figure 4.4A and C). To have a
clear comparison between UBQLN4 86C and UBQLN2 109C, we overlayed the turbidity
curves of similar concentrations, 25 μM of UBQLN4 86C and 20 μM of UBQLN2 109C
(Figure 4.4C, right). In addition, temperature-concentration phase boundaries of
UBQLN4 86C and UBQLN2 109C were mapped out by using two concentrations of
UBQLN4 86C (35 μM and 50 μM) and two concentrations of UBQLN2 109C (20 μM and
10 μM) (Figure 4.4B). Cloud point temperatures were determined by fitting a Four
Parameter Logistic Regression model to the data (Figure 4.4E) (see section 4.4.4 for
details).
Turbidity data suggested that UBQLN4 86C and UBQLN2 109C showed different
temperature-dependent LLPS behaviors. The concentrations required for phase
separation of UBQLN2 109C was much lower than that of UBQLN4 86C. Specifically,
20 μM of UBQLN2 109C phase separates at 20 ºC, whereas UBQLN4 86C with a
higher concentration (25 μM) doesn’t phase separate until the temperature reaches 52
ºC. The phase diagram provides us a clear comparison between the two UBL deletion
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constructs (Figure 4.4B). The phase boundary of UBQLN2 109C is on the left of
UBQLN4 86C, suggesting that the concentration required for UBQLN2 109C to phase
separate is lower than UBQLN4 86C.
Similar as FL proteins, SEC assays were conducted to study the oligomerization
propensity of the two UBL deletion constructs (Figure 4.4D). The data showed that
UBQLN2 109C eluted slightly earlier than UBQLN4 86C. To determine the
oligomerization propensity of the proteins and to draw detailed conclusions, SEC under
different concentrations needs to be performed.
To study droplet morphology of UBQLN4 86C, we used bright field microscopy to
monitor the shape and size of the droplets. LLPS was induced with 400 mM NaCl, and
all samples were incubated in 37 °C for 15 minutes before imaging. Droplets were round
and grew in size over time as a result of droplet fusion, which suggested liquid-like
behavior for UBQLN4 86C. (Figure 4.4F).
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Figure 4.4. UBQLN4 86C and UBQLN2 109C phase separate differently
(A) Average turbidity assays as a function of temperature comparing LLPS of UBQLN4
86C and UBQLN2 109C under different concentrations in 20 mM HEPES and 400 mM
NaCl (pH 7). Each concentration was performed at least twice to ensure reproducibility.
(UBQLN4 86C assay was repeated 6 times at 50 μM protein concentration; UBQLN4
86C assay was repeated 2 times at 35 μM and 25 μM; UBQLN2 109C assay was
repeated 2 times at 20 μM and 10 μM). Error bars represent standard deviation. (B)
Temperature-concentration phase boundaries for UBQLN4 86C (orange) and UBQLN2
109C (black). (C) Left: raw turbidity assay data of UBQLN2 109C as shown in (B).
Middle: raw turbidity assay data of UBQLN4 86C as shown in (B). Right: overlay of raw
turbidity assay data of similar concentrations 20 μM UBQLN2 109C and 25 μM
UBQLN4 86C as shown in (B). Error bars represent standard deviation. (D) SEC of
UBQLN2 109C and UBQLN4 86C at 10 μM in 20 mM HEPES (pH 7) without NaCl. (E)
Representative fitting curves of Four Parameter Logistic Regression model, which was
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used to determine could point temperatures of the protein samples under different
concentrations. Blue dots are the raw data points and red line is the fitting curve. Fitting
was done in MatLab. (F) Bright field microscopy of UBQLN4 86C over 15 minutes of
incubation at 37 °C using 70 μM protein in 20 mM HEPES (pH 7) buffer, in presence of
400 mM NaCl. Scale bar, 5 μm.
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4.2.5 Deletion of UBL domain promotes LLPS in UBQLN2, but not in UBQLN4
Despite high sequence similarities, equivalent UBQLN4 and UBQLN2 C-terminal
constructs showed different temperature-dependent LLPS behavior under the same
conditions. The concentrations required for phase separation of both UBQLN2 FL and
109C were lower than those of UBQLN4 proteins. The phase diagram provides us a
clear comparison between UBQLN4 and UBQLN2 (Figure 4.5). The phase boundaries
of UBQLN4 FL and 86C are similar whereas the phase boundaries of UBQLN2 FL and
109C are distinct.
Previous work from our lab showed that STI1-II region, residues in the linker region
between PXX and UBA, and UBA domain play a key role in UBQLN2 LLPS. UBQLN2
self-interactions among these residues promotes LLPS (Dao et al. 2018). However,
UBQLN2 109C LLPS data suggest that the UBL inhibits UBQLN2 phase separation, as
removal of the UBL domain lowers the saturation concentration of protein threshold for
phase separation. Further NMR experiment revealed that UBL domain of UBQLN2
interacting with UBA domain and the linker region between PXX and UBA (residue 555570) disrupt the stickers from involving in oligomerization that drive LLPS (Dao et al.
2018; Zheng, Galagedera, and Castañeda 2021). Consequently, removal of UBL
domain can release residues 555–570 and UBA domain and enables these two regions
to participate in LLPS-mediating interactions.
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However, the phase diagram of UBQLN4 constructs suggests that UBL domain is
not vital in the phase behavior of UBQLN4, as UBQLN4 FL and 86C phase boundaries
are close to each other. The result may be because that UBL domain in UBQLN4
interacts weakly with the residues involved in oligomerization, or does not interact with
other segments of UBQLN4 at all. The differences in the effects of the UBL domain
deletion on phase behavior of UBQLNs suggest that the domain contributions to LLPS
are different among UBQLN proteins. Further experiments are needed to determine the
regions essential in UBQLN4 oligomerization and whether UBL is interacting with the
LLPS-driving stickers.
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Figure 4.5. Phase boundaries for UBQLN4 and UBQLN2 constructs.
Temperature-concentration phase boundaries for UBQLN4 FL (purple), UBQLN4 86C
(orange) and UBQLN2 FL (red) and UBQLN2 109C (black). Each concentration was
performed at least twice to ensure reproducibility (UBQLN4 FL assay was repeated 6
times under 50 μM; UBQLN4 FL assay was repeated 2 times under 35 μM; UBQLN4
86C assay was repeated 6 times under 50 μM; UBQLN4 86C assay was repeated 2
times under 35 μM; UBQLN2 FL assay was repeated 2 times under 35 μM and 20 μM;
UBQLN2 109C assay was repeated 2 times under 20 μM and 10 μM). Error bars
represent standard deviation. Representative fitting curves are shown in Figure 4.2F
and 4.4E.
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4.2.6 Ubiquitin binding disrupts UBQLN4 LLPS
Similar to UBQLN2, UBQLN4 is also an UBL-UBA shuttle protein. UBQLN4
contains a ubiquitin-binding (UBA) domain which interacts with Ub molecules of
ubiquitinated substrates (Ko et al. 2004). As shown in Chapter 3 and previous work by
our lab, Ub binding affect UBQLN2 phase behavior (Dao et al. 2018). To see if Ub
binding affects UBQLN4 LLPS, we conducted spectrophotometric assays of UbUBQLN4 mixtures at a molar ratio of 1:1 (Figure 4.6). Cloud point temperature
increased significantly for both UBQLN4 FL and 86C with the addition of Ub, consistent
with the idea that Ub drives UBQLN4 condensate disassembly. As discussed in chapter
3.3, specific binding between Ub and UBQLN2 reverses UBQLN LLPS, which is an
example of polyphasic linkage (Wyman and Gill 1980; Dao et al. 2018). In this case, Ub
binding shifts the UBQLN LLPS transition such that the dilute phase of UBQLN is
stabilized and the dense phase is destabilized (Dao et al. 2018). The data suggested
that Ub binding may disrupt the interactions needed to mediate UBQLN4 phase
separation. More experiments are needed to clarity the effect Ub plays on UBQLN4
LLPS.
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Figure 4.6. Ubiquitin binding disrupts UBQLN4 LLPS
(A) Average turbidity assay as a function of temperature for mixtures containing both Ub
and UBQLN4 proteins at molar ratio [UBQLN4]:[Ub] = 1:1. Assays consisted of 50 mM
UBQLN4 (FL and 86C) in pH 7 HEPES buffer with 400 mM NaCl. (B) Top: raw turbidity
assay data of UBQLN4 FL with the addition of Ub, as shown in (A). Bottom: raw turbidity
assay data of UBQLN4 86C with the addition of Ub, as shown in (A). Each assay with
the addition of Ub was performed twice to ensure reproducibility. Error bars represent
standard deviation.
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4.3 Discussion and Conclusions
In this work we showed that, like UBQLN2, UBQLN4 exhibits temperature- and
concentration-dependent LLPS behavior. However, FL UBQLN4 and UBQLN4 Cterminal construct 86C showed different temperature-dependent LLPS behavior
compared to its UBQLN2 equivalent, FL and 109C. UBQLN2 phase separation is more
promoted compared with UBQLN4 under the same condition. Interestingly, UBQLN4 FL
phase separates in similar manner as 86C, whereas UBQLN2 109C exhibits different
phase transitions compared with UBQLN2 FL by promoting its LLPS drastically. By
comparing the turbidity data of UBQLN4 FL, 86C and UBQLN2 FL and 109C, we
learned that the different temperature-dependent LLPS profiles stem from the difference
in domains involved in interactions that are important for LLPS.
Previously our lab discovered the domains and sequences involved in
oligomerization that drive LLPS, which include STI1-II region, some residues in the
linker region between PXX and UBA domain, and UBA domain (Dao et al. 2018). It has
been shown that UBL domain interacts with STI1-I domain, UBA domain and the linker
region between UBA and PXX (residue 555-570) (Zheng, Galagedera, and Castañeda
2021). The removal of the UBL domain in UBQLN2 (109C construct) promotes
UBQLN2 LLPS significantly (Zheng, Galagedera, and Castañeda 2021). This
enhancement in phase separation behavior is due to several reasons. First, removal of
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UBL can release UBA domain and residue 555-570, thus enables these two regions to
participate in UBQLN2 self-interactions that drive LLPS; second, deleting UBL may
affect the interactions that involve STI1-II, which is the main LLPS-driving domain of
UBQLN2, but whether UBL interacts with STI1-II region is unknown (Zheng,
Galagedera, and Castañeda 2021). However, based on the turbidity assays and phase
diagrams, UBQLN4 86C doesn’t enhance the phase behavior of UBQLN protein as
UBQLN2 109C does, suggesting that UBL domain of UBQLN4 doesn’t affect its phase
behavior drastically. More experiments are needed to investigate the domain and
sequence contributions of UBQLN4 LLPS, and to determine the interactions among
domains that affect LLPS.
To achieve the goal, next steps include the following. First, it is necessary to
characterize other UBQLN4 deletion constructs, including 262C, 393C and 464C. To
understand how differently UBQLN2 phase separates compared with UBQLN4, and to
determine how domains of UBQLN4 modulate its phase behavior, the entire low
concentration arm of the phase diagram should be mapped out by turbidity assays.
Secondly, NMR titration experiments of UBQLN4 at different concentrations should be
performed to determine the sticker regions important for self-interactions. By running
TROSY-HSQC experiments of UBQLN4 at different concentrations, we can track the
chemical shifts of peaks, which represent the backbone amide of each residue. By
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analyzing the chemical shift perturbations, we can determine the residues involved in
oligomerization, which has been shown to be the prerequisite of UBQLN LLPS (Dao et
al. 2018). Third, to study the oligomerization property of the constructs, we can conduct
SEC experiments under different concentrations. Fourth, microscopy experiments using
the UBQLN4 deletion constructs should be performed to study the morphology of the
droplets. Since UBQLN1, 2 and 4 share similar domain architectures and all serve as
shuttle factors in cells, it will be interesting to study how these differences across
UBQLNs affect UBQLN LLPS properties and their functions in cell.
This project also showed that Ub binding disrupts UBQLN4 LLPS. However,
questions remain: is the binding between Ub and UBQLN2 or UBQLN4 the same? How
do polyUb chains of different linkages affect UBQLN4 phase separation behavior? To
answer these questions, more detailed studies should be done, including turbidity
assays and microscopy experiments on how different polyUb chains affect UBQLN4
phase separation, and NMR experiments to map out the interactions between Ub
chains and UBQLN4.
Furthermore, we successfully obtained a series of UBQLN4 C-terminal constructs,
including FL, 86C, 262C, 393C and 464C. These various constructs provide powerful
platforms for future studies of UBQLN4 self-interactions, as well as studies of UBQLN4
binding partners.
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4.4 Material and Methods
4.4.1 PCR Mutagenesis
Primers were designed by the author and synthesized by Invitrogen. A tryptophan
codon was added to the C-terminal end of UBQLN4 393C and UBQLN4 464C
(constructs with His-tag) to facilitate determination of protein concentration. For all the
UBQLN4 E. coli codon-optimized constructs, including UBQLN4 86C, UBQLN4 262C,
UBQLN4 393C and UBQLN4 464C, primers were first phosphorylated using the Thermo
PNK enzyme kit. UBQLN4 deletion constructs were generated from FL UBQLN4 using
Phusion Site-Directed Mutagenesis Kit (Thermo Scientific). Primers, template, dNTP,
Phusion buffer, and Thermo Phusion enzyme were then combined with the
recommended ratio. A Biorad T100 thermocycler was used for PCR reactions. The PCR
products were then subjected to Dpn1 digestion followed by T4 ligase reactions and
used to transform NEB Turbo competent cells. DNA of all constructs was confirmed
using the Genewiz DNA sequencing service.

4.4.2 UBQLN4 Constructs Growth and Purification
E. coli Rosetta 2 (DE3) pLysS cells were transformed with a pET24b(+) plasmid
containing the desired DNA sequence for the UBQLN2 FL, UBQLN4 86C, UBQLN4
393C or UBQLN4 464C gene. E. coli NiCo 21 cells were transformed with a pET24b(+)
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plasmid containing the desired DNA sequence for the UBQLN4 262C gene. The cells
containing UBQLN4 FL, UBQLN4 86C, UBQLN4 262C and UBQLN4 464C (with Histag) were grown in Luria-Bertani (LB) broth at 37 °C while the cells containing UBQLN4
393C were grown in Terrific Broth (TB) broth at 37 °C. The cells were collected after
inducing expression overnight. The cell pellet was frozen and thawed before cells were
resuspended in lysis buffer. 50 mM Tris-Cl, 0.1 mg/mL DNAse, 5 mM MgCl2, and 0.5
mM PMSF, pH 8 buffer was used as lysis buffer for UBQLN4 FL, UBQLN4 86C, UBQLN
262C and UBQLN4 464C. GoldBio bacterial cell lysis buffer was used to lyse UBQLN4
393C. The pellet was resuspended and centrifuged at 20,000g for 20 min. UBQLN4
proteins were purified via the same “salting out” process as described in Chapter 2.4.1.
NaCl was added to the room temperature cleared lysate to the final concentration of 0.5
M - 1 M. UBQLN4 droplets were pelleted and then resuspended in cold, pH 7, 20mM
HEPES, 0.1 mM TCEP, 0.5 mM EDTA, 0.02% sodium azide buffer.
Further chromatography purification was conducted for UBQLN4 FL and UBQLN4
86C constructs. UBQLN2 FL was loaded onto HPSP cation exchange column (GE
Healthcare) and washed by a pH=7 buffer containing 20mM HEPES, 0.1 mM TCEP, 0.5
mM EDTA, 0.02% sodium azide, and was eluted by a pH=8 buffer of the same
ingredients. Protein was collected, concentrated, and purified by size exclusion
chromatography (HiLoad 16/600 superdex 2000 column). UBQLN2 86C was loaded
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onto HPSP cation exchange column and washed by a pH=4 buffer containing 50 mM
HN4Ac and 0.02% sodium azide and was eluted by a pH=7 buffer containing 20mM
HEPES, 0.1 mM TCEP, 0.5 mM EDTA, 0.02% sodium azide. Protein was collected,
concentrated, and purified by size exclusion chromatography (HiLoad 16/600 superdex
2000 column). SDS-PAGE gels were performed to confirm the purity of the proteins.
Purified proteins were frozen at -80°C. The identity and molecular weight of UBQLN4 FL
and 86C were verified using electrospray mass spectrometry in positive mode on a
Shimadzu 8040 MS.
After salting out process, left over NaCl in UBQLN4 262C, 393C and 464C was
removed through HiTrap desalting column (GE Healthcare). Further purification
methods need to be built up for UBQLN4 262C, 393C and 464C.
UBQLN2 FL protein expression and purification was discussed in Chapter 2.4.1.

4.4.3 Spectrophotometric Absorbance/Turbidity Measurements
Turbidity assays with UBQLNs proteins only: Protein solutions were prepared by
diluting UBQLN4 stock solution into cold HEPES buffer (pH 7, 20mM HEPES, 0.1 mM
TCEP, 0.5 mM EDTA, 0.02% sodium azide). The concentrations of the protein solutions
were doubled compared with the desired final sample concentrations. The protein
samples were prepared by mixing UBQLN4 protein solutions and the cold NaCl buffer
192

(pH 7, 800 mM NaCl, 20mM HEPES, 0.1 mM TCEP, 0.5 mM EDTA, 0.02% sodium
azide) of the same volume. All the solutions were kept on ice for at least 5 minutes
before mixing. Final samples contain 400 mM NaCl, unless otherwise noted.
Absorbance at 600 nm was recorded as a function of temperature by a Cary 3500 UVVis spectrophotometer using a temperature ramp rate of 1 °C/min increasing from 16 °C
to 60 °C. Net absorbance values were recorded after subtracting the absorbance value
of a buffer control. At least two trials (n = 2) were conducted to ensure reproducibility.
Data were plotted using Mathematica (Wolfram Research).
Turbidity assays on how ubiquitin affects UBQLN4 droplets formation: Protein
samples were prepared by mixing protein solution containing UBQLN4 and Ub (the
concentrations of the protein stock solutions were doubled compared with the sample
concentrations) and cold NaCl buffer (pH 7, 800 mM NaCl, 20mM HEPES, 0.1 mM
TCEP, 0.5 mM EDTA, 0.02% sodium azide) at 1:1 stoichiometry. All the solutions were
kept on ice for at least 5 minutes before mixing. Absorbance at 600 nm was recorded as
a function of temperature by a Cary 3500 UV-Vis spectrophotometer using a
temperature ramp rate of 1 °C/min increasing from 16 °C to 60 °C. Net absorbance
values were recorded after subtracting the absorbance value of a buffer control. At least
two trials (n = 2) were conducted to ensure reproducibility. Data were plotted using
Mathematica (Wolfram Research).
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4.4.4 Phase diagram measurements
For the LCST (lower critical solution temperature) phase transition, i.e. mapping the
phase boundary as temperature is increased, process was the same as described in
Chapter 2.4.3. Protein samples were prepared as described for the turbidity
measurements. Absorbance at 600 nm was recorded as a function of temperature by a
Cary 3500 UV-Vis spectrophotometer using a temperature ramp rate of 1 °C/min
increasing from 16 °C to 60 °C. At least two trials (n = 2) were conducted using two
different concentrations of UBQLN4 proteins for each arm. Cloud point temperatures
were determined by fitting a Four Parameter Logistic Regression model to the data.
𝑦=𝑑+

𝑎−𝑑
𝑥 𝑏
𝑐

(Equation 1)

1+( )

Cloud point temperatures used were the points of inflection (c). Cloud point
temperatures were then used to define the coexistence curve as a function of protein
concentration. Fitting and plotting of data were done with MatLab.

4.4.5 Bright-field Imaging of Phase Separation
UBQLN4 FL and 86C constructs were prepared to contain 70 μM protein in 20 mM
HEPES, 400 mM NaCl, 0.1 mM TCEP, and 0.5 mM EDTA (pH 7). Samples were added
to MatTek glass bottom dishes that had been coated with 5% bovine serum albumin
(BSA) to minimize changes as a result of surface interactions, and incubated at 37 oC
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for 15 mins. Phase separation was imaged on an ONI Nanoimager (Oxford
Nanoimaging Ltd, Oxford, UK) equipped with a Hamamatsu sCMOS ORCA flash 4.0 V3
camera using an Olympus 100×/1.4 N.A. objective. Images were prepared using Fiji
(Schindelin et al., 2012) and FigureJ plugin (Mutterer and Zinck, 2013).

4.4.6 Size Exclusion Chromatography
Purified UBQLN4 FL and 86C, and UBQLN2 FL and 109C constructs at 10 μM were
subjected to chromatography over a ENrichTM SEC 650 10 x 300 column (Biorad) on a
Biorad NGC FPLC system. Experiments were conducted using 250 μL of protein at
ambient temperature using 1 mL/min flow rate in pH 6.8 buffer containing 20 mM
HEPES, 0.1 mM TCEP, and 0.5 mM EDTA (pH 7) with no added NaCl.
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Chapter V:
Conclusions and future directions
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5.1 Introduction
Cells form and accumulate misfolded proteins or aggregates even under normal
growth conditions (Balch et al., 2008; Chen et al., 2011; Takalo et al., 2013; Voisine et
al., 2010), let alone the existence of environmental stresses, metabolic stresses and
pathological stresses such as aging and cancer (Chen et al., 2011; Haigis and Yankner,
2010). To content with potential problems and to maintain proteome integrity, eukaryotic
cells adopt protein quality control (PQC) strategies to monitor and maintain protein
homeostasis (Bukau et al., 2006; Frydman, 2001; Hartl and Hayer-Hartl, 2009), which
include protein refolding, degrading and sequestration of misfolded proteins (Chen et
al., 2011; Hartl and Hayer-Hartl, 2009; Powers et al., 2009; Takalo et al., 2013). Each
strategy has its strengths and risks, but how PQC network components crosstalk and
decide whether a misfolded protein should be degraded, sequestered or sent to be
refolded remains a big question.
The overarching goal of our lab is to elucidate how PQC mechanisms function on
molecular and cellular levels. In this work, three projects were carried out to address our
goals, with two projects targeted to understand how the UBQLN family of proteins,
which are UBL-UBA shuttle proteins involved in PQC, form droplets via phase
separation (Chapter 2 and 4), and one on how UBQLN2 liquid-liquid phase separation
behavior is regulated by interactions with PQC proteins, specifically ubiquitin and
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polyubiquitin chains (Chapter 3).

5.2 Hydrophobic amino acid substitutions in the sticker region alter
UBQLN2 LLPS
Characterizing multivalent interactions that drive phase separation is important in
studies of LLPS systems. But since these interactions are usually transient and weak,
this study can be challenging. As a compromise, a “sticker and spacer” framework from
associative polymers was developed, which categorizes polypeptide segments to be
classified as a sticker or a spacer region (Choi et al., 2019, 2020; Harmon et al., 2017;
Posey et al., 2018; Wang et al., 2018). Residues that promote self-interactions and
phase separation are called “stickers” and the sequences separating stickers are called
“spacers (Choi et al., 2019; Martin et al., 2020).
To determine the physical forces that drive UBQLN2 phase separation, we applied
the “sticker” and “spacer” framework to our NMR-derived molecular map of selfinteractions, whereby “stickers” were those residues that exhibited significant
concentration-dependent CSPs and “spacer” residues were those that did not (Dao et
al., 2018). Previous studies found that the temperature-dependent LLPS behavior of a
protein is largely determined by its overall amino acid composition (Dignon et al., 2019;
Martin and Mittag, 2018). Since we found that the stickers in UBQLN2 are mostly
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composed of amino acids with hydrophobic or polar properties, we hypothesized that
the main driving force of UBQLN2 phase separation are hydrophobic interactions.
To test our hypothesis, we systematically introduced all 19 amino acids at three
“sticker” and two “spacer” positions, leading to a UBQLN2 library of 95-point mutants.
Turbidity assays that monitored lower critical solution temperature (LCST) and upper
critical solution temperature (UCST) phase transitions were conducted to map out the
low concentration arm of the temperature-concentration phase diagrams. From the
turbidity assay screen and phase diagrams, we further determined that LLPS of
UBQLN2 450-624 is largely driven by hydrophobic amino acids (Yang et al., 2019).
Hydrophobic amino acid substitutions in sticker regions, but not spacer regions,
increased UBQLN2 oligomerization propensity, altered the shape of the temperatureconcentration phase diagrams and changed liquid-to-solid phase transitions. Our results
demonstrated that single amino acid substitutions followed a molecular code to tune
phase transition behavior of biopolymers (Yang et al., 2019). Moreover, our data
showed that some mutations in the stickers exhibited increased aggregation propensity
(such as P497H, P497S, and P506T), which is consistent with studies from other labs
that certain UBQLN2 disease mutants show increased propensity to aggregate
(Ceballos-Diaz et al., 2015; Kim et al., 2018; Osaka et al., 2016; Sharkey et al., 2018).
This work can be used to elucidate effects of disease-linked mutations in phase203

separating systems, and to design thermoresponsive biopolymers. In addition, this work
showed the excellent property that UBQLN2 protein presents in using UBQLN2 as a
model LLPS system. Future studies should take advantage of it to design and
benchmark analytical models and molecular simulations of phase separation.

5.3 Compact Ub4 chains (K11, K48) largely drive disassembly of
UBQLN2 condensates, whereas flexible Ub4 chains (K63, M1) promote
UBQLN2 LLPS
Our lab previously found out that some regions in STI1-II domain and UBA domain
are important for mediating UBQLN2 oligomerization (Dao et al., 2018) which is
important for its LLPS (Dao et al., 2019). Interestingly, we also discovered that Ub
binding modulates UBQLN2 phase behavior, and K48-Ub4, which generally signals for
targeting proteins to the proteasome for degradation, drives the disassembly of
UBQLN2 droplets in vitro (Dao et al., 2018). In addition, recent studies showed that p62
forms condensates with polyUb chains, which acts as a precursor of autophagosomes
(Sun et al., 2018; Zaffagnini et al., 2018). These data strongly suggest that LLPS plays
a functional role in cells. UBQLN2 could be recruited to biomolecular condensates, and
interactions with polyUb chains promote a ligand-induced phase transition which may
be also related to their functions in cells.
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To study how polyUb chains regulate UBQLN2 LLPS, we enzymatically assembled
polyUb chains of different linkages (K48, K63, K11 and M1) and lengths (Ub2, Ub3 and
Ub4). We observed LLPS by UV-Vis spectrophotometry assays and microscopy, and
obtained experimental phase diagrams. The data showed that addition of the small Ub
chains (mono-Ub and Ub2) eliminated the phase separation of UBQLN2, while longer
polyUb chains (Ub3 and Ub4) enhanced LLPS before eliminating it. Notably, the binding
affinity between mono-Ub and UBQLN2 450C is around 3 μM, which shows a slightly
stronger binding than the one between HOTag-Ub and UBQLN2 450C (Kd around 16
μM), however, HOTag-Ub promotes UBQLN2 LLPS drastically compared with mono-Ub,
suggesting that the difference in polyUb modulating UBQLN2 LLPS does not stem from
differences in binding affinity. In addition, compact Ub4 chains (K11, K48) largely drove
disassembly of UBQLN2 condensates, whereas extended and flexible Ub4 chains (K63,
M1) enhanced phase separation by acting as scaffolds to promote the interactions of
polyUb chains and UBQLN2.
This work indicated that PQC components such as polyUb chains regulate the LLPS
of UBQLN2. However, the questions remain, how do shuttle proteins such as UBQLN2
crosstalk among different PQC pathways? Is it done via interactions with polyUb of
different linkages? Do the interactions between polyUb chains and UBQLN2 regulate
their functions in cells?
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5.4 UBQLN4 phase separates in vitro but in a different manner than
UBQLN2
Previously our lab revealed that UBQLN2 undergoes phase separation without the
PXX region (Dao et al., 2018). Since UBQLN4 doesn’t have PXX region and shares
similar structure with UBQLN2, we hypothesized that UBQLN4 can undergo LLPS in
vitro under physiological or near-physiological conditions as well. To test our hypothesis,
we successfully expressed and purified full-length UBQLN4. Turbidity assay data
suggested that the phase behavior of FL UBQLN4 is concentration- and temperaturedependent, but in a different manner compared with FL UBQLN2.
The overall goal of this work was to dissect the phase separation behavior of
UBQLN4, to demonstrate the sequence and structural basis for the phase behaviors of
the protein and to decipher the underlying mechanisms that cause the discrepancies in
the phase behaviors of UBQLN4 and UBQLN2. To achieve these goals, I designed,
cloned and expressed various UBQLN4 C-terminal deletion constructs, which are
equivalent to UBQLN2 C-terminal deletion constructs our lab has recently studied
(Zheng et al., 2021). To date, I successfully purified UBQLN4 86C (construct without
UBL domain), which is equivalent to UBQLN2 109C. I collected preliminary turbidity
assay data and mapped out the temperature-concentration phase diagram. The phase
diagram showed that UBQLN4 and UBQLN4 86C phase separated in a similar way,
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whereas the two UBQLN2 constructs phase separated differently. UBL disrupted
UBQLN2 LLPS drastically, while UBL doesn’t affect UBQLN4 phase behavior much.
More stringent studies are needed to unravel the differences in LLPS properties of
UBQLN4 and UBQLN2.
In this work, we obtained a series of UBQLN4 deletion constructs, including
UBQLN4 86C, UBQLN4 262C, UBQLN4 393C and UBQLN4 464C. These constructs
can be used in future studies to investigate the domain contributions of UBQLN4 LLPS,
as well as compare the difference between UBQLNs. Future studies should investigate
whether the LLPS difference between UBQLN2 and UBQLN4 is related to their
respective functions in cell.

5.5 Future directions
The overarching goal of our lab is to illuminate how LLPS affects PQC, as well as
how PQC components affect UBA-UBL shuttle proteins’ phase behavior and functions in
cell. In this thesis, my research elucidated the molecular driving forces of UBQLN2
LLPS, demonstrated the effect of polyUb chains on UBQLN2 phase behavior, and
highlighted implications on the roles of polyUb chains in PQC, and expanded our
established molecular and cellular approaches to understanding the phase behavior of
another UBA-UBL shuttle protein, UBQLN4.
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In Chapter 2, to determine the physical driving forces of phase separation, we
applied the “stickers” and “spacers” framework from associative polymers (Harmon et
al., 2017; Posey et al., 2018; Wang et al., 2018) to our molecular map of UBQLN2 selfassociation (Dao et al., 2018). We introduced amino acid substitutions at three “sticker”
and two “spacer” positions and obtained the temperature-concentration phase
diagrams. From there we determined that LLPS of UBQLN2 is largely driven by
hydrophobic amino acids (Yang et al., 2019). However, some data can be further
explained and tested by experiments. For example, further experiments are needed to
tease out why Asp and Glu mutations at both stickers and spacers in UBQLN2 reduced
LLPS and significantly compressed the phase-separating regime in the UBQLN2 phase
diagram (Figure 2.2). First, the sticker region contains a Glu, by introducing another
acidic amino acid may introduce repulsive charge-charge interaction that changes
electrostatic energies and prevents UBQLN2 from self-interacting. Second, these acidic
mutations are phosphomimetic substitutions, which may introduce potential posttranslational modifications (PTMs) such as phosphorylation and may modulate phase
separation behavior (Bence, Sampat, and Kopito 2001; Adams 2003). To answer that
question, we can block the only Glu in the sticker region by mutating it into a noncharged amino acid, and study whether and how it regulates LLPS. Future studies can
also study the effect of PTMs on UBQLN2 LLPS.
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In this study, we used UBQLN2 450-624 instead of UBQLN2 FL. Despite the fact
that UBQLN2 450-624 phase separates in a similar manner as UBQLN2 FL, the 450624 construct is not the same as full-length protein, especially as other UBQLN2
domains tune its LLPS behavior (Dao et al., 2018; Zheng et al., 2021). Future study can
expand this project to the FL system to obtain more physiologically-relevant data.
Additionally, as some mutations showed effects on droplet morphology, it is worthwhile
to study whether these mutations in FL UBQLN2 also change droplet morphology and
phase separation behavior, and whether these mutations affect the binding between
UBQLN2 and other PQC components, such as proteasomal receptors, polyUb chains,
and other shuttle proteins. Turbidity assays and microscopy can be conducted to tackle
these questions. Further studies may help to build a model for the formation of
aggregates/inclusions in cells.

In Chapter 3, we learned that interaction between UBQLN2 and the PQC
component polyUb chains regulates its LLPS behavior (Dao et al., 2018). In the future,
we may expand our study to the regulation of UBQLN condensates by other PQC
components. However, due to the complex and everchanging cellular environment, it is
challenging to tease out how different protein-protein interactions regulate LLPS in cells.
In chapter 3, we adopted a reconstituted in vitro system in which individual protein
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levels can be finely tuned and specific protein-ligand interactions can be well studied.
By applying this study to other systems, we can examine if and how the dynamic
interactions between PQC components influence the formation and properties of
UBQLN condensates. Furthermore, it will help us to understand how the up or down
regulation of PQC components contribute to assembly/disassembly of condensates in
the cell stress response, and how dysregulation of protein degradation pathways may
lead to diseases.
To investigate whether and how different PQC components regulate UBQLN LLPS,
we first need to express and purify these PQC components. After obtained pure
materials, we can quantitively map out the effects of each component on UBQLN2
LLPS via turbidity assays. We can obtain phase diagrams as a function of UBQLN2 and
ligand concentrations from the turbidity assays. To study the interaction on a molecular
level, we will conduct NMR spectroscopy experiments, to monitor the conformational
state of UBQLN2 when it is simultaneously bound to the ligands. The changes in droplet
morphology and material properties of UBQLN2 upon binding of partners can be
determined by fluorescence recovery after photobleaching (FRAP) and droplet
relaxation rates experiments. Moreover, to test for conformational changes to UBQLN2
upon PQC component binding, we can perform small-angle neutron scattering (SANS)
and small-angle X-ray scattering (SAXS) experiments. In addition, we can expand all
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these studies to other polyUb chains of any linkage (K6, K11, K27, K29, K33).

To date, the LLPS studies of the UBQLN family have been mainly carried out with
UBQLN2, while the phase separation properties of other UBQLNs are unknown. Given
that fact UBQLN1, 2 and 4 are widely expressed in all tissues with highly similar
structures (Marín, 2014; Zheng et al., 2020), and they all play functional roles in PQC
mechanisms (Ko et al., 2004; Lim et al., 2009; Liu and Tsai, 2020; Şentürk et al., 2019a,
2019b; Suzuki and Kawahara, 2016; Yun Lee et al., 2013), we postulate that all of them
undergo LLPS which may be fundamental in their functions in cell. In Chapter 4, we
showed that UBQLN4 undergoes LLPS as well, but much work has not been
quantitatively analyzed in detail. To determine the domain contributions of UBQLN4 to
LLPS, we will characterize other UBQLN4 deletion constructs, including 262C, 393C
and 464C and obtain the low concentration arm of the phase diagram by turbidity
assays. NMR titration experiments of UBQLN4 at different concentrations should be
performed to determine the sticker regions important for self-interactions. Microscopy
experiments should be conducted to study the morphology of the droplets, and SEC
should be done to determine oligomerization propensity.
From Chapter 3, we learned that PQC components regulate LLPS of UBQLN2,
which may associate with their functions in cell. We learned from this work that UBQLN4
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also undergoes LLPS in vitro. It will be interesting to study how PQC components,
including polyUb chains and ubiquitin receptors of proteasomal units Rpn1, Rpn10, and
Rpn13, affect UBQLN4 LLPS. In addition, we can also study how different UBL-UBA
shuttle proteins interact with each other and affect their functions. For example, turbidity
assays can be used to study the LLPS of UBQLN2 and UBQLN4. NMR spectroscopy
experiments can monitor the conformational change of either UBQLNs when interacts
with to the other components. Since UBQLNs share similar structures and all play a role
in PQC, the additional research will help us to compare among different UBQLNs LLPS
and their canonical functions in cell.
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